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Thymic microenvironments act to control T-cell development and selection. While thymic 
epithelial cells are key regulators of these processes, the thymus also contains multiple 
accessory cells that influence its function. Considering this, the major aim of this thesis is to 
examine the roles of dendritic cells and eosinophils in thymus biology. As regulation of 
thymic DC has previously been correlated to the thymic medulla we focused on the medullary 
regulator LTβR and generated cell type specific LTβR deficient mice. We found LTβR 
signalling regulates mTEC in a cell intrinsic manner, independent of thymic DC maintenance. 
Thymic DC alternatively require LTβR signalling on thymic mesenchyme for their regulation. 
Additionally, disruption of the medulla in Ltbr-/- mice was distinct from tolerance breakdown, 
which we instead found to correlate to reduced DC and impaired negative selection. Further 
we found the CCR7 ligand CCL21 was also required to control thymic DC, suggesting a link 
between these two pathways. Finally, dblGATA mice were used as a model of eosinophil 
deficiency and we identify a role for eosinophils in thymus recovery following sublethal 
irradiation damage. Collectively these findings shed new light on accessory cells during key 
aspects of thymus tolerance and regeneration.  
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CHAPTER ONE:  
GENERAL INTRODUCTION 
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1.1 The Immune System Overview 
The general function of the immune system is to provide essential protection against foreign 
pathogens through mechanisms that prevent destruction and damage caused by pathogenic 
entry into the host. The desperate requirement for a functioning immune system is illustrated 
in individuals where the immune system has become dysfunctional. This is apparent in 
immunodeficiency with underactive immune responses leading to disease manifestation or 
overactive immune activation, in turn assisting the development of autoimmune diseases and 
allergic responses. Acting in addition to this are the environmental and heritable factors which 
can further skew the immune system response (Brodin and Davis, 2017). Therefore, 
regulation of the immune system is pivotal to its correct functioning and host protection.  
The immune system has evolved to contain two main arms; the innate and the adaptive. The 
cells of the innate immune system contains the feature of receptor commonality and as a 
result, innate immune cells have shared expression of recognition molecules that detect a wide 
range of common pathogenic molecular identifiers (Brubaker et al., 2015). However, the 
alternative adaptive arm of the immune system, operates on a far more specific basis with the 
expression of a unique and diverse range of receptors. These receptors have been acquired 
through gene rearrangements during adaptive immune cell development and are able to 
support identification of exclusive pathogenic features thus acting as a far more targeted 
immune response.  Yet despite the diversification in the roles of innate versus adaptive, there 
is vast interplay between these two arms, with the preliminary activation of the adaptive 
immune response heavily being reliant upon initial innate triggering.  
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Upon entry through the primary barrier of the skin by pathogens, surpassing mucosal layers, 
innate immunity is one of the first lines of defence (Turvey and Broide, 2010). It is poised 
with a large number of cells that recognise common pathogenic features but most importantly 
these cells are equipped to initiate a rapid immune response. Innate cells can then become 
activated to supply the factors required to recruit and support the adaptive response (Gasteiger 
and Rudensky, 2014). However in the resting state, cells of the adaptive immune system are 
maintained at a far smaller antigen specific clonal number. As a result, upon activation, these 
selected adaptive immune cells are required to undergo clonal expansion through the process 
of proliferation (Burnet, 1959). Clonal expansion obtains sufficient numbers to support an 
effective response but due to the time taken to increase cell numbers, it results in a delay 
period in the immune response initiation. Despite this, adaptive immunity is longer lived with 
the provision of memory cells allowing for immediate responses upon future re-exposure to 
the same pathogen - providing a vast level of host protection (MacLeod et al., 2010).  
1.1.1 The Innate Immune System 
The innate immune system is composed of both cellular and humoral factors. Focusing firstly 
on the cellular aspect, this category includes cells such as neutrophils, eosinophils, dendritic 
cells (DC), natural killer cells and macrophages. These cells express a plethora of pattern 
recognition receptors (PRRs) that recognise common pathogenic structures known as 
Pathogen Associated Molecular Patterns (PAMPs) which include cell wall components, 
nucleic acids and metabolic products (Janeway and Medzhitov, 2002). The process of PAMP 
recognition through PRRs ultimately acts to trigger a cascade of responses from the innate 
immune cells to support the clearance of the pathogenic material that has entered the host.  
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1.1.1.1 Soluble Pattern Recognition Receptors 
PRRs themselves are either categorised as being soluble as they circulate in plasma, or 
cellular due to receptor expression on the innate cell surface. Soluble PRRs bind to foreign 
PAMPs, coating their surface in a process known as opsonisation, which allows for these 
tagged cells to be identified by additional innate immune cells expressing complementary 
receptors to the PRRs. Subsequently, binding of innate immune cells such as macrophages to 
opsonised pathogens initiates a process of uptake, removal and destruction termed 
phagocytosis (Bidula and Schelenz, 2016).  Soluble PRRs include collectins (Mannose 
Binding Lectin), pentraxins (C-reactive protein), antibodies (IgM) and plasma complement 
(C3b) (Janeway and Medzhitov, 2002).  
More specifically, complement adds another layer into the regulation of pathogen destruction 
by innate immune cells as it has three cascades of activation that all interlink with other 
soluble PRR mechanisms of pathogen opsonisation. The classical, alternative and mannose 
binding pathways activate complement through; presence of complexes of antigen and 
antibodies, spontaneous lysis of plasma complement C3 which binds to pathogen surfaces and 
presence of mannose binding lectin on bacterial and viral cell walls respectively (Noris and 
Remuzzi, 2013, Sarma and Ward, 2011). The complement cascade is composed of different 
complement proteins C1-9, but all pathways act via an intermediate major complement 
associated molecule C3 convertase which is central to the complement cascade (Carroll, 
2004). C3 convertase triggering by the classical, alternative and mannose binding pathways 
results in production of C3a and b. C3a can initiate localised inflammation supporting 
recruitment of innate cells whereas C3b binds directly to bacterial cell membranes to induce 
further opsonisation for internalization by macrophages and neutrophils (Sarma and Ward, 
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2011, Camous et al., 2011). Furthermore the C3 convertase can become bound to C3b 
inducing formation of a C5 convertase. C5 convertase allows production of the 
chemoattractant C5a but also C5b which is necessary, along with C6-9, for formation of a 
membrane attack complex which punches holes in pathogenic walls upon recruitment, 
inducing pathogen death and clearance (Parkin and Cohen, 2001).  
1.1.1.2 Cellular Pattern Recognition Receptors 
Cellular PRRs include families of membrane bound receptors such as Toll-Like Receptors 
(TLRs) with different TLRs (1-9) recognising various surface expressed common pathogenic 
features (O'Neill et al., 2013). For example TLR-4 recognises the endotoxin 
Lipopolysaccharide (LPS) and TLR-5 has an affinity for flagellin on bacterial cells (Akira and 
Takeda, 2004). In addition, some TLRs are expressed internally within endosomes (TLR 3,7-
9) to sense the presence of non-host nucleic acids which would suggest pathogenic invasion
of host cells (Beutler, 2009). Alternative PRRs also exist, with different families being 
cytosolically expressed. These include Nucleotide binding Oligomerisation Domain receptors 
(NOD- like receptors) that can detect bacterial PAMPs in the cytosol along with Retinoic acid 
Inducible Gene receptors (RIG-like receptors) that recognise RNA PRRs in the cytosol 
(Petrilli et al., 2007, Loo and Gale, 2011). Upon activation, all receptors initiate the 
beginnings of an immune response targeted towards pathogen clearance.  
The subsequent binding of PAMPs to PRRs, either soluble or cellular, triggers the activation 
of downstream signalling pathways associated with the induction of inflammation to support 
the release of cytokines and chemokines for enhanced cell recruitment to the affected area 
(Kawai and Akira, 2011). Recruitment of other innate cells is necessary for prolonged 
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detection of foreign antigens and sustained death of invading microorganisms. Neutrophils are 
important in this process as they mediate phagocytosis of pathogens. This is possible as 
antibody or complement opsonised bacteria can bind to neutrophils via FC or complement 
receptors respectively (Appelberg, 2007). Upon binding, subsequent membrane projections 
from the neutrophil form a phagosome around the pathogen, this can fuse with cytoplasmic 
lysosomes to generate a phagolysosome from which cytotoxic granules or reactive oxygen 
species can then induce pathogenic death (Parkin and Cohen, 2001). Macrophages are also 
pivotal in supporting the clearance of apoptotic bodies again via phagocytosis (Galli et al., 
2011). As a result, the innate immune system is key in initial immune responses to support the 
clearance of pathogenic material. But importantly one of the main roles of innate immunity is 
to induce activation of the adaptive arm which can occur through inflammatory cytokine and 
chemokine release by innate cells but also occurs through dendritic cell (DC) recruitment for 
subsequent antigen processing and presentation (Kumar et al., 2009). Activated DC trigger 
the upregulation of their costimulatory molecules CD80 and CD86 which can in turn support 
increased activation of adaptive immune cells as DC circulate through lymph nodes and 
spleen (Delves and Roitt, 2000).  
1.1.2 The Adaptive Immune System 
The defining feature of the adaptive immune system is its ability to express a wide repertoire 
of receptors each specific for one key pathogenic feature.  The adaptive immune system is 
comprised of T lymphocytes (T-cells) and B lymphocytes (B-cells).  T-cells will be discussed 
in greater detail in 1.1.4.  
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1.1.2.1 B-cells 
B-lymphopoiesis initially occurs from a pool of pluripotent hematopoietic stem cells in the
fetal liver. This process then continues in the bone marrow where it subsequently is 
maintained throughout adult life. During differentiation, B-cells express the endonucleases 
Recombinase Activating Gene 1/2 (RAG 1/2), which is required to support rearrangement of 
Variable, Diverse and Joining (VDJ) segments of the surface expressed immunoglobulin 
genes (Jung and Alt, 2004). It was indeed shown that there was a requirement for Rag1 as 
well as Rag2 gene expression to support the initial activation of VDJ recombinase activity, 
with clonal transfection of only Rag1 cDNA to non-lymphoid cells resulting in an apparent 
inability to confer VDJ recombinase activation which was supported only upon co-transfer of 
Rag1 and Rag2 (Oettinger et al., 1990). Such rearrangements are required for the 
reconfiguration of cell surface immunoglobulin (Ig) genes to form a cell surface receptor 
capable of pathogen recognition (Bassing et al., 2002). This process occurs with the formation 
of a functional Ig heavy chain, productive rearrangement of the µ chain occurs and the heavy 
chain can then be expressed on the cell surface with surrogate light chains themselves 
combining to constitute a pre-B-cell receptor (Tonegawa, 1983, Melchers, 2005). 
Successfully rearranged light chain variable regions subsequently combine as complete light 
chains which join with heavy chains to form a IgM molecule inserted onto the cell membrane, 
bound by the constant region thus leaving the highly specific antigen binding domain exposed 
(Pieper et al., 2013). If rearrangements are unsuccessful, cells die as they fail to receive key 
survival signals. During the rearrangement process, developing B-cells are screened against 
self-antigens. This is absolutely necessary as random gene rearrangement could lead to 
production of B-cells with a B-cell receptor that is capable of self-recognition and therefore 
screening against self prevents the release of potentially autoreactive B-cells. 
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Consequentially, autoreactive B-cells can undergo clonal deletion, receptor editing to try and 
rearrange the receptor to a non-autoreactive variant or clonal anergy such that the receptor is 
unable to be triggered peripherally by cognate antigen(Goodnow et al., 2005,Nemazee and 
Hogquist, 2003).  
B-cells expressing IgM leave the bone marrow and migrate to secondary lymphoid organs
where they mature and acquire the capacity to produce IgD through alternative mRNA 
splicing (Loder et al., 1999). B-cells then await activation by successful interaction with 
cognate pathogenic antigens to in turn be directed down T-cell dependent or T-independent 
cell fates where they can undergo clonal expansion, further maturing into antibody secreting 
plasma cells (Liu et al., 1991). Through interaction with activated T-cells, B-cells can enter 
into germinal centre reactions to begin somatic hypermutation and class switch recombination 
to become IgG, IgA or IgE and again successful interactions with antigen during this process 
will allow for selection and emergence of higher affinity B-cell clones (LeBien and Tedder, 
2008, Liu et al., 1989, Kranich and Krautler, 2016).  
Importantly, it is the process of gene rearrangement in B-cells that helps to support the 
diversity in the B-cell receptor (BCR) repertoire and peripherally this acts to allow B-cell 
activation to a wide range of antigens directly. The most important functional feature of B-
cells is their ability to go on to provide both long-lived memory cells and plasma cells with 
the capacity to produce high affinity antibody following germinal centre reactions (Zhang et 
al., 2016). In addition, more recent evidence has shown production of memory B-cells also 
from T independent responses – further supporting the important and diverse immune 
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function of B-cells in host protection upon future reinfections (Obukhanych and 
Nussenzweig, 2006) (Alugupalli et al., 2004).  
1.1.3 T-cells 
T-cells develop through similar steps to B-cells with regards to gene rearrangements to
produce a surface expressed T-cell receptor (TCR) that forms part of a distinct self-tolerant 
repertoire. However unlike B-cells, development of T-cells occurs in the thymus from 
precursors that are recruited from the bone marrow. Due to the thymus centric focus of this 
thesis, the development of T-cells will be discussed in a latter section 1.2 in greater detail.  
1.1.3.1 T-cell Subsets Overview 
T-cell populations are themselves either composed of αβ T-cells or γδ T-cells – both of which
are generated in the thymus and exit the thymus with a pre-determined lineage commitment. 
Functions of γδ T-cells are perhaps less well characterised compared to the αβ T-cell 
population. However what remain clearly apparent are the functional differences between 
these two populations. αβ T-cells reside in secondary lymphoid organs such as spleen and 
lymph nodes, whereas the γδ T-cells have been suggested to be mainly localised to epithelial 
layers of the tissue which include intestinal epithelium and skin (Allison and Havran, 1991).  
γδ T-cells bear receptors with a tendency to recognise antigens that are more commonly 
associated with a stressed or diseased state and greatly differ from αβ T-cells in that they can 
be directly activated and therefore have little dependency on activation through an antigen 
presenting cell intermediate (Hayday, 2000) (Vantourout and Hayday, 2013). It has been 
shown in fact that following stress, γδ T-cells can detect signals via TLR triggering to 
produce substances such as cytotoxic granzymes that directly act to clear pathogens through 
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lytic molecule release (Dieli et al., 2001, Dudal et al., 2006). This feature causes γδ T-cells to 
appear to have a phenotype that correlates more directly with that seen in innate immune cells 
which is supported also by their participation in the early immune response (Xiong and 
Raulet, 2007).  
αβ T-cells are classified as being either CD4+ or CD8+ depending upon their surface 
expression of these molecules and both have T-cell receptors that tend to recognise 
pathogenic material that is presented to them in a preprocessed manner rather than directly. 
Their primary positioning both within and migrating through secondary lymphoid organs 
allows these αβ T-cells to be localised to regions where they are most likely to come into 
contact with an antigen presenting cell (APC) for activation. APCs can present antigen to T-
cells as it is presented within the context of a major histocompatibility complex (MHC) on the 
APC surface which can be recognised by cognate αβTCR; differing significantly from γδ T-
cells (Haas et al., 1993). Interaction between αβ T-cells and APCs allows αβ T-cells to then 
differentiate into distinct effector subsets with a helper role being assumed by CD4 T-cells 
and a cytotoxic role by CD8 T-cells.  
Overall it appears that the roles of γδ and αβ T-cells are distinct which in turn is directly 
reflected by their non-overlapping TCR repertoires and additionally highlights the 
developmental divergence of these populations, which is postulated to be early in 
development (Prinz et al., 2006). Going forward; due to the more relevant role of αβ T-cells 
to the purpose of this thesis, there will only be reference from this point onwards to the αβ T-
cell lineage and development.  
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1.1.3.2 CD4 T-cell Subsets 
CD4 T-cells are released from the thymus as naïve conventional cells or natural T-regulatory 
cells (nTreg). nTreg are fully functional upon exit from the thymus with the capacity to be 
peripherally activated to suppress autoreactive T-cells that have escaped negative selection. 
Conventional T-cells are thought to develop intrathymically based upon their medium affinity 
binding to self-antigens expressed in the medulla which has been illustrated through 
Nur77GFP models where GFP levels relate to strength of TCR signals. From this, higher 
TCR signal strengths directly correlated with Treg induction rather than the lower level of 
GFP and signal strength which was required for T-conventional cells (Moran et al., 2011). 
Furthermore, generation of nTreg is absolutely dependent upon the medulla, whereas it 
remains dispensable for T-conventional cells – a finding that appears to directly relate to the 
requirement for self-antigen exposure to drive nTreg production (Cowan et al., 2013).  
There have been two proposed precursors for nTreg development. The conventional two-step 
process suggests that following binding through the TCR to antigen with a medium affinity, 
there is upregulation of CD25 (the α chain of the IL-2 receptor) causing cells to become 
CD25+Foxp3- conventional precursors. These can then mature as IL-2 signaling drives 
STAT5 to support Foxp3 expression and development into CD25+Foxp3+ nTreg (Lio and 
Hsieh, 2008, Hsieh et al., 2012). Alternatively, Treg have also been proposed to develop from 
a Foxp3+CD25- Treg precursor. Foxp3 is thought to be acquired initially through the TCR 
binding causing a consequential increase in phosphorylation of the proapoptotic molecule 
Bim. From this there is a requirement for common γ cytokine (IL-7, IL-2 and IL-15) exposure 
to promote Bcl-2 pro-survival factors that in turn rescue cells through CD25 expression as 
they become CD25+Foxp3+ nTreg (Tai et al., 2013). Additional reports supported this 
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alternative hypothesis through tetracycline inducible Zap-70 models, which indicated high 
levels of the alternative precursor within the thymus and its requirement for IL-15 to develop 
whereas IL-2 exposure was subsequently required for efficient maturation of these alternative 
precursors to CD25+Foxp3+ nTreg (Marshall et al., 2014).        
Unlike nTreg, naïve CD4 T-cells are required to undergo peripheral maturation to then be 
able to perform specific functions in immune responses. For this to occur, multiple steps need 
to be met; this begins with activation of the TCR by APCs such as DC or macrophages, 
presenting cognate antigen in an MHC class II specific manner. As well as this, there needs to 
be interaction between CD28 on T-cells and CD80/CD86 on APCs to provide a supportive 
level of co-stimulation for full T-cell activation. Finally, the determining factor for the destiny 
of the naïve T-cell, relates to exposure to the lineage inducing cytokines released by the APC 
(Kaiko et al., 2008, Zhu and Paul, 2010). This will allow the CD4 naïve T-cells to become a 
specific phenotype of different T helper (Th) subsets.  
From this, a Th1 phenotype is assumed if there is exposure to IL-12 and Interferon γ  (IFN-γ) 
as it drives the transcription factor T-bet which defines the Th1 lineage (Szabo et al., 2000). 
These cells in turn produce IL-2 and IFN-γ to support the destruction of intracellular 
pathogens (Zhu and Paul, 2008).  Exposure of naïve T-cells to IL-4 supports the lineage 
transcription factor GATA-3, driving a Th2 phenotype with these cells producing IL-4 and 
IL-5 to support B-cell class switching and in addition the removal of extracellular parasites 
(Zheng and Flavell, 1997, Kopf et al., 1994). As well as this there is the Th17 phenotype 
which occurs through exposure to Transforming Growth Factor β  (TGFβ) in association with 
IL-6. These cells use the transcription factor RAR-Related Orphan Nuclear Receptor γ 
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(RORγt) and produce IL-6 and IL-17 to support extracellular bacteria and fungi destruction 
(Harrington et al., 2005, Ivanov et al., 2006, Weaver et al., 2006).  
All T-cell populations can become dysregulated to some degree and have individually been 
implicated in destructive responses against self; Th1 and Th17 have been closely linked to 
autoimmunity and Th2 has been associated with allergy and asthma responses (Zhu and Paul, 
2008). Therefore as well as the predetermined nTreg presence peripherally, there are also 
naïve T-cells which can be induced into a Treg phenotype to assist in regulating this 
peripheral T-cell pool. Treg induction is driven by exposure of naïve T-cells following TCR 
triggering to TGFβ alone which turns on Forkhead box P3 (Foxp3) transcription factor (Chen 
et al., 2003). The requirement for Treg was clearly shown in mice whereby a mutation in the 
Foxp3 transcription factor resulted in ‘scurfy mice’ which ultimately died at an early age from 
lymphoproliferation and multiple organ cellular infiltration (Brunkow et al., 2001). Similarly 
in man the Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome 
(IPEX) has been shown to develop whereby mutations in the Foxp3 transcription factor can 
lead to dysfunctional Treg and resultant multiorgan autoimmune disease (Barzaghi et al., 
2012, Oftedal et al., 2015). Therefore the requirement for Treg is significant in the immune 
system and their expression of Foxp3 drives a plethora of immune regulatory factors that are 
essential in immune homeostasis, with the suppression of autoreactive T-cell and immune 
resolution. 
Treg can fulfill their regulatory phenotype as they produce inhibitory cytokines such as 
TGFβ, IL-10 and IL-35. These have been shown to; inhibit proliferation of effector T-cells by 
the attenuation of cell cycle regulators, inhibit IL-2 production by effector T-cells to cause a 
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halt in their expansion and generally prevent proliferation of T effector cells (Vignali et al., 
2008). In addition Treg produce granzyme B and perforin to induce cytolysis. These 
molecules are released along microtubules between Treg and effector T-cells upon activation, 
where perforin supports entry of granzyme B into the cell to disrupt mitochondrial pathways 
and cause cell death (Lieberman, 2003).  This mechanism has also been shown to be used by 
Treg to control B-cells as well (Zhao et al., 2006).  Treg can also additionally induce 
metabolic disruption by CD39 and CD73, which are involved in pericellular adenosine 
production binding to the adenosine A2A receptor on effector T-cells to induce suppression 
(Deaglio et al., 2007, Sitkovsky et al., 2008). Finally expression of CTLA-4 by Treg acts to 
cause downregulation and further removal of costimulatory molecules CD80/86 on DC, 
which due to the essential requirement of these molecules in the activation of naïve T-cells, 
there is a resultant reduction in peripheral naïve T-cell triggering and a halt in the progression 
of the response (Qureshi et al., 2011).   
1.1.3.3 CD8 Cytotoxic T-cells 
CD8 T-cells similarly require multiple signals to ensure full activation in the periphery. This 
includes TCR engagement via antigen, costimulatory molecule exposure and stimulation 
through inflammatory cytokine receptors (Obar and Lefrançois, 2010). CD8 T-cells however 
greatly differ to CD4 T-cells in that they recognise antigen being presented in the context of 
MHC class I. These molecules are expressed on all cells and antigen is processed 
intracellularly by cellular proteasomes and presented via MHC class I (Blum et al., 2013). 
Activated CD8 T-cells have a role in removal of viruses and tumours which they are equipped 
to carry out due to their ability to produce perforin and granzyme molecules and induce cell 
death via Fas-FasL interactions (Bannard et al., 2009).  
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1.1.4 Antigen Presentation For T-cell Activation 
As previously mentioned, CD4 and CD8 T-cells become activated by antigen presentation in 
MHCII and MHCI molecules respectively. However the mechanisms that govern the methods 
of antigen presentation differ between these two populations with presentation of exogenously 
and endogenously derived peptides respectively.  
Expression of MHCII is restricted to the surface of APCs and the MHCII complex itself is 
produced in the endoplasmic reticulum where it is primarily tethered to an invariant chain to 
prevent inappropriate activation and instead guide the complex towards the antigen 
processing compartments through the antigenic motifs that it contains (Blum et al., 2013, 
Bryant and Ploegh, 2004). Within processing compartments, the invariant chain is degraded 
leaving a class II associated invariant chain  (CLIP) peptide that will support the binding and 
loading of lysosomally produced peptides (Cresswell, 1996). Peptides for loading are present 
within these endosomal/lysosomal compartments, as they have been taken up from 
extracellular sources during immune responses via receptor mediated endocytosis, 
phagocytosis, autophagy and macropinocytosis (Figure 1.1A) (Roche and Furuta, 2015) 
(Dengjel et al., 2005). MHCII can then be loaded with peptide and transported in a vesicle to 
the plasma membrane for presentation to naïve CD4 T-cells. 
MHCI is expressed by all cells which therefore have the capability to present endogenous 
peptides from within the host cell – this process is particularly important during viral 
infections as host cells become taken over and therefore it supports identification of invasion. 
Cells can therefore use this mechanism to present viral peptides in MHCI molecules and 
identify infected cells for destruction by CD8 cytotoxic T-cells (Vyas et al., 2008).  
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Endogenous peptides are retrieved for MHCI loading through the molecule transport 
associated with antigen processing (TAP) from the endoplasmic reticulum, following their 
proteasomal degradation (Figure 1.1B) (Neefjes et al., 2011). TAP forms part of the peptide 
loading complex containing the transmembrane glycoprotein tapasin and other chaperone 
proteins which transfer cytosolic peptides from the endoplasmic reticulum to the MHCI 
molecules (Blum et al., 2013). MHCI molecules can then be expressed on the surface of 
nucleated cells and if infected, presentation of antigenic peptide will be sufficient to trigger 
the CD8 cytotoxic lineage and an immune response (Figure 1.1B).  
1.1.5 T-cell Receptor Structure and Function 
In order for the wide range of antigens being held in MHC molecules to be detectable by the 
TCRs expressed on the T-cell surface, an equally extensive range of TCRs is required to be 
present in the host. This is possible due to the variability in the TCR that can be obtained 
during generation in the thymus. The generation of a functional α and β chain for the TCR 
requires rearrangement of the variable regions of the gene which are grouped together under 
the umbrella of complementarity determining regions (CDRs). Within this, recombination of 
variable (V) diverse (D) and joining (J) elements occurs for the β chain and only V-J for the α 
chain. This process is similarly driven by the expression of both recombinase activating gene 
1/2 (RAG 1/2) as previously discussed with relation to B-cells (Nemazee, 2000, Jung and Alt, 
2004, Mombaerts, 1995). Successfully recombined gene regions are subsequently joined to 
the constant region allowing the ultimate generation of an α or β chain which will come 
together to form the TCR. As well as this, even greater variation and structural diversity can 
occur through the incorporation of additional nucleotides, along with the deletion of others, at 
the joining sections during recombination (Nikolich-Zugich et al., 2004).  Due to this process 
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of random segment selection, each TCR generated will be unique and vitally support 
sufficient diversity of the TCR repertoire such that an overabundance of foreign antigens can 
be accommodated for and further recognised, to support a continuously robust immune 
response.   
Equally as important as the dynamic diversity of the TCR repertoire is the ability of the TCR 
to be functional and responsive with the TCR structure on the cell surface shown in Figure 
1.2. The functionality of the TCR is therefore checked prior to release from the thymus into 
the periphery. The intracellular domain of the αβTCR is short and therefore alone it cannot 
signal intracellularly following TCR activation, as a result, the TCR is linked non-covalently 
to the CD3 molecule to connect to a signalling cascade within the cell (Cantrell, 2002). The 
CD3 complex is composed of CD3εδ, CD3εγ heterodimers, and CD3ζζ homodimers with 
CD3ε/δ/γ containing a single immunoreceptor tyrosine based activation motif (ITAM) 
whereas the CD3ζζ homodimers contain three ITAMs (Call et al., 2006, Sun et al., 2001, 
Arnett et al., 2004). These all exist in an equivalent ratio with one TCRαβ being associated 
with CD3εγ, CD3εδ, CD3ζζ dimers (Call et al., 2002). As a result, TCR triggering can 
therefore successfully lead to intracellular signals as it initiates CD3 ITAM phosphorylation 
by the Src family of tyrosine kinases LCK and FYN (Brownlie and Zamoyska, Samelson, 
2002) (Deindl et al., 2007). When there has been phosphorylation, ITAMs are able to recruit 
the SYK family member ζ-chain associated protein kinase of 70kDa (ZAP-70) through high 
affinity binding to SH2 domains of ZAP-70 (Au-Yeung et al., 2009, Weiss, 1993). This 
binding exposes sites on ZAP-70 for its phosphorylation by Lck-mediated mechanisms 
allowing activated ZAP-70 to target downstream adaptor linker for activation of T-cells 
(LAT) which in turn enables full TCR signalling including Protein Tyrosine Kinase  (PTK) 
18 
and Mitogen Associated Protein (MAP) activation (Wang et al., 2010a). Therefore triggering 
of the TCR in the thymus can allow for functionality checks, with the assessment of 
downstream signalling cascade activation prior to developmental progression – therefore also 
acting as a selection mechanism. Additionally, once in the periphery this TCR triggering 
along with the other necessary accessory signals can functionally activate the T-cell. This will 
enable it to perform its function and undergo successful gene activation to induce 
transcription of required genes such as those needed for growth, adhesion and proliferation.  
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Figure 1.1: 
Process of MHC Antigen Presentation 
A) Process of MHCII antigen processing with antigens endocytosed and taken into cells in an
endocytotic vesicle. This can then be taken into the endoplasmic reticulum with antigenic 
peptides processed in this compartment. Peptides can then be loaded onto MHCII molecules 
with the degradation of the invariant chain that is bound to MHCII allowing MHCII to be 
associated with invariant chain (CLIP) that acts to support peptide loading to MHCII 
molecule. Loaded MHCII molecules can then be transported to the cell surface.  
B) Processing of intracellular antigens for presentation on MHCI surface. Antigens are
processed in the proteasome of the cells and then transferred via the transport associated with 
antigen processing (TAP) molecule into the endoplasmic reticulum for loading onto MHCI 













Structure of T-cell Receptor 
The T-cell receptor is surface expressed on T-cell surface and is composed of a complex in 
which α and β TCR chains These are joined and linked intracellularly to immunoreceptor 
tyrosine based activation motifs (ITAMs). During TCR signalling to support an intracellular 
signalling cascade, CD3 molecules are required to non-covalently connect to the TCR and 
allow for the transmission of the TCR signals into the cells. The CD3 complex is composed of 



















1.2 T-cell Development  
The thymus is an organ that is composed of two lobes and is anatomically positioned in the 
centre of the thoracic cavity above the heart. The thymus provides a unique microenvironment 
comprised predominately of thymic epithelial cells that act to support the development of T-
cells from precursors recruited from the bone marrow. It can be divided into two main areas, 
the cortex and the medulla, composed of cortical thymic epithelial cells (cTEC) and 
medullary thymic epithelial cells (mTEC) respectively (Boehm and Swann, 2013). The cortex 
supports the development of thymocytes until the single positive stage, which occurs 
following positive selection. Whereas the medulla is mainly concerned with negative 
selection of potentially autoreactive T-cells and central tolerance induction (Boehm, 2008). 
This process is summarised in Figure 1.3.  
 
1.2.1 Thymus Organogenesis  
During embryogenesis in mice, the thymus arises from the third pharyngeal pouch (3PP) of 
the endoderm, surrounded by neural crest mesenchyme (Hollander et al., 2006). By E12.5, the 
thymus begins to physically separate from the parathyroid gland which, until this point, have 
been closely associated as both develop from the 3PP (Rodewald, 2008) (Vaidya et al., 2016). 
The thymus additionally separates from the parathyroid gland with regards to functional 
alterations which are transcription factor mediated. Thymus identity is controlled through 
expression of the master regulator forkhead (Fox) superfamily of transcription factors 
containing Foxn1, whereas the parathyroid development remains controlled by Glial cells 
missing 2 (Gcm2) (Liu et al., 2007). This separation in expression is apparent relatively early 
as it can be distinguished in the third pharyngeal pouch where Foxn1 expression has been 
shown to be driven by Bone-Morphogenic protein 4 (BMP-4) and also Wnt4 signalling 
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Figure 1.3: 
T-cell Development In Thymus
The process of T-cell development is illustrated from the progenitor population that enters the 
thymus at the corticomedullary junction before progressing through the cortex and 
rearranging TCR genes during various double negative (DN) stages of development. 
Subsequent to this, a TCR is presented on the cell surface and cells become double positive 
(DP) expressing both CD4 and CD8. Positive selection can then occur through successful 
interaction with cTEC allowing cells to become single positive (SP) in phenotype. 
Upregulation of CCR7 allows SP cells to migrate from the cortex into the medulla to undergo 
tolerance induction by interacting with tissue restricted antigens (TRAs) expressed by Aire+ 
mTEC and presented by mTEC and dendritic cells. Autoreactive cells are negatively selected 
and those that are non-responsive can progress through central tolerance induction to mature 
intrathymically and be able to egress from the thymus as naïve T cells.  
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(Gordon and Manley, 2011). Foxn1 drives the formation of the thymus by supporting the 
development of the thymic epithelial cell lineage (TEC) which constitutes the basis of the 
thymic microenvironment required to support T-cell development (Nehls et al., 1994) (Nehls 
et al., 1996).  In the mouse, BMP signalling is required for the sustained maintenance of 
Foxn1 expression in TEC – with repression of BMP resulting in loss of Foxn1 expression and 
TEC reverting to a state of pharyngeal epithelium that is subsequently unable to support T-
cell development (Soza-Ried et al., 2008). This process of thymus organogenesis further 
appears to be conserved between mice and humans (Farley et al., 2013). 
1.2.2 Thymic Progenitor Colonisation 
The thymus requires continuous seeding of progenitor cells from the bone marrow or fetal 
liver in order to be able to maintain the development of functional naïve T-cells. However the 
phenotype of the most initial thymus settling progenitor (TSP) that can give rise to a T-cell 
population has been difficult to determine.  
Within the bone marrow, hematopoietic stem cells (HSCs) have the capacity to develop into 
any blood cell lineage and lie directly upstream of multipotent progenitors (MPPs) whom 
themselves maintain a broad developmental capacity (Morrison et al., 1997) (Kondo, 2010). 
MPPs can be identified from HSCs through high levels of fms-like tyrosine kinase receptor-3 
(Flt-3) expression and can support the generation of both a lymphoid and myelo-erythroid 
lineage (Kondo et al., 2000, Akashi et al., 2000). Emergence of lymphoid cells from MPPs is 
through the intermediate common lymphoid progenitor (CLP), which requires expression of 
the Ikaros transcription factor (Allman et al., 2003). CLPs also express high levels of IL-7Rα 
and of Flt-3 and possess the capacity to give rise to both B and T lymphocytes (Sitnicka et al., 
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2002). Despite this, the presence of CLPs has not been identified in either the blood or the 
thymus, suggesting that there may be an additional population downstream of this progenitor 
which has T-lineage potential following its release from the bone marrow and migration 
towards the thymus (Scimone et al., 2006).  
 
Nevertheless, ultimately for the successful development of the T-cell lineage, progenitors 
need to be able to migrate from the bone marrow through the blood and into the thymus 
(Schwarz and Bhandoola, 2006). For this to occur, there needs to be release of progenitors 
from the bone marrow niches for them to be able to then travel into the blood – such 
mobilization requires that there is cleavage of cell adhesions and also removal of chemokine 
gradients that subsequently were acting to retain the cells in the bone marrow (Schwarz and 
Bhandoola, 2004). Within the blood, identification of a T-cell progenitor has also been 
difficult to detect, with the Lineage negative, stem cell antigen 1 and cKit positive  (LSK) 
population, which contains HSCs and MPPs, ultimately being shown to be the only known 
primary progenitor that is present within the circulation and able to possess T-lineage 
potential (Schwarz and Bhandoola, 2004).  
 
Despite this, the mechanisms of progenitor recruitment have been determined through various 
experimental approaches – most utilising techniques of molecular blockade causing reduced 
T-cell development as a consequence. Circulating TSPs appear to enter the thymus in narrow 
zones close to the corticomedullary junction through the process of the multi-step adhesion 
cascade (Scimone et al., 2006). To initiate extravasation into the thymus, tethering/rolling 
along endothelium occurs by expression of platelet selectin (P-selectin) and P-selectin 
glycoprotein ligand 1 (PSGL1) on the vasculature and progenitors respectively (Rossi et al., 
	25 
2005) (Gossens et al., 2009).  Expression of CD44 also appears to be important towards the 
support of progenitor recruitment with antibody mediated blockade of this fully preventing 
entry by thymus colonizing progenitors (Bhandoola and Sambandam, 2006).  
 
Subsequent exposure of progenitors to chemokines and consequential signalling through G-
protein coupled receptors (GPCR) on the progenitor surface, acts to rapidly activate integrins 
that are loosely tethered such as through α4β1 and Vascular Cell Adhesion Molecule -1 
(VCAM1) expression on progenitor and endothelial surfaces respectively to support firm 
adhesion and extravasation (Scimone et al., 2006). In particular it appears that CCR7 and 
CCR9 play key roles in this process with the expression of their ligands CCL19/CCL21 and 
CCL25 being shown to be by thymic stroma (Takahama, 2006). An important study, 
highlighted that in adult mice there is upregulated CCR7 expression on progenitors that lie 
downstream of HSCs and MPPs, linking them to recruitment to the thymus (Zlotoff et al., 
2010). This requirement for such chemokines was further supported in this study through 
generation of CCR7/CCR9 double knock out (dKO) mice whereby under competition with 
wildtype counterparts in mixed bone marrow chimeras, dKO failed to compete with regards to 
their ability to seed the thymus.  
 
Interestingly, it is thought that the same chemokines may play a role in early embryonic 
thymic progenitor settling with progenitors at this stage developing in the fetal liver between 
E10.5-12.5 in mice gestation and then migrating into the thymic anlage from surrounding 
mesenchymal areas (Masuda et al., 2005) (Liu et al., 2006) (Bleul and Boehm, 2000) (Foster 
et al., 2008). As this early process occurs prior to the development of vascularisation it 
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remains to be dependent upon chemokine gradients – being attracted to thymic epithelial 
sources of CCL21 and CCL25 expression (Takahama, 2006).   
1.2.3 Commitment To The T-cell Lineage 
Initial TSPs are thought to give rise to the early thymic progenitor (ETP) population, which is 
the earliest identifiable T-cell progenitor currently available to study in the thymus so is 
therefore commonly used as a read out of thymus settling and progenitor recruitment (Benz et 
al., 2008, Ramond et al., 2015). However for ETP to obtain a committed phenotype to the T-
cell lineage, the preceding TSP must have been exposed to Notch signalling (Radtke et al., 
2010). This signalling via Delta-Like ligand 4 which is itself expressed by cTEC, occurs 
through the Notch 1 receptor on lymphocyte progenitors and suppresses the ability of these 
TSPs to develop into B-cells and rather supports only a T-lineage commitment (Radtke et al., 
2013, Yuan et al., 2010). ETP have been shown to fail to develop under absence of functional 
Notch1 signalling, highlighting its requirement to support the stage between TSP and ETP 
(Sambandam et al., 2005, Tan et al., 2005).  
ETP themselves reside within a double-negative 1 (DN1) population. The DN stage has 
subdivisions which relate to the expression of CD25 and CD44; DN1 CD25-CD44+ to DN2 
CD25+CD44+ to DN3 CD25+CD44- and finally DN4 CD25-CD44- (Shah and Zuniga-Pflucker, 
2014). The DN1 population itself is made up of subpopulations DN1a-e based again on 
expression of surface markers CD117 and CD24 with the DN1a-b population being shown to 
be where ETP are positioned and provide the most potent subclass able to give rise to T-cell 
lineage (Porritt et al., 2004). ETP can then undergo sequential stages in order to develop into 
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thymocytes progressing from DN stage being CD4-CD8- through to double positive (DP) 
CD4+CD8+ and finally single positive (SP) CD4+ or CD8+. 
 
1.2.4 Development Of Thymocytes Through The Cortex 
DN1 cells are positioned near the site of progenitor entry at the corticomedullary junction 
(CMJ) and have the capacity to proliferate extensively through expression of IL-7 by cTEC 
upon entry into the thymus (Porritt et al., 2003). In addition it is the process of Notch 
signalling, as previously mentioned, that is required to drive these ETP populations down the 
thymocyte developmental pathway (Schmitt et al., 2004). DN1 cells transition to DN2 cells as 
they begin to undergo expression of RAG 1/2 genes and CD25 (Di Santo et al., 2000). DN2 
cells mature as they migrate towards the subcapsular zone (SCZ), which is thought to be 
supported by their expression of CXCR4 and subsequent exposure to the corresponding 
ligand CXCL12, by both occasional cTEC and presence within the SCZ (Takahama, 2006). 
This chemokine-ligand interaction was shown to be key to support SCZ migration through the 
generation of p56lckCre/CXCR4loxP/loxP chimeras, where DN thymocytes lacked CXCR4 
expression (Janas et al., 2010, Trampont et al., 2010, Plotkin et al., 2003). Analysis showed 
that such thymocytes were arrested at DN1 and immunofluorescent localisation reflected 
accumulation in the cortex near the CMJ where they had initially entered the thymus. As a 
result this demonstrates the requirement for CXCR4 expression on thymocytes to support 
migration from the CMJ to the SCZ. 
 
By the time cells reach the SCZ they are DN2 in phenotype and can begin rearrangement of 
the TCRβ and pre-TCRα genes supported by their RAG expression. Rearrangement of the 
TCR genes ultimately lends itself to the association of the randomly rearranged TCRβ chain 
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and CD3 signalling molecules with a pre-TCRα chain to form a pre-TCR complex – from 
which point cells are confirmed to be DN3 in phenotype (von Boehmer and Fehling, 1997). 
The DN2 to DN3 transition period acts as a key checkpoint to ensure that only DN2 cells, 
which have undergone TCRβ chain selection, are allowed to continue differentiation beyond 
DN3. This is possible due to the requirement for signals at this point through the pre-TCR 
complex which are thought to be cell-autonomous and occurring in a ligand independent 
manner but necessary to enable continued development (Yamasaki et al., 2006).  Ultimately 
these signals prevent cells from undergoing apoptosis and cause the cessation of further 
rearrangements of TCRβ genes with successful β–selection acting to drive the downregulation 
of CD25 and as a result further support final progression towards the DN4 phenotype (Dudley 
et al., 1994). Cells which fail to successfully rearrange their TCRβ genes will be triggered to 
undergo apoptosis as they will be unable to receive the required survival signals. The 
successfully generated DN4 cells will however continue in development and upregulate CD8, 
producing an intermediate SP8 population (iSP8), before upregulating CD4 to become DP in 
phenotype (Ciofani and Zuniga-Pflucker, 2007, MacDonald et al., 1988). 
DP thymocytes are then required to successfully rearrange their TCRα chains to express a 
complete αβ TCR on their surface and become positively selected through cTEC interaction. 
Reversing upon the initial movement of the DN progenitors towards the SCZ, the DP 
progenitors begin to relocate back towards the cortex region where they randomly migrate 
(Dzhagalov and Phee, 2012). DP thymocytes were shown to be highly motile within the 
cortex, with cells seen to only pause upon interaction with cTEC (Witt et al., 2005) (Bousso et 
al., 2002). This interaction is necessary for cells to undergo a process known as positive 
selection, which is itself designed to test the functionality of the newly generated TCR against 
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the peptide:MHC complex on the cTEC (Werlen et al., 2003). Cells that can interact with a 
low-affinity can then be directed towards either a CD4 or CD8 single positive phenotype 
depending upon which MHC molecule class the developing DP thymocyte tends to respond to 
(detailed in section 1.1.6) (Takahama, 2006, Klein et al., 2009, Takada et al., 2017). 
Additionally in this selection process, the downstream TCR signalling molecule Zap-70 has 
been shown to be necessary along with sustained TCR signalling to generate a positive 
feedback loop that in turn supports differentiation into CD4 SP thymocytes under MHCII 
selecting ligands or CD8 SP under MHCI interaction during positive selection (Sinclair et al., 
2015). 
 
The process of positive selection aims to select cells that would be useful peripherally in 
being responsive to foreign antigens. As a result, failure of the DP thymocytes to interact will 
also result in death of the thymocytes by neglect through a programmed cell death mechanism 
(Palmer, 2003). On the other hand, cells which bind strongly via their TCR to ubiquitously 
expressed self-antigens in the cortex, are triggered to undergo a process known as negative 
selection which involves programmed cell death (Stritesky et al., 2013, McCaughtry et al., 
2008, Goldman et al., 2005). This process of negative selection was particularly assessed in 
one study that was able to identify distinct populations of apoptotic cells based upon their 
expression of Caspase-3 and subsequently whether these cells were undergoing either death 
by neglect or death as a result of negative selection (Stritesky et al., 2013). Caspase-3 was 
used to define apoptotic cells due to its involvement in both the extrinsic death ligand and 
intrinsic mitochondrial associated apoptotic death pathways. Here Caspase-3 is cleaved within 
the cell by initiator caspases, themselves triggered through apoptosis signalling events. T-cells 
undergoing apoptosis specifically through negative selection or via death by neglect could be 
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discriminated in this study by the segregation of Caspase-3 positive cells between CD5 and 
CD69 expression – double positive (CD5+CD69+) cells represented those having been 
triggered through their TCR as both molecules become upregulated during this process; CD5 
acting as a negative regulator of TCR signalling and CD69 acting as a maturation marker. 
Alternatively, cells that were Caspase-3 expressing but CD5-CD69- were identified as 
undergoing death by neglect following no TCR signal. Due to this rigorous selection process, 
it is proposed that only three to five percent of developing thymocytes actually survive past 
this positive selection stage (Goldrath and Bevan, 1999).  
 
1.2.5 Commitment To CD4 or CD8 T-cell Lineage  
The process of commitment to either CD4 or CD8 T-cell lineage appears to depend upon 
binding of the DP thymocyte to MHCII or MHCI respectively. Various models have then 
been proposed as to how this interaction leads to the commitment to either the CD4 or CD8 
lineage and all appear to involve ideas surrounding length of interaction time, strength of 
signalling and additional cytokine involvements. One classical model that has long been 
proposed is known as the ‘strength of signal instructional model’ and suggests CD4 and TCR 
co-engagement induces stronger signals from increased intracellular Lck kinase binding on 
the cytosolic tail of CD4 compared to that of CD8 which induces lower strength signals. This 
difference in signal strength therefore links to the designated phenotype adopted by the DP 
cell (Hernandez-Hoyos et al., 2000, Sohn et al., 2001) (Singer et al., 2008).  
 
Alternative models have however been suggested with duration also being thought to be as 
important as signal strength (Yasutomo et al., 2000, Brugnera et al., 2000). Additionally the 
stochastic selection model suggests systematic coreceptor downregulation following TCR 
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involvement, with intermediate cells then requiring rescue through a second TCR signal and 
selection if the TCR and the downregulated co-receptors were correctly matched (Chan et al., 
1993, Davis et al., 1993, Robey et al., 1994). Finally, the ‘Kinetic signalling model’ proposes 
that following TCR interaction CD8 becomes downregulated and if signals continue through 
the TCR then cells adopt a CD4+ phenotype or if signals cease they re-express CD8 and 
become CD8+ through supportive presence of IL-7 and other common gamma chain cytokines 
(Singer, 2002, Singer and Bosselut, 2004, Brugnera et al., 2000). However following the 
proposal of so many different models, the defining signalling pathway that determines cell 
fate will remain to be of considerable interest.  
Yet despite the exact mechanism of cell signalling being debated, what is clear is the 
involvement of Tumour Necrosis Factor (TNF) signalling and activation of the NFκB 
signalling pathway in the acquisition of a single positive phenotype (Webb et al., 2016). This 
study investigated mice that failed to express both subunits of the complex inhibitor of κB 
(IKK 1/2), within the early thymic progenitor populations, which are required as part of the 
NFκB signalling cascade. From this it was shown that there was a lack of CD4 and CD8 
maturation in the single positive phase which could only be rescued upon TNF blockade as 
this prevented TNF induced cell death under absence of IKK1/2. Therefore further suggesting 
that TNF activation of the NFκB pathway is necessary for thymocyte survival and SP 
progression with CD8 cells being particularly receptive to this process.  
Despite continuous dispute as to which model fundamentally is correct in the guidance of DP 
cells into a SP phenotype, what remains clear is that for full lineage commitment there is 
involvement of several transcription factors. For CD4 single positive thymocytes there is a 
32 
role for ThPOK, TOX and GATA-3 and rather RUNX proteins are necessary for CD8 lineage 
development.  
ThPOK was shown to be important for CD4 lineage commitment but not CD8 cells through 
the identification of a mutation in ThPOK which resulted in mice that failed to develop CD4 
T-cells (He et al., 2005, Sun et al., 2005, Keefe et al., 1999). Additional experiments driving
overexpression of ThPOK found that MHCI selected T-cells could be redirected towards a 
CD4 SP lineage (He et al., 2005). TOX was also identified as being upregulated following 
TCR signalling in DP thymocytes and therefore was another possible regulator in lineage 
commitment. This was investigated as TOX deficiency showed that DP thymocytes failed to 
differentiate into CD4 SP cells but CD8 T-cells remained unperturbed; rather it was seen that 
reversal of this deficiency through transgene insertion was able to promote differentiation into 
CD4 lineage (Aliahmad and Kaye, 2008).  GATA-3 is a zinc finger protein and was suggested 
to be expressed in a preferential manner by CD4 SP cells (Hendriks et al., 1999). Clonal 
deletion of GATA-3 in the DP population supported this, as it led to reduced CD4 T-cell 
generation but again CD8 development was not affected (Pai et al., 2003). RUNX proteins, 
especially one and three, have been linked to a CD8 SP phenotype as they were illustrated to 
bind to CD4 silencer elements and therefore suppress CD4 expression; with experimental 
systems of RUNX deficiency leading to CD4 gene transcription (Grueter et al., 2005, Kohu et 
al., 2005, Taniuchi et al., 2002). As a result, the vital role for transcription factors in lineage 
determination of DP thymocytes is clearly apparent.  
Following positive selection, CD4/CD8 SP cells can relocate to the medulla from the cortex. 
This process is thought to be driven by the expression of the chemokine receptor CCR7 as 
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developing thymocytes have been shown to upregulate expression following successful 
positive selection (Kim et al., 1998) (Campbell et al., 1999). The mTEC population expresses 
CCR7 ligands and therefore it acts to provide a gradient for recruitment of single positive 
thymocytes from the cortex to the medulla (Kwan and Killeen, 2004). In addition, mice that 
are deficient for CCR7 are found to undergo maturation post positive selection within the 
cortex as they fail to be able to migrate into the medullary areas (Ueno et al., 2004).  
 
1.2.6 Medullary Regulation of Developing Thymocytes  
Positively selected thymocytes have been able to progress in their development and enter into 
the medulla of the thymus solely due to their ability to bear a TCR that can recognise 
MHC/peptide complexes. However due to the process of TCR generation itself (detailed in 
1.2.4) requiring the random rearrangement of TCR genes, there is ultimately the possibility 
that a TCR could be generated with potential self autoreactivity. Upon entry into the medulla, 
thymocytes therefore undergo tolerance induction, which when taking place in the thymus 
itself, is generally known as central tolerance and predominantly involves TCR screening 
(Klein et al., 2014).       
 
1.2.6.1 Negative Selection Of Autoreactive Thymocytes 
Screening occurs by medullary thymic epithelial cells and also other antigen presenting cell 
populations such as DC, which play a major role in tolerance and will therefore be discussed 
in more detail within section 1.3 (Oh and Shin, 2015). Migrating thymocytes can come into 
contact with self antigens expressed by both medullary APCs and mTEC and bind with 
differing affinities depending upon responsiveness of their TCR to particular self peptides. 
Presentation of self-antigens is possible due to the expression of transcriptional regulators; 
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Autoimmune Regulator (Aire) and Fez family zinc finger 2 (Fezf2), which both drive tissue 
restricted antigen expression on thymic epithelial cells (Takaba et al., 2015, Anderson et al., 
2002). Both studies into these transcription factors showed that under their absence there were 
resultant autoimmune manifestations that remained distinct from one another but highly tissue 
specific.  
 
For a decision to be made as to the fate of the cell, interacting thymocytes have been reported 
to undergo calcium flux that triggers rapid migratory arrest upon encounter with cognate 
antigen, holding cells stationary for a subsequent thymocyte fate decision to be determined 
through TCR signals and cell signalling pathway activation (Dzhagalov et al., 2013). The 
main determinant of developing thymocyte fate relates overwhelmingly to how strongly their 
TCR recognises self antigens presented within the medulla with weak interactions correlating 
to successful development (Morris and Allen, 2012). Dendritic cells and mTEC coordinate 
this process of self-antigen presentation but also play pivotal roles in Treg generation, which 
relates to more of an intermediate strength affinity binding of the TCR to the cognate self-
antigens (Klein et al., 2011).  Strong interactions with self-antigen on the other hand, leads to 
the initiation of a death pathway to remove the autoreactive cells from the repertoire, which 
requires activation of various downstream signalling molecules. Within the medulla, the high 
concentrations of DCs support more efficient negative selection upon interaction with 
autoreactive cells due to their particularly high expression of costimulatory molecules CD80 
and CD86 which can interact with CD28 on thymocytes and support signalling into the 
thymocyte and fate decisions therefore acting additionally alongside the primary TCR 
MHC/peptide interaction (Walunas et al., 1996).   
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There have previously been two suggestions for the pathways responsible for negative 
selection of autoreactive T-cells; death receptors and Tumour Necrosis Factor Receptors 
(TNFRs) or Bcl-2 proteins (Palmer, 2003, Hernandez et al., 2010). Death receptors include 
Fas which is activated by Fas Ligand on stromal cells, however despite the likelihood that Fas 
could be important in supporting negative selection, experiments infact proved that it is not 
solely required and may act more in a supportive manner to improve negative selection 
efficiency rather than be the initial instigator (Newton et al., 1998) (Villunger et al., 2004). 
Additional work from this study went on to show no clear role for Fas associated death 
domain containing receptors such as TNFRs either in negative selection.  
As a result, the role of Bcl-2 protein members in negative selection was considered and 
subsequently it was shown that high avidity binding of TCRs to self antigens leads to the 
engagement of the intrinsic mitochondrial pathway of apoptosis that is itself regulated by the 
Bcl-2 protein family (Strasser, 2005) (Dzhagalov et al., 2013). Deletion of the BH3-only 
member of Bcl-2 family Bim, (Bcl-2 interacting mediator of cell death), caused a subsequent 
inability of cells to undergo any form of negative selection (Bouillet et al., 2002) (Enders et 
al., 2003). As a result Bim plays a vital role in the regulation of negative selection through 
apoptosis induction. Additional work identified the requirement for Bak - a Bcl-2 antagonist 
and Bax - a Bcl-2 associated X protein, in the support of Bim and cell mediated death (Zong 
et al., 2001). Activation of these molecules through strong TCR/MHCI interaction, supports 
apoptosis through disruption of the mitochondrial outer membrane and cytochrome c release 
into the cytosol causing apoptosome formation and caspase activation which in turn leads to 
protein cleavage and cell destruction (Strasser et al., 2011) (Starr et al., 2003).  
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More recent work has added to these initial observations and suggested that as well as Bim 
playing an important role in prevention of autoimmunity by promoting negative selection 
following strong TCR signals, absence of Bim alone was insufficient to cause peripheral 
widespread autoimmunity. This suggested the presence of additional supporting factors that 
cooperatively regulate negative selection in the thymus. It was then shown that only under the 
absence of the BH3-only protein Puma in conjunction with Bim, was it sufficient to cause 
spontaneous peripheral autoimmunity further indicating that negative selection is controlled 
through cooperation between Puma and Bim BH3-only proteins (Gray et al., 2012).  
 
For activation of these death inducing molecules, intracellular signals are involved and tend to 
specifically map to the mitogen activated protein kinase (MAP kinase) pathway which itself 
contains extracellular signal regulated kinases (ERK) along with Jun amino terminal kinase 
(JNK) (Bettini and Kersh, 2007). These pathways have been associated with the regulation of 
both positive and negative selection but these differing cell fates can be distinguished simply 
by the level of binding between the TCR and MHC peptide complex and the subsequent 
signal strength that ensues. The high affinity binding that results in negative selection, causes 
quick recruitment of ERK, combining with the activation of p38 and JNK to lead to cell 
death, whereas the positive selection outcome is supported by lower level binding causing 
reduced signal strength and prolonged activation of intracellular mediators - critical for the 
differentiation between positive and negative selection (Daniels et al., 2006).    
 
Negatively selected cells can be cleared from the thymus due to a small proportion of thymus 
resident macrophages which are primed to clear the apoptotic matter (Dzhagalov et al., 2013). 
In addition, cells that have been screened against self and are tolerant, are able to mature 
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within the medulla although the period of residence is controversial (Egerton et al., 1990, 
McCaughtry et al., 2007). During this time they can undergo maturation where they are 
primed to be able to leave the thymus and contribute towards the naïve T-cell pool.  
 
1.2.7 Maturation Of Developing Thymocytes And Egress 
In order for thymocytes to be able to survive once they leave the thymus, there is a need for 
them to acquire the correct developmental phenotype prior to their egress. This relates to 
alterations in expression of maturation markers such as CD62 ligand (CD62L) which is a 
lymphocyte specific L-selectin linked to the ability of cells to egress from the thymus and 
enter into peripheral lymph nodes (Takahama, 2006). CD69 as an alternative marker, is used 
often in conjunction with CD62L as during maturation these two markers are alternatively 
regulated allowing clear population segregation - as CD62L expression increases with 
maturation whereas CD69 is downregulated; cells therefore progress from CD69+CD62L- to a 
phenotype of CD69-CD62L+ as a mature SP thymocyte population (Reichert et al., 1986) 
(Sancho et al., 2005). Alternatively the maturation of naïve T-cells can be detected based on 
their expression of heat stable antigen (HSA) and Qa-2 with cells progressing again from 
HSAhiQa-2low semi mature to HSAlowQa-2hi mature phenotype (McCaughtry et al., 2007) 
(Bendelac et al., 1992) (Ramsdell et al., 1991). Semi mature thymocytes are thought to be 
vulnerable to apoptosis whereas those which are fully mature lose that susceptibility, 
regulating the release of only mature cells into the periphery (Kishimoto and Sprent, 1997).  
 
Despite this, a recent study has built on previous knowledge to redefine how mature T-cells 
can be separated and identified. In this study, SP populations were divided into three 
subpopulations based upon CD69 and MHCI expression progressing from semi mature - SM 
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(CD69+MHCI-) to mature 1 - M1 (CD69+MHCI+) and finally mature 2 - M2 (CD69-MHCI+) 
(Xing et al., 2016). With increased maturation it was proven that there were also increases in 
proliferation ability, emigration competency and cytokine responsiveness which are all 
hallmarks of greater maturational capacity. Signalling through the NFκB pathway was shown 
to be absolutely necessary for late stage development involving both functional maturation 
and proliferation with it further protecting cells from TNFR mediated cell death (Webb et al., 
2016). Additionally independent of NFκB, constitutively produced interferons within 
medullary areas and subsequent signalling through interferon alpha receptor (IFNαR) were 
shown to support maturation by priming T-cells with the capacity to respond to cytokines 
(Otero et al., 2013, Lienenklaus et al., 2009, Xing et al., 2016).  
In addition to this, models can be used to actively track maturation of thymocytes and these 
are predominately based upon RAG1/2 expression, which is triggered to be expressed during 
TCR recombination (McCaughtry et al., 2007, Boursalian et al., 2004).  This has come about 
through the generation of transgenic mice with the insertion of a bacterial artificial 
chromosome encoding for a green fluorescent reporter protein in the place of RAG2 which 
acts to map levels of RAG2 expression (RAG2p-GFP reporter mice) such that the stage of 
thymocyte development can be tracked (Yu et al., 1999). The level of fluorescence degrades 
with time and therefore newly generated SP thymocytes will have high RAG2p-GFP levels 
whereas those that are negative for GFP represent mature and possibly peripheral 
recirculating cells. With increasing evidence for the capacity of T-cells, including both 
conventional and T Regulatory, to recirculate to the thymus, this molecular timer has grown 
in importance as a tool to discriminate most mature naïve T-cells that are about to leave the 
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thymus and will be RAG2p-GFP positive, from those which are peripheral recirculants and 
have lost RAG2p-GFP expression (Cowan et al., 2016) (McCarthy et al., 2015).  
 
Prior to egress, as previously suggested, it has been shown that thymocytes undergo 
programmed proliferation and cellular expansion (Xing et al., 2016). This proliferative step is 
cytokine regulated and more specifically occurs due to IL-7 production by epithelial cells, 
identified as being key to this process for the provision of survival signals through IL-7Rα 
expression on thymocytes. IL-7Rα is indeed upregulated following positive selection and this 
expression is an active process dependent upon TCR signalling and as a result this regulates 
proliferation of only selected cells that have received all of the correct developmental cues 
prior to their release into the periphery (Hare et al., 2000). This upregulation of IL-7Rα has 
however itself been shown to be dependent upon NFκB signalling which was necessary for 
initial expression of IL-7Rα but not for this receptor maintenance post maturation. This was 
indeed illustrated through IKK2 deletional models, a key complex in the NFκB signalling 
cascade, at different T cell maturational stages (Silva et al., 2014).  
 
For thymocytes to leave the thymus there is also a requirement for them to express the G-
protein coupled receptor sphingosine 1 phosphate receptor (S1P1), with expression being 
upregulated as the marker CD69 becomes downregulated through maturation (Shiow et al., 
2006) (Alfonso et al., 2006). Thymocytes express S1P1 and require signalling in a cell 
intrinsic manner for egress along the corresponding chemotaxis gradient of the bioactive 
sphingolipid, and S1P1 ligand, S1P (Takeda et al., 2016). S1P formation is regulated by 
phosphorylation of kinases sphingosine1/2 (Sphk1/2) and a gradient is maintained between 
the thymus and blood with levels of ligand expression being low and high respectively to 
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support emigration (Matloubian et al., 2004, Allende et al., 2004) (Pappu et al., 2007). S1P 
has recently been suggested to be maintained at low levels in the thymus through ceramide 
synthase 2 (Cers2), which converts the S1P abundant precursor sphingosine to long chain 
ceramides in thymic stromal cells as well as hematopoietic populations (Rieck et al., 2017). 
Considering this, research has shown that there is a role for Cers2 in the thymic regulation of 
S1P through knockout models which indicated selective accumulation of the most mature 
thymocytes, further highlighting a role for Cers2 in limiting thymic levels of S1P and 
maintaining the gradients between thymus and blood (Rieck et al., 2017). 
 
S1P degradation in the thymus has also been suggested to occur via the production of a S1P 
lyase with blockade of this enzyme leading to retention of thymocytes (Schwab et al., 2005). 
It was suggested that S1P lyase was mainly expressed by vascular endothelial cells, pericytes 
and reticular fibroblasts with a more recent emphasis on neural crest derived pericytes which 
ensheath thymic blood vessels being implicated in thymic egress (Maeda et al., 2014) 
(Zachariah and Cyster, 2010). Additionally there has been suggestion through deletion of S1P 
lyase in different thymic populations, that thymic dendritic cells were shown to play a more 
pivotal role in mediating egress over and above stromal or epithelial mediated expression 
(Zamora-Pineda et al., 2016). However despite conflicting results, the localisation near the 
site of exit of these S1P lyase expressing cells appears to allow for the maintenance of S1P 
degradation at points of exit which is necessary to generate the gradient for egress of mature 
thymocytes.  
 
Additionally, under an absence of LTβR an accumulation of mature SP thymocytes was 
previously reported, similar to the phenotype reported under FTY720 treatment, an S1P1 
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agonist resulting in receptor internalization and inability of mature thymocytes to egress 
(Boehm et al., 2003, Cyster, 2005) (Yagi et al., 2000). However whether mechanisms of 
LTβR signalling and the S1P axis are linked or remained to be distinct is yet to be determined 
and how in turn LTβR may impact on the new role of Cers2 also is unknown. 
Nevertheless, this mechanism of emigration differs in adult to embryo where embryonic 
thymocyte emigration is determined by expression of CCR7 and CCL19 mediated signalling; 
differing from the adult whereby there is thought to possibly be a switch to this S1P axis 
(Ueno et al., 2002). Egress of thymocytes and the phenotype that they possess at this stage, 
allows them to enter into the periphery and further become recruited into lymph nodes where 
they can await further maturation and later priming by cognate antigen to initiate effective 
immune responses. 
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1.3 Cellular Regulators of Central Tolerance  
1.3.1 Thymic Epithelial Cells 
1.3.1.1 Development of Thymic Epithelial Cells 
For the development of the thymus to support T-cell production, there is an overarching 
dependency on the development of the core thymic structure, which is composed 
predominately of thymic epithelial cells although mesenchymal cells, fibroblasts and 
endothelial cells also support this structure (Abramson and Anderson, 2017, Takahama et al., 
2017).  
 
It is widely accepted that the development of both the medullary and cortical areas occurs 
through the presence within the thymus of a common endodermal bipotent progenitor 
(Gordon et al., 2004, Rossi et al., 2006, Bleul et al., 2006). Recently this concept was 
confirmed in the adult thymus through the presence of bipotent epithelial cell progenitors with 
the capacity to give rise to both cortical and medullary areas whilst still remaining persistent 
throughout adulthood (Ucar et al., 2014, Ulyanchenko et al., 2016, Hamazaki, 2015). Further 
adult analysis showed that there was indeed the presence of a stem-cell like TEC progenitor 
with the potential to form colonies in in vitro culture systems and differentiate into mTEC and 
cTEC both in vivo and in vitro (Wong et al., 2014). Additionally this stem cell population 
appeared to differ in gene expression analysis from that identified in embryo and therefore 
highlights the likelihood of different mechanisms being necessary for tissue homeostasis that 
is required in adult, compared to whole generation of the thymus itself during embryogenesis 
(Ucar et al., 2016). 
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From this, embryonic work into the formation of the thymus investigated this potential 
bipotency at the level of the embryo. At the stage of E12, the ability of early TEC progenitors 
to give rise to both mTEC and cTEC was investigated with the transfer of E12 TEC into host 
thymus in in vitro cultures. Subsequently, analysis for corresponding progeny clearly 
confirmed bipotency potential - yet despite this the mechanisms that directly controlled this 
process still remained to be completely resolved (Rossi et al., 2006). Further analysis of early 
embryonic thymus, confirmed bipotency through the presence of key markers specifically 
related to the cTEC lineage such as the endocytic receptor CD205 and the proteasomal marker 
β5t that could be detected on stromal populations as early as E11, therefore already appearing 
to define cells with a cTEC lineage propensity (Baik et al., 2013). However upon isolation 
and transfer of these cells it was surprisingly shown that as well as cTEC progeny developing, 
as was somewhat expected, there was also mTEC progeny. This mTEC population was 
identified through expression of mTEC related markers such as MHCII, Aire and 
Osteoprotegerin (OPG) which are indicative of mTEC function. Yet moreover, these cells 
possessed a distinct ability to respond to stimulation of the TNF-Receptor superfamily 
member, receptor activator for NF-κB (RANK) stimulation; with RANK expression and 
responsiveness further being a hallmark of mTEC, thus confirming their mTEC phenotype 
(Baik et al., 2013). This process is summarised in Figure 1.4. 
 
Additionally, this concept remains supported by the work of many others, which suggest the 
presence of a cTEC associated progenitor in the thymus that remained to be somewhat 
transient and allow for additional development into mTEC through a sequential 
developmental pattern (Ohigashi et al., 2015, Mayer et al., 2016, Meireles et al., 2017, Alves 
et al., 2014). This was further proposed to be possible also at the postnatal stage of 
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development, highlighting one study that investigated this through the use of 
IL7YFPCCRL1GFP mice, with IL-7 expression being related to cTEC and CCRL1 being a late 
cTEC associated marker (Ribeiro et al., 2014). In this study, it was shown that the CCRL1int 
phenotype, through stimulatory culture conditions in FTOC and also in vivo in reaggregate 
thymic organ cultures (RTOC), indeed could give rise to a subpopulation of cells with mTEC 
potential further being UEA+CD80+, despite possessing previous cTEC associated traits. 
The mTEC population itself is highly heterogeneous but remains predominately composed of 
two main populations; MHCIIloCD80lo populations known as mTEClo and MHCIIhiCD80hi 
mTEChi populations. Within these populations there is a further breakdown with a proportion 
of mTEClo expressing CCL21 and a proportion of mTEChi expressing the transcription factor 
Aire (Hubert et al., 2008, Ueno et al., 2004). It further appears that development of these 
populations may also be diverse with development of the mTEChi population from cells 
within the mTEClo compartment through RANK exposure; shown in reaggregate thymic 
organ cultures (Rossi et al., 2007). However in turn it has also been revealed that mTEChi 
populations can give rise to an mTEClo phenotype that can express CCL21 through LTβR 
stimulation (Lkhagvasuren et al., 2013).  
Due to such apparent developmental and population based diversity, it appears unsurprising 
for research to have identified that as well as mTEC potentially developing from a cTEC 
progenitor as previously described, there remains the opportunity for mTEC to develop from a 
cTEC-independent progenitor. Further from this, evidence has grown to suggest mTEC 
development independent of cTEC associated progenitors and thus it was suggested that there 
was the presence of mTEC committed progenitors in the embryo (Figure 1.4). These were  
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Figure 1.4: 
Thymic Epithelial Cell Development In Thymus 
TEC develop from a stem cell population expressing the transcription factor Foxn1. These can 
give rise to bipotent progenitors with the ability to produce both mTEC and cTEC via a cTEC 
associated progenitor population. mTEC can then go through a maturational series and 
produce both mTEClo and mTEChi populations driven by RelB transcription factor expression 
and RANK receptor expression dependency respectively. Mature cTEC can also arise. mTEC 
can also develop independently of a cTEC associated population with stem cells directly 
giving rise to mTEC through a serial developmental progression model.  
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indeed identified through the known expression of the tight junction components, Claudin3/4 
(Cld3/4hi) in Aire positive mTEC populations and subsequently expression of Cld3/4 was 
found in embryonic thymus. Isolation of this population at E13.5 and reaggregation in thymic 
organ cultures prior to kidney capsule transfer showed, through analysis at a later time point, 
that the Cld3/4 population was a direct mTEC progenitor with the subsequent presence of 
Aire+ mTEC (Hamazaki et al., 2007). Most recently this was expanded by (Sekai et al., 2014) 
showing that these Cld3/4 cells were able to produce and maintain the mTEC population long 
term and actually correct for any dysfunctions in central tolerance when transferred into 
mTEC deficient hosts. However further to this, it was shown that a subpopulation of Cld3/4 
expressing cells actually co-expressed the embryonic stem cell marker SSEA-1 and following 
sorting and reaggregate generation, these also had the capacity to produce mature mTEC 
populations demonstrating a clonogenic nature which remains to be indicative of a stem cell 
phenotype. This was further seen to be traceable to the adult mouse with this Cld3/4hiSSEA1+ 
population remaining to be present and mTEC committed.  
Additionally later work showed that there was a dependency on NFκB signalling through 
RelB for progressional development of SSEA1+ mTEC stem cells to express the mTEC 
defining RANK receptor (Baik et al., 2016). Additional research showed that tumor necrosis 
factor receptor-associated factor 6 (TRAF6) dependent RANK signalling was required to 
acquire the Aire+ mTEC phenotype from mTEC progenitor associated populations (Akiyama 
et al., 2016). However, the mechanism directly regulating this expression of RANK and 
commitment to the mTEC lineage is still unclear – yet it is anticipated that there may be a role 
for LTβR signalling at this point as it has been postulated to play a pivotal role in RANK 
upregulation and mTEC development in embryonic analysis (Mouri et al., 2011).  
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Additionally, evidence has been acquired over the possible role of LTβR in mTEC 
development as it previously had been reported that loss of LTβR signalling on thymic stroma 
led to a phenotype of reduced mTEC populations, suggesting a role for LTβR in mTEC 
development within the thymus (Boehm et al., 2003). This remained relatively unexplored 
until a recent study which used K14CrexLtbrfl/fl mice to conditionally remove LTβR expression 
from TEC and infact recapitulated the phenotype seen in the germline knockout with reduced 
mTEC numbers, highlighting a cell intrinsic requirement for LTβR signalling to support 
mTEC development but through a mechanism that remained independent of proliferation or 
survival (Wu et al., 2017). Importantly, the number of Cld3/4hiSSEA1+ mTEC progenitors 
were analysed in these mice and were also significantly reduced at the neonatal stage 
suggesting LTβR signalling may be necessary for the development of mTEC and possibly in 
the maintenance of these mTEC progenitors; however how this finding in turn alters the 
developmental pathway of mTEC and at what specific stage LTβR may be acting is yet to be 
determined.  
As a direct result, it is clearly apparent that developmentally there are a lot of questions, 
which remain to be answered with regards to TEC development, and potentially this could be 
crucial research to influence thymus regeneration post injury and following thymic involution 
with age.  
1.3.1.2 cTEC Function 
cTEC support the process of positive selection which is necessary to allow DP thymocytes to 
progress to either a CD4 or a CD8 SP phenotype. cTEC are functionally able to drive positive 
selection as they present endogenous antigens on their cell surface in the context of an MHC 
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molecule for developing thymocytes to interact with (Ohigashi et al., 2016). cTEC present 
antigen within MHCI and MHCII complexes with recent research unveiling a novel 
mechanism by which cTEC are able to stabilise MHCII expression on their cell surface, to 
support CD4+ positive selection. Previously, the molecule CD83 has been associated with 
activation of dendritic cells and was recently shown to stabilise MHCII expression on DC by 
preventing ubiquitination and MHCII ligation which results in MHCII downregulation (Tze et 
al., 2011). Considering this along with knowledge that CD83 deficient mice were shown to 
have defective CD4 selection, the impact of this mechanism on cTEC was examined 
(Fujimoto et al., 2002). Further investigations identified that CD83 was infact strongly 
expressed by cTEC and indeed necessary to stabilise MHCII expression through antagonism 
of March8, an E3 ligase, therefore preventing the loss of MHCII from cTEC surface and the 
subsequent reduction in positive selection (von Rohrscheidt et al., 2016, Liu et al., 2016). As 
a result, it appears that cTEC additionally contain molecular mechanisms that allow them to 
be primed to sustain high levels of positive selection as well as also having unique antigen 
processing capacities.  
 
 cTEC contain a variety of cell specific, unique features that allow for a different range of 
self-antigens to be expressed within the cortex compared to that seen within the medulla, 
preventing all positively selected cells being negatively selected under presentation of the 
same peptide repertoire (Kincaid et al., 2016). One of the ways cTEC are specialised is their 
ability to perform autophagy – a process which is usually restricted to conditions of starvation 
(Levine and Klionsky, 2004). Autophagy occurs as cTEC form autophagosomes that contain 
intracellular proteins. These can fuse to lysosomes for proteolysis producing peptides that can 
be presented by MHCII molecules for CD4 SP T-cell selection (Nedjic et al., 2008). As a 
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result, in this study deficiency in Atg5, necessary for the formation of autophagosomes, led to 
altered positive selection of MHCII restricted TCR transgenic CD4 thymocytes.  
 
Furthermore, unlike other antigen presenting cells that express the lysosomal endopeptidase 
Cathepsin-S, cTEC express Cathepsin–L and thymus specific serine proteases (TSSP) which 
both function to support CD4 T-cell selection through production of MHCII restricted self-
peptides (Nakagawa et al., 1998, Honey et al., 2002, Klein et al., 2009). Considering this, 
alterations in the expression of TSSP, itself encoded by Prss16, especially under situations of 
TSSP deletion, were shown in transgenic OT-II models to significantly impair positive 
selection of CD4+ thymocytes (Gommeaux et al., 2009, Viret et al., 2011).   
 
In addition to the unique features of cTEC for CD4+ selection, there are also features to 
support CD8+ positive selection in the cortex. Mainly this relates to the presence of Psmb11, 
which is required to encode for the proteasomal subunit β5t that forms part of the 
thymoproteasome found in cTEC (Murata et al., 2007). The expression of this subunit 
supports presentation of a unique set of MHCI restricted peptides that are alternatively 
cleaved to reveal unique motifs associated with lower affinity binding of the TCR, in turn 
providing ideal conditions to select fully competent CD8+ thymocytes in the cortex (Sasaki et 
al., 2015, Xing et al., 2013). As a result, investigations using mice deficient in Psmb11 were 
shown to have a limited and defective CD8+ repertoire (Nitta et al., 2010, Takada et al., 
2015). Positive selection in the cortex to a diverse range of antigens is fundamental for the 
stability of thymocyte development as it selects for a wide array of thymocytes that can then 
progress into the medulla for tolerance induction.  
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In addition, cTEC contain a subpopulation of thymic nurse cells, which remain somewhat 
functionally distinct whilst still maintaining a role in the support of positive selection. Thymic 
nurse cells are indeed large epithelial cells that form multicellular complexes and are thought 
to hold developing thymocytes (Takahama et al., 2017). Initial research into these cells 
suggested that their main role was to infact support proliferation and differentiation of 
developing thymocytes and possibly impact upon positive selection in the cortex (Li et al., 
2005, Shortman et al., 1986, Wick et al., 1991). However subsequent research has proposed 
that nurse cells encompass CD4+CD8+ thymocytes and encourage them to undergo secondary 
rearrangements of their TCR-Vα genes, in turn ultimately providing another chance for 
successful positive selection without being directly involved in positive selection (Nakagawa 
et al., 2012).  
1.3.1.3 mTEC Function 
The medulla is predominately associated with the role of negative selection of autoreactive 
thymocytes and central tolerance induction. In order for this to be possible, mTEC are 
required to express self-antigens on their surface that peripherally could activate thymocytes 
and induce autoimmunity.  mTEC are able to support negative selection due to a proportion of 
mTEChi cells expressing the transcription factor Autoimmune Regulator (Aire) (Anderson et 
al., 2002). This expression is driven by RANK signalling in mTEClo populations, unlike 
initial studies that proposed LTβR mediated regulation of Aire expression, further analysis 
showed that expression of Aire per cell under the absence of LTβR remained unchanged and 
there was no role for LTβR in Aire expression in mTEC (Rossi et al., 2007, Venanzi et al., 
2007, Martins et al., 2008). Aire expression drives the presentation of tissue-restricted 
antigens (TRAs) onto the mTEC cell surface via MHCI and MHCII to screen the TCR of 
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developing thymocytes against self for selection (Anderson et al., 2002). Conditions where 
there are mutations in the Aire gene are sufficient to result in autoimmune related diseases 
and can be seen in man through an autosomal recessive disease known as autoimmune 
polyendocrine syndrome type 1 (APS-1) and further less severe mutations such as those in the 
plant homeodomain zinc finger of Aire have also been associated with suppressed expression 
of Aire related genes and autoimmunity (Oftedal et al., 2015, Husebye et al., 2009).   
 
The molecular mechanisms that appear to underlie the ability of Aire to drive TRA expression 
have been more recently explored with growing interest into this regulation and many ideas 
proposed as a consequence (Bansal et al., 2017, Mathis and Benoist, 2009). Some studies 
suggested that Aire functions through its recruitment to target genes where it can then induce 
localised histone modifications via either histone acetylation or methylation to cause 
relaxation of chromatin and allow for subsequent TRA transcription (Org et al., 2009). It has 
further been discovered that in mature Aire expressing mTEC, the protein deacetylase Sirtuin-
1 or Sirt1 was highly expressed and remained closely associated with Aire causing its 
deacetylation which in turn is necessary for Aire’s transcriptional activity. Furthermore, 
removal of Sirt1 created a gene expression profile mirroring that under Aire absence (Chuprin 
et al., 2015).  
 
In addition to Aire expression, a proportion of mTEC have further been proposed to express 
another transcription factor FEZ family zinc finger 2 (Fezf2), to drive the presentation of an 
additional array of Aire independent TRAs (Takaba et al., 2015). This was the first study to 
indicate the possibility of an alternative TRA regulator and showed that under an absence of 
Fezf2, there was a subsequent autoimmune phenotype with inflammatory infiltrates and 
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autoantibodies detected in and against multiple organs. Gene analysis of the expression of 
different TRA associated genes under the presence or absence of Fezf2 indicated no reduction 
in Aire regulated TRAs; similarly Fezf2 related genes were not reduced in Aire deficient mice 
further segregating the regulation of these two independent TRA gene sets. Specifically Fezf2 
removal from thymic epithelial cells using a Foxn1Cre+xFezf2fl/- system, resulted in disrupted 
mTEC and peripheral autoimmunity whilst maintaining normal Aire expression. This 
phenotype was further shown at a regulatory level to only occur under the absence of LTβR 
and not RANK; again providing more evidence for the differential regulation of the 
transcription factors Fezf2 and Aire which both act independently to drive distinct TRA 
expression in the thymus for tolerance.  
1.3.2 Dendritic Cells 
As well as the documented function of mTEC in central tolerance, the requirement for DC in 
supporting this process is very clearly apparent. Mouse models lacking thymic DC, such as 
the CD11c-Cre/R-DTR mice whereby dendritic cells express the diphtheria toxin and 
treatment with diphtheria toxin results in the ablation of the DC population, have been shown 
to have widespread peripheral autoimmunity due to the escape of autoreactive T-cells from 
central tolerance induction (Ohnmacht et al., 2009, Birnberg et al., 2008, Ganguly et al., 
2013).  
DC populations can be found in the thymus from the late stages of embryogenesis, 
predominately located in the thymic medulla where their overarching function is to increase 
the thymic pool of self-antigens in both repertoire and frequency thus supporting central 
tolerance induction (Klein et al., 2001, Dakic et al., 2004). There is significant heterogeneity 
within the thymic DC pool with the presence of conventional and plasmacytoid subsets (Li et 
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al., 2009, Donskoy and Goldschneider, 2003). The conventional dendritic cells (cDC) can be 
identified based upon expression of CD11c and when subsequently split upon Signal 
regulatory protein α (Sirpα) expression, the conventional population can be segregated into a 
Sirpα positive population known as cDC2 and a negative population known as cDC1 (Wu and 
Shortman, 2005, Proietto et al., 2008a, Lahoud et al., 2006). Furthermore, this cDC 
population can be alternatively segregated using CD8α and CD11b expression with cDC1 
being CD8α+CD11b- and cDC2 being CD8α-CD11b+. This phenotyping is consistent with the 
identification method that we are using (CD11c and Sirpα), causing these markers to not be 
included in staining for DC populations.  In addition there is a third DC population that is 
CD11cint and expresses the plasmacytoid marker PDCA-1, known as plasmacytoid DC (pDC) 
(Hadeiba et al., 2012).  
 
Dendritic cell development takes place in the bone marrow, with DC being of myeloid origin 
with Macrophage and Dendritic cell Precursors (MDP) giving rise to Common Dendritic cell 
Progenitors (CDP) (Figure 1.5). CDP can directly generate pDC through a stepwise 
developmental programme which can be traced through a pre-pDC stage that is 
CD11c+SiglecH- to a SiglecH+CCR9lo intermediate before giving rise to CCR9+ differentiated 
pDC (Dursun et al., 2016). Additionally, CDP also give rise to pre-cDC with all stages 
requiring exposure to fms-like tyrosine kinase 3 ligand (Flt3L) (Liu and Nussenzweig, 2010). 
Pre-cDC are able to migrate out of the bone marrow and enter the periphery where they can 
then give rise to cDC1 and cDC2 (Liu et al., 2009) (Figure 1.5). Further it has been suggested 
that there may be priming that occurs in the bone marrow skewing the cDC precursors 
towards either the cDC1 or cDC2 lineage prior to their release (Schlitzer et al., 2015). 
Additionally it appears possible that lineage skewing may relate to the expression of the 
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transcription factor Zeb2 which was shown to be required for the development of the cDC2 
population as well as pDC with CD11cCrexZeb2fl/fl mice having significant skewing towards 
cDC1 to the detriment of cDC2 (Scott et al., 2016).   
 
1.3.2.1 Intrathymic cDC1 
The exact origin of the cDC1 that develop within the thymus has been an issue that has long 
been debated in the literature. Early reports were suggestive of thymic DC development from 
a common T/DC associated progenitor with evidence for this stemming from the presence of 
DHJH immunoglobulin rearrangements, common to both intrathymic DC and developing 
thymocytes with further intrathymic transfers of CD4low precursors developing into both 
thymocytes and intrathymic cDC populations (Corcoran et al., 2003, Ardavin et al., 1993, Wu 
et al., 1996).  
 
However a more recent proposal suggests that pre-cDC migrate into the thymus from the bone 
marrow and contribute towards the DN1c subpopulation of early thymic settling progenitors 
which is associated with cDC1 development (Luche et al., 2011). There was further 
confirmation in this study of thymocyte dependent cDC1 development, as depletion of the 
cDC1 population through Interferon Regulatory Factor 8 (Irf8)-/- models saw that the cDC1 
population was not reconstituted by DN1a/b thymocyte associated progenitors but rather an 
independent population. Supporting this study was additional work showing that through the 
mapping of the lymphocyte associated IL-7 receptor in a reporter model, IL-7R was only ever 
associated with thymocytes and that intrathymic cDC1 populations remained again to be a 




Dendritic Cell Development 
Dendritic Cell development begins in the bone marrow with Macrophage and Dendritic cell 
Precursors (MDP) giving rise to monocytes which develop into macrophages in the tissues. 
But MDP can also give rise to Common Dendritic cell Progenitors (CDP) through Flt3L 
exposure. CDP then are able to reconstitute the dendritic cell lineage with production of pre-
cDC, which egress from the bone marrow into tissue to develop into conventional dendritic 
cell populations of cDC1 and cDC2. CDP can also produce pre-pDC, which develop into 
pDC the bone marrow providing a pre-determined phenotype prior to their release into the 





















The potential for crossover between lineages however was later shown with a subpopulation 
of DN1a/b being identified that were able to express CX3CR1. Further, under the conditions 
of an empty dendritic cell niche within the thymus, it was seen that this CX3CR1+ population 
has the potential to give rise to cDC1 (Lyszkiewicz et al., 2015). However despite this, the use 
of barcoding in this study later highlighted that when looking at thymic DC, splenic DC and 
T-cells there was indeed a closer association of thymic and splenic DC than that between
thymic DC and T-cells suggesting again a myeloid developmental origin for cDC1 that 
remained to be distinct from that of the lymphoid lineage under normal developmental 
conditions. As a result, research has been varied concerning the origin of thymic cDC1 
however it appears to be clear from more recent findings that under normal developmental 
conditions, cDC1 develop from a pre-cDC progenitor that is distinct from the lymphoid 
lineage (Luche et al., 2011).  
Intrathymic cDC1 are typically localised to the thymic medulla which is mainly due to their 
expression of the C-subfamily of chemokine receptors XCR1 and the production of its ligand 
XCL1 in an Aire-dependent manner by mTEC (Lei et al., 2011). Their localisation is however 
important in their function as they have been suggested to assist central tolerance 
predominately by cross-presenting antigen from Aire expressing mTEC through the uptake of 
self-antigens via apoptotic material release or trogocytosis (Viret et al., 1999, Kyewski and 
Feuerer, 2014).   
1.3.2.2 Migratory Thymic cDC2 and pDC  
As pre-cDC enter the periphery such as the spleen from the bone marrow, they can also give 
rise to cDC2 and extrathymic cDC1. Peripherally, cDC2 along with pDC, reside in the spleen 
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and circulate in the periphery accessing lymph nodes through the blood via high endothelial 
venules where they can integrate within the dendritic cell network to subsequently mature and 
await antigen activation in an immune response (Geissmann et al., 2010). 
 
Further common to both cDC2 and pDC is their ability to migrate and reside within the 
thymus. Following peripheral maturation, these populations of DC can home to the thymus at 
a general level through cell adhesion molecule expression (Bonasio et al., 2006).  In this 
study, interaction between P-selectin and P-selectin glycoprotein ligand 1 (PSGL-1) was 
shown to be necessary for DC rolling on the endothelial surface. Additionally there was 
involvement of α4 integrin which constitutes the molecule very late antigen 4 (VLA-4) on DC 
and binds to vascular cell adhesion molecule -1 (VCAM-1) on endothelium, to support 
extravasation into the thymus with blockade causing a subsequent reduction in homing ability 
of these DC populations. 
 
cDC2 are specifically thought to be recruited to the thymus through their expression of CCR2 
with the corresponding ligand Monocyte Chemotactic Protein-2 (MCP-2) being mainly 
expressed on cortical keratin-8 positive stromal cells (Baba et al., 2009). This study went on 
to show that cDC2 tend to be localised around blood vessels through MCP-2 expression in 
perivascular regions. pDC on the other hand migrate towards the thymus via CCR9 
expression, attracted to cTEC producing CCL25 (Hadeiba et al., 2012). This study used 
multiple different knockout models such as CCR9-/- which highlighted the requirement for 
pDC to express CCR9 to gain entry into the thymus, as absence of CCR9 led to abrogation of 
pDC thymic entry. Additionally, whether pDC may possibly be recruited to the thymus 
through CCR7 ligands is still a contentious issue as it was shown that despite low receptor 
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expression by pDC, they still appeared receptive to the ligands when present in transwell 
migration assays in lymph node studies (Seth et al., 2011).  
 
Furthermore, this migratory potential of cDC2 and pDC was shown in a study by Hadeiba et 
al., 2012, where it was illustrated through intravenous flurosphere injections, that cDC2 and 
pDC could both capture flurospheres and migrate to the thymus transporting the flurospheres 
with them for intrathymic presentation. In addition painting of flurospheres on the skin also 
led to DC within the thymus that were flurosphere positive –highlighting the widespread 
ability of DC to capture, process antigen and migrate to thymus (Bonasio et al., 2006). 
 
1.3.2.3 Dendritic Cells and Negative Selection 
cDC2 and pDC populations have been shown to be able to support the process of negative 
selection following migration into the thymus carrying peripheral self-antigens. At a 
phenotypic level, the capacity of migratory DC populations to potentially support negative 
selection became apparent when thymic DC were compared with splenic counterparts and it 
was shown that cDC2 undergo extensive proliferation upon entry into the thymus with 
upregulation of MHCII, CD11c and CD86 expression. Similarly pDC were shown to enlarge 
and upregulate MHCII when entering the thymus along with their expression of CD86 whilst 
still maintaining a plasmacytoid morphology, making both populations primed to interact 
with developing thymocytes and support tolerance induction (Li et al., 2009). Their ability to 
physically induce negative selection was suggested using Ovalbumin (OVA) models whereby 
OVA-pulsed DC were transferred into transgenic OT-II Rag-/- expressing mice and 
consequentially there was a resultant peripheral reduction in OT-II T-cells compared to 
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controls, due to the interaction of developing cognate thymocytes with OVA expressing DC 
and the induction of negative selection (Bonasio et al., 2006).  
In addition cDC2 were further shown to capture and present blood-borne antigen for negative 
selection within the thymus as they lay situated around blood vessels (Atibalentja et al., 2009, 
Atibalentja et al., 2011). This was shown through injection of serum IgG and Ovalbumin 
(OVA) that was later seen captured by cDC2 within the thymus (Baba et al., 2009). 
Furthermore an interesting study suggested that there may be temporal variations in the ability 
of the different DC populations to support central tolerance through the monitoring of 
negative selection during ontogeny.  This study illustrated in mice that there was inefficiency 
in negative selection at newborn stages of ontogeny but that this capacity increased by 4 
weeks and appeared to directly correlate with greater levels of cDC2 migrating into the 
thymus, with increased antigen processing and presentation ability compared to cDC1 or pDC 
at 4 weeks of age (Kroger et al., 2016). Therefore this suggests that there is a vast requirement 
for cDC2 at early stages of development to support central tolerance within the thymus.   
Additionally, supporting migratory DC, cDC1 have been long associated with the acquisition 
of antigen directly from mTEC and using this process to in turn cooperatively support 
tolerance. This was shown to be important particularly regarding CD4 T-cell deletion in a 
study where the RIP-mOVA model was used to address deletion of OT-II CD4 SP T-cells 
(Gallegos and Bevan, 2004). It was seen that when OT-II bone marrow (BM) was transferred 
into a RIP-mOVA model there was efficient deletion of OT-II T-cells. However when OT-II 
MHCII-/- BM was transferred into RIP-mOVA mice there was reduced deletion. Therefore 
there was a requirement for hematopoietic expression of MHCII for cross-presentation of 
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OVA from mTEC, later shown specifically to map to DC for the effective deletion. 
Additionally in a recent study, combined depletion of mTEC along with cDC1 led to the 
induction of organ specific autoimmunity that was not seen when either mTEC or cDC1 were 
singularly reduced– again highlighting the cooperation between these two populations in 
negative selection (Herbin et al., 2016). Similarly in aly/aly mice that have a point mutation in 
the NFκB inducing kinase (NIK) gene, mTEC and cDC1 numbers were disrupted and 
consequentially autoimmunity was seen in these mice as it was again suggested that there is a 
requirement for cross-talk between cDC1 and mTEC for correct negative selection which in 
this study was shown to be dependent upon normal NIK presence (Mouri et al., 2014).  
 
Furthermore, it was recently shown that thymic DC can actively acquire EpCAM-1 from TEC 
which increases DC ability to bind to TEC and as a result support increased peptide MHC 
complex transfer between TEC and DC (Kroger et al., 2017). cDC1 appeared to be by far the 
most efficient at this process, however there was some small contribution also from cDC2. 
This transfer was cell-cell contact dependent and restricted completely to thymic cDC – 
reinforcing the ability of thymic DC to support self-antigen presentation within the thymus to 
ensure central tolerance. 
 
1.3.2.4 Dendritic Cells and T Regulatory Cell Induction 
As well as DC being strongly associated with a role for negative selection, they are also 
suggested to support central tolerance through induction of T Regulatory cells within the 
thymus (Proietto et al., 2008b). However this idea was originally controversial as it was 
shown that ablation of DCs led to comparable Treg numbers as seen in WT (Ohnmacht et al., 
2009) (Darrasse-Jeze et al., 2009). However as general transgenic models indicated that 
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cognate antigen presented by DC could promote Treg development, the role of DC in Treg 
induction gained support. Further work has suggested that different DC populations may be 
more effective at this process than others, whilst some arguments remain as to whether DC 
are actually more important than mTEC at Treg induction or not, or alternatively if there is a 
synergy between both DC and mTEC in this process (Herbin et al., 2016).   
 
Importantly, the capacity of APCs to support thymic Treg induction was confirmed through 
analysis of Treg TCR clones utilising various transfer models (Perry et al., 2014). Transfer of 
MHCII-/- BM resulted in a marked reduction in enrichment of Treg and specifically saw 
reduced Aire dependent TRA expression as a consequence, further supporting a role for Aire 
specific antigen cross-presentation by thymic APCs in Treg generation. Importantly using a 
CIITA knockdown model, which reduces the MHCII expression on mTEC, only a modest 
alteration was seen in the frequency of Treg which were reduced to far less of an extent than 
when MHCII deficient BM – suggestive that BM APCs supported selection of more frequent 
Treg TCRs. Further work showed that DC were responsible and additionally using CD8α+ 
Batf3-/- hosts that indeed suffer cDC1 loss, the same phenotype was recapitulated with regards 
to Treg population selection. As a result this study highlights further that the cross-
presentation of antigen from mTEC via cDC1 is not only pivotal for negative selection but 
also the induction of nTreg.  
 
Additionally cDC2 have been implicated in Treg studies through in vitro co-culture assays 
using cDC2 and Treg precursor cells that were CD4+CD25-CD8- in phenotype. This showed 
that there was clear induction of precursors into a Treg phenotype and that furthermore this 
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was far greater by thymus specific cDC2 than it was when completed with cDC1 (Proietto et 
al., 2008b).  
As a result, combining all of this previous research, it is becoming more apparent that whilst 
still considering the necessary requirement for mTEC in tolerance, there is an overwhelming 
necessity for the presence of DC populations within the thymus for full induction of central 
tolerance and autoimmune prevention. This lies not only with the process of negative 
selection of autoreactive T-cells, for which all thymic DC populations appear to be effectively 
skilled, but also through their individual abilities to drive the production of Treg within the 
thymus which peripherally remain vital to maintain tolerance.  
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1.4 General Aims 
The thymus is the site of central tolerance, acting to prevent the escape of autoreactive 
thymocytes into the periphery where they have the ability to initiate an autoimmune response, 
causing damage to the host. As a result, the factors regulating the maintenance of the cellular 
mediators of this process are important to determine. Furthermore, the cooperation between 
dendritic cells and mTEC in this process, lends itself to question whether these populations 
are somewhat dependent upon one another for successful negative selection. Furthermore, 
despite information concerning how pDC and cDC2 are recruited to the thymus, how 
intrathymic cDC1 progenitors are recruited to support persistence of the cDC1 population in 
the thymus has been little described. 
As a result chapter one and two aim to address: 
1) What the involvement of the factors regulating the medulla are in the maintenance of
thymic DC? There will also be consideration of the subsequent impact of any alterations in 
tolerance regulators on the peripheral development of autoimmunity.  
2) How are the progenitors to the intrathymic cDC1 population regulated by the thymus?
Finally, given that dendritic cells in the thymus have had their function well defined, the third 
chapter will consider the alternative accessory cell - thymic eosinophils, by addressing: 
3) What is the requirement for thymic eosinophils? Are they implicated in thymus














All mice used for experimental work were bred within the Biomedical Services Unit 
(Birmingham, UK). All breeding was conducted under specified regulations as stated by the 
Home Office. For experimental purposes, all mice were sacrificed and culled under Schedule 
1 procedure, with adult mice being between the ages of 8-12 weeks and of mixed gender 
unless otherwise stated (Table 2.1). For analysis of transgenic mouse strains, depending upon 
the background, wild-type (WT) C57/BL6 or Balb/c controls were taken alongside for 
unmanipulated comparison. For thymic analysis at the embryonic level, timed matings were 
arranged and the presence of a Vaginal Plug (VP) in the female was used to identify the start 
of the gestation period (D0) which usually lasts between 18 and 21 days. Pregnant females 
were harvested when embryos were at Embryonic Day 15-18 (E15-E18) for thymic analysis. 
2.2 Media For Cell Preparations and Cell Cultures 
For cells to be analysed by either disaggregation or tissue enzymatic digestion, tissues were 
prepared for both methods in RF10 medium – detailed in Table 2.2. All enzymes used in this 
process have been listed (Table 2.3) For analysis of samples following the digestion process 
however, RF10 was no longer used and MACs Buffer (Table 2.4) was used instead due to the 
presence of EDTA in the medium in turn acting to prevent the clumping of the more sticky 
digested material.  For culturing of cells Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Table 2.5) was used. All media were stored in the fridge at 4°C until use and all reagents 
were obtained from Sigma Aldrich (Poole, UK). For culturing of embryonic tissue in Fetal 
Thymic Organ Culture (FTOC) (section 2.3.4), DMEM was again used but sometimes in 
order to remove all haematopoietic cells and maintain the core thymic epithelial structure as 
an empty niche - 2-deoxyguanosine (dGuo, Sigma) was added at a final concentration of 
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1.35mM from the stock (9mM) and stored in aliquots at -20°C. This method was necessary 
for FTOC preparation prior to Kidney Capsule Transplant (KCT) to explore the colonisation 
of populations of interest into this ‘empty’ thymus (section 2.3.4).  
Table 2.1 Wildtype and Genetically Altered Mouse Strains Used 
Strain Phenotype Source 
C57Bl/6 Wildtype BMSU 
Balb/c Wildtype BMSU or externally 
BoyJ Wildtype BMSU 
CD45.1xCD45.2 Wildtype BMSU 
Ltbr-/- Mice suffer from alterations in secondary 
lymphoid organs with; disrupted splenic 
architecture, an absence of Peyers Patches and 
all lymph nodes (Futterer et al., 1998).  
Klaus Pfeffer 
University of Düsseldorf 
Ltbrfl/fl Mice were generated through cre/loxP 
technology with targeting of the Ltbr allele with 
loxP flanking (Wang et al., 2010b). 
Alexei V. Tumanov 
University of Chicago 
Foxn1Cre Mice are heterozygous for Cre with insertion 
next to the Foxn1 gene. Mice were used for 
control purposes so did not have any detrimental 
phenotype (Gordon et al., 2007). 
The Jackson Laboratory 
Foxn1Crex Ltbrfl/fl Crossing of Foxn1Cre mice with homozygous 
Ltbrfl/fl mice; mice were generated whereby 
LTβR was absent from Foxn1 expressing cells. 
Mice had no aberrant autoimmune phenotype. 
Lymph nodes were present.  
Generated in house 
PDGFRβCre Mice are heterozygous for Cre with insertion 
next to the PDGFRβ gene. Mice were used for 
controls so did not have a detrimental phenotype 
(Foo et al., 2006). 
Cancer Research 
Technologies, London 
PDGFRβCrexLtbr fl\fl Mice were generated by crossing heterozygous 
PDGFRβCre mice with homozygous Ltbrfl/fl mice. 
Mice had a normal phenotype.  
Generated in house 
Tie2Cre Mice are heterozygous for Cre which is driven 
by expression of the endothelial specific 
promoter Tie 2. Mice were used for control 
purposes so did not have any detrimental 
phenotype (Kisanuki et al., 2001). 
The Jackson Laboratory 
Tie2Cre x Ltbrfl/fl Generation of mice by crossing Tie2Cre with 
homozygous Ltbrfl/fl mice. Mice had a deletion of 
LTβR from Tie2 expressing endothelial cells. No 
detrimental phenotype was detected.  
Generated in house 
Wnt1Cre Generation of mice that express the Cre 
recombinase under control of Wnt1 promoter in a 
The Jackson Laboratory 
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heterozygous manner. These mice have no 
detrimental phenotype and were used as controls 
for Wnt1CrexLtbrfl/fl mice (Lewis et al., 2013).  
Wnt1CrexLtbrfl/fl Mice were generated by crossing Ltbrfl/fl and 
Wnt1Cre mice. This targeted deletion of LTβR 
from Wnt1Cre expressing mice.  
Generated in house 
Flk1Cre Generation of Cre recombinase gene insertion 
into exon 1 of the Flk1 promoter, with mice 
being heterozygous for Cre. Mice have no 
detrimental phenotype and were used as 
Flk1CrexLtbrfl\fl controls (Motoike et al., 2003).  
The Jackson Laboratory 
Flk1CrexLtbrfl\fl Generated through the crossing of Flk1Cre and 
Ltbrfl\fl mice to result in the deletion of LTβR 
from Flk1Cre expressing cells.  
Generated in house 
TCRα-/- Mice have a targeted mutation leading to the loss 
of the αβ T-cell receptor expression. As a result, 
mice suffer from a loss of CD4+ or CD8+ T-cells. 
The Jackson Laboratory 
Ccr7-/- Mice have loss of the CCR7 receptor expression 
and so are unresponsive to CCR7 ligands.  
Antal Rot 
University of York 
plt/plt Mice contain a spontaneous deletion on 
chromosome 4 of the Ccl21/Ccl19 loci. 
Ultimately this leads to removal and loss of the 
production of these ligands.  
Antal Rot 
University of York 
Ccl19-/- Mice have no clear detrimental phenotype with 
maintenance of lymph nodes and splenic 
architecture, but simply carry a homozygous 
deletion of Ccl19 gene (Link et al., 2007). 
Sanjiv Luther 
University of Lausanne 
Ccl21-/- Mice were generated to lack Ccl21 expression by 
a knock-in system using a targeting vector 
containing Ccl21a genomic BAC fragments and 
tdTomato-encoding cDNA. When both alleles 
were targeted there was loss of Ccl21 
expression. Deficient mice were found to 
develop some peripheral autoimmunity (Kozai et 
al., 2017). 
Yousuke Takahama 
University of Tokushima 
dblGATA Mice have an x -linked deletion of a high affinity 
double Gata-binding site in the Gata1 promoter. 
As a result there is selective loss of eosinophils 
(Yu et al., 2002).  
The Jackson Laboratory 
Il4rα-/-  Homozygous absence of Il4ra in these mice 
generated by homologous recombination using 
Cre\loxP method (Mohrs et al., 1999).  
Frank Brombacher 




Table 2.2: Constituents of RPMI-1640 Hepes Medium (RF10-H) 
 
Table 2.3: Enzymes Used During Tissue Digestion 
 
   
Stock Substance Volume  Final Concentration Company Source 
RPMI-1640 including 20mM Hepes, 
L-glutamine and w/o bicarbonate 
20ml - Sigma, Poole, UK 
Fetal Calf Serum (FCS) 
 – Heat Inactivated 
2ml 10% Sigma, Poole, UK 
200mM L-Glutamine 200µl 2mM Sigma, Poole, UK 
5000IU/ml Penicillin and 
Streptomycin 
400µl 100 IU/ml Sigma, Poole, UK 
Stock Substance Volume  Final 
Concentration 
Company Source 
RF10 composed as in table 2.2 1ml sample - Sigma, Poole, UK 
Collagenase D or Collagenase 
Dispase 10mg/ml 
25µl 2.5mg/ml Sigma, Poole, UK 
Deoxyribonuclease 1 100mg/ml 40µl 0.4mg/ml Sigma, Poole, UK 
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Table 2.4: Constituents of MACs Buffer 
Table 2.5: Constituents of Dulbecco’s Modified Eagle’s Medium (DMEM)	
Stock Substance Volume Final Concentration Company Source 
Dulbeccos phosphate buffered saline 
without calcium or magnesium 
500ml - Sigma, Poole, UK 
Fetal Calf Serum (FCS) 
Heat Inactivated 
2.5ml 5% Sigma, Poole, UK 
EDTA 0.05M 2ml 0.02M Sigma, Poole, UK 
Stock Substance Volume Final Concentration Company Source 
Dulbecco’s medium with 3.7g/l 
bicarbonate and w/o glutamine 
20ml - Sigma, Poole, UK 
Fetal Calf Serum (FCS) 
Heat Inactivated 
2ml 10% Sigma, Poole, UK 
5000 IU/ml Penicillin and 
Streptomycin 
400µl 100IU/ml Sigma, Poole, UK 
200mM L-Glutamine 400µl 4mM Sigma, Poole, UK 
1M Hepes 200µl 10mM Sigma, Poole, UK 
5000 M2 Mercaptoethanol 200µl - Sigma, Poole, UK 
100x Non-essential amino acids 200µl - Sigma, Poole, UK 
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2.3 Isolation of Mouse Tissue For Analysis 
Sacrificed adult mice were dissected within the BMSU facility to remove thymus and often 
spleen. These organs were removed using scissors and forceps before being placed into RF10 
medium. In the laboratory, organs were cleaned under a microscope to ensure the removal of 
any fat or blood that remained on the tissue. Depending upon the cell type being analysed, 
preparation of tissues differed and are detailed according to target cell type in the subsections 
of 2.3 below. For the isolation of embryonic thymi, within a laminar flow hood, embryos 
were removed from the amniotic sac and placed under a dissection microscope. There was 
then subsequent identification and careful removal of the embryonic thymic lobes. Embryonic 
thymi were then stored in RF10 for immediate analysis or transferred into culture medium, 
DMEM, for further study in an FTOC or KCT system.  
 
2.3.1 Preparation of Mouse Tissue For Dendritic Cell and Eosinophil Analysis 
Thymus and spleen, once isolated and cleaned, were placed into the enzyme mix containing 
Collagenase D and DNAse I (Sigma) diluted in RF10 for digestion – detailed in table 2.3. 
Tissue was then cut into small pieces of around 2mm using scissors in an eppendorf before 
being transferred into 5ml Polypropylene round-bottomed tubes for digestion (Falcon, 
Thermo Fisher Scientific). Digestion occurred at 37°C on a Thermoblock (Eppendorf 
Thermomixer C) which shook at 650rpm. This digestion process occurred for approximately 
20-30 minutes or until all of the tissue appeared to have been digested. Regular pipetting 
during this time was employed to help to encourage the fragmentation and disaggregation of 
tissue. Once digested, tissue was removed from the thermoblock and enzyme activity was 
stopped through the addition of 30µl of 0.5M EDTA (Sigma Aldrich), which chelated 
magnesium and calcium ions and therefore prevented sustained enzyme action. Samples were 
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then washed with MACs Buffer before being filtered through membrane-mesh into a 15ml 
Falcon (Corning Centistar, RNAse/DNAse free) and spun in the centrifuge for 4mins 
1400rpm at 4°C – these are the typical conditions always used for centrifugation unless stated 
otherwise. Supernatant was removed and thymus samples were resuspended in 2ml of MACs 
buffer. Splenic samples were resuspended in Red Blood Cell (RBC) lysis buffer Hybri-max 
(Sigma Aldrich) for 10 minutes at room temperature before being neutralized with an 
equivalent volume of MACs buffer – spun down in the centrifuge and resuspended in 2ml 
MACs. When samples were not being used, tubes containing cells were always kept on ice. 
Following resuspension, cells were counted using AccuCount Blank Beads (Spherotech Inc) 
whereby a known number of beads could be added to a known volume of cells from the 2ml 
total sample suspension. By running samples for counting on the LSR Fortessa Machine 
(BD), the beads and total cells could be distinguished and gated for counting due to different 
granularity and sizing of the cells. A known number of beads could be collected and 
compared to the subsequent number of cells obtained and a calculation then allowed the 
generation of the cell counts per thymus or spleen. This technique for cell counts was 
maintained throughout the entire study.  
 
2.3.2 Preparation of Mouse Tissue For T-cell Analysis 
To allow for T-cell analysis of thymic and splenic tissue, cleaned tissue was disaggregated 
using cut edge frosted end glass slides (Thermo Scientific) to release the cells into a petri-dish 
containing RF10 medium. The slides were then washed in RF10 and discarded, leaving cells 
suspended in medium. This was then filtered through a membrane-mesh filter into 15ml 
Falcon tubes (Corning Centistar RNAse/DNase free) to allow any remaining clumps to be 
removed prior to analysis. Centrifugation then occurred and supernatants were removed 
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before pellets were resuspended in 2mls RF10 for thymic tissue and placed on ice whereas 
splenic tissue was resuspended in RBC lysis buffer Hybri-max (Sigma Aldrich) and left at 
room temperature for 10 minutes. Following successful lysis, samples were neutralized with 
an equivalent volume of RF10 before being centrifuged and resuspended in 2mls RF10. 
Samples were then ready to be counted as specified in 2.3.1.  
2.3.3 Preparation of Mouse Tissue For Thymic Epithelial Cell Analysis  
To enable the isolation of thymic epithelial cells (TEC) a different variation of enzyme mix 
was used compared to that previously described for eosinophil and dendritic cell populations. 
For TEC, Collagenase Dispase and DNAse I were used and diluted in RF10 medium as listed 
in table 2.3. Thymus samples were placed into the digestion mix and cut into small pieces 
approximately 2mm in size, in eppendorfs before being transferred into 5ml Polypropylene 
round bottom Digestion tubes (Falcon, Thermo Fisher Scientific). Digestion on the 
Thermoblock (Eppendorf Thermomixer C) was at 37°C with it continuously rotating at 
650rpm. This digestion process was maintained for up to 30 minutes or until tissue was 
disaggregated fully. Samples were then removed from the thermoblock and enzymes 
neutralized with the addition of EDTA (0.5M, Sigma Aldrich). Samples were then washed 
with MACs buffer and transferred through filters of membrane-mesh into 15ml Falcon tubes 
(Corning Centristar). Centrifugation of samples then allowed supernatant to be removed and 
resuspension in 2mls MACs to prepare the cells ready for counting (as in section 2.3.1). For 
TEC analysis, an additional step was required post counting and prior to antibody staining 
such that there could be depletion of CD45+ cells to enrich the TEC populations (CD45-). This 
was possible as counted cells were then incubated in the fridge at 4°C with anti-CD45 beads 
(Miltenyi Biotech) in MACs buffer for 20 minutes. Cells could then be passed through a LS 
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Column (Miltenyi Biotech) on a MACs Magnet to allow for the magnetic separation of CD45 
labelled cells. This system acted to pull the CD45+ cells from the cell suspension and as a 
result, allowed the relative enrichment of the TEC population within the thymus. Cells were 
collected in 15ml Falcon tubes (Corning Centristar) and then centrifuged and resuspended 
prior to cell staining.  
 
2.3.4 Fetal Thymic Organ Culture System 
Upon isolation of thymic lobes from embryos, lobes could be cultured in an FTOC system, 
which provided a supportive growth environment to encourage survival of FTOC at this early 
stage. Often, dGuo was added to cultures (mentioned in section 2.2) in order to remove 
hematopoietic cells from thymic lobes which was necessary in experiments utilising 
engraftment under the kidney capsule; possible 5-7days after dGuo culture. This approach 
was required to study the colonisation of these grafted thymic lobes by host progenitor cells 
as it provided an empty thymic niche within an in vivo system. For culture set-up, DMEM 
medium was either supplemented with dGuo or left as DMEM alone and placed in either 
35mm or 90mm petri-dishes (Sterilin). These held 2mls DMEM (+300µl dGuo) or 4mls 
DMEM (+600µl dGuo). In these dishes sterile artiwrap sponge supports (Medipost Ltd) 
around 1cm2 in size were placed. On top of this, 0.8µm sterile nucleopore filters were 
positioned. Using a mouth pipette with a sterile glass pipette attached, lobes were transferred 
onto filters. Up to six lobes could be placed onto one individual filter. Following this, petri 
dishes were put in a humidified chamber at 37°C 10% CO2 for 10 minutes to normalise pH to 
between 7.2 and 7.4. Culture boxes containing the petri dishes were then sealed and left in the 
incubator for 5-7 days prior to experimental transfer (section 2.8).  
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2.4 Flow Cytometric Analysis of Target Populations 
2.4.1 Cell Surface Antibody Staining 
Antibodies used to stain markers to identify target cell populations for analysis were, for the 
most part, primary and directly conjugated antibodies. These have been listed in Table 2.6 
along with any secondary antibodies used to identify any unconjugated or biotin tagged 
primary antibodies. For staining, samples were loaded into a 96 well-plate (Thermo 
Scientific). For all analysis, 5 million cells were stained – unless there were fewer to begin 
with due to irradiation damage or depletion techniques. If this occurred, then the entire sample 
would be stained. 100µl of antibody was always used per sample. Staining was completed on 
ice in a covered box for 20 minutes. The only exception being detection of CCR7 expression 
whereby the plate was covered with foil and incubated at 37°C for 20 minutes when this 
antibody was added. Primary antibodies were added initially, then samples were washed twice 
with 100µl of MACs buffer (Table 2.4) and centrifuged at 1400rpm, 4°C for 2 minutes before 
the supernatant was flicked off. Pellets were then resuspended in the secondary or 
subsequently additional tertiary antibodies and the same incubation on ice for 20 minutes took 
place. Within staining combinations it was imperative to include samples as controls within 
the combination whereby there were samples without the primary step, or isotype controls 
were used as well as possibly fluorescence minus one samples. All controls were used to set 
the fluorochrome level for negative staining such that positive populations could then be 
easily identified as levels of fluorescence above this negative gate.  Once staining was 
completed, cells were washed again, resuspended in fresh MACs buffer and transferred into 
polystyrene 12.5ml FACS tubes (Falcon) to be run on the LSR fortessa (BD).  
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Table 2.6: Antibodies For Flow Cytometric Analysis 
Antibody 
Specificity 
Clone Flurochrome Dilution 
Factor 
Company 
Aire 5H12 FITC  eBioscience 





BrdU MoBU-1 APC 1:100 BD 
CCL21 Polyclonal 
rabbit 
- 1:100 Lifespan 
Biosciences 
CCR7 4B12 PE 1:50 eBioscience 
CD115 AFS98 APC 1:100 eBioscience 
CD11b M1/70 BV711 1:200 Biolegend 

































CD40 323 PE 1:100 BD Pharmingen 
CD45 30-F11 APCCy7 1:800 eBioscience 
CD45.1 A20 APCCy7 1:200 eBioscience 
CD45.2 30-F11 BV786 1:400 Biolegend 
CD5 53-7.3 Biotin 1:100 eBioscience 
CD62L MEL-14 APC 1:3000 eBioscience 
CD69 H1.2F3 PerCpCy5.5 1:200 eBioscience 
CD8 53-6.7 BV510 1:200 Biolegend 
CD80 16-10A1 BV605 1:400 Biolegend 
CD86 GL-1 BV650 1:400 Biolegend 
cKit 2B8 PerCpCy5.5 1:50 eBioscience 
Cleaved Caspase-
3 
5A1E PE 1:50 Cell Signalling 
Technology 




- 1:200 IBL 












Goat-anti Rabbit  IgG Alexa Fluor 647 1:200 Molecular Probes 
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gp38 eBio8.1.1 PE 1:800 eBioscience 
Gr1 RB6-8C5 FITC 1:200 Biolegend 
LTβR eBio3C8 Biotin 1:100 eBioscience 
LTβR Isotype IgG1κ  Biotin 1:100 eBioscience 
Ly51 BP-1 PE 1:800 BD Pharmingen 






PDCA-1 927 Pacific Blue 1:200 Biolegend 












Streptavidin - PeCy7 1:1500 eBioscience 
TCRβ  H57-597 APCCy7 1:200 eBioscience 
Ter119 TER-119 A700 1:200 Biolegend 
UEA-1 - Biotin 1:10,000 Vector Labs 
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2.4.2 Intracellular Antibody Staining 
Intracellular staining was occasionally required additionally after surface staining (section 
2.4.1), to identify transcription factors such as Foxp3 or Aire as well as apoptotic markers 
such as Cleaved Caspase-3. All staining for this was maintained in a 96 well-plate subsequent 
to initial primary antibody staining, with washes being in a 100µl volume and centrifugation 
being completed at 1400rpm, 4°C for 2 minutes.  
For the analysis of Foxp3, Aire and Caspase-3, all required a Transcription Factor Staining 
Buffer Set (eBioscience). For this technique, cells were surface stained and then incubated 
with the eBioscience Fixation/Permeabilisation Solution; composed of 1 part fixative 
concentrate to 3 parts diluent with a volume of 200µl added per well per sample. Foxp3 and 
Aire staining required that cells were fixed for 40 minutes on ice, however for the Caspase-3, 
cells were fixed for only 10 minutes. Following this, cells were then all washed with the 
permeabilisation buffer in the kit which required diluting from the 10x stock provided, to a 
workable 1x diluted solution made using distilled water. This wash was completed twice. 
Following this, cells were then stained for Foxp3, Aire or Caspase-3 and again staining 
occurred on ice for 20 minutes.  These intracellular antibodies were further diluted in the 1x 
permeabilisation buffer. All subsequent washes were also completed with the 
permeabilisation buffer but prior to FACs analysis (LSR Fortessa) of samples, they were all 
ultimately resuspended in MACs buffer.  
2.4.3 Bromodeoxyuridine Proliferation Analysis 
To support the detection of proliferating cells, the technique of Bromodeoxyuridine (BrdU) 
incorporation was used. For this process, 1.5mg BrdU was injected into mice intraperitoneally 
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18hours prior to sacrifice. For analysis, tissues were harvested and digested as appropriate for 
the cell type being analysed (Section 2.3). Once in a 96 well plate, cells were surface stained 
as section 2.4.1, for the identification of the desired target. Following washing of the cells 
after primary staining, samples were resuspended in 100µl BD Fix/Perm for 30 minutes 4°C. 
Samples were then washed with 1xPerm Buffer made with distilled water from 10x stock 
bottle, from the APC BrdU Flow Kit (BD Pharmingen). BD Cytoperm buffer plus, contained 
within the set, could then be added neat to samples for 10 minutes on ice. Washing again with 
1x Perm Buffer, cells were resuspended in 100µl BD Fix/Perm for 5 minutes on ice. Cells 
were washed again with perm buffer and resuspended in 100µl of diluted DNAse as 
manufacturers instructions and kept at 37°C for 1 hour.  Following another perm buffer wash, 
cells could then be stained for BrdU, with the antibody being made up in 1x Perm Buffer 
solution and incubated at room temperature for 40 minutes before being washed, samples 
were resuspended in MACs buffer and then ran on the LSR fortessa. 
2.4.4 Flow Cytometric Analysis 
All samples that were prepared and stained with antibody were ready to run on the fortessa. 
The LSR Fortessa (BD) was used for all flow cytometric analysis. This machine used the BD 
FACS diva software from which data was then exported for additional analysis on FlowJo 
8.7.3. Single colours were ran first as they were used to set voltages and compensations 
against the other colours in the combination. Cells analysed were initially pre-gated on FSC 
and SSC to only include viable cells. Samples that were controls for the staining such as 
isotype controls were than ran to set positive gates for the desired populations. This allowed 
positive staining from fluorochromes in actual samples to be determined and recorded.  
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2.5 Immunohistochemical Analysis 
2.5.1 Preparation of Tissue Sections 
Following successful isolation of tissue from adult mice, the thymus was cleaned to ensure 
removal of blood and excess fat from the lobes before being frozen on dry ice simply within a 
foil casing. All frozen tissue was mounted using Optimal Cutting Temperature compound 
(OCT) onto the microtome. Sections could then be cut on the cryostat machine which were 
7µm in depth and collected sections were placed onto multisport glass slides (Hendley-
Essex). Slides were then allowed to air dry for around an hour at room temperature before 
being fixed in acetone (Baker) for 20 minutes at 4°C. Slides were then air-dried again before 
being stored in the freezer at -20°C, ready to be antibody labelled for immunofluorescence.  
2.5.2 Staining of Tissue Sections For Immunofluorescence 
Stored sections were removed from the freezer and allowed to dry at room temperature for 30 
minutes before being rehydrated in Phosphate Buffered Saline (PBS, Sigma Aldrich) for 15 
minutes. During this time, antibodies were prepared and made up in 1% Bovine Serum 
Albumin (BSA) diluted in PBS (Sigma Aldrich). Rehydrated sections were then stained with 
primary antibodies (listed in Table 2.7). All antibody steps occurred in a humidified chamber 
at room temperature for 30 minutes. Slides were then washed in a PBS bath for 5 minutes 
before the next step could be added if necessary. Following all antibody staining steps, 
sections were covered with 4',6-diamidino-2-phenylindole (DAPI) which is a nuclear stain 
and assists with cellular visualisation during immunofluorescence. After another wash in 
PBS, sections were covered using a coverslip (Sigma Aldrich) and sealed using 1,4 
diazabicyclooctane (DABCO) in glycerol pH 7 to support the vital preservation of the 
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fluorochromes. Coverslips were then sealed using clear nail varnish around the edges and 
once dry, stored at -20°C. Confocal imaging was conducted using the Zeiss 780 Zen 
microscope. Various magnifications were used (x10, x25, x40).  
Table 2.7 Antibodies Used For Immunohistology Analysis  
Antibody 
Specificity 
Host/Clone Fluorochrome  Dilution 
Factor 
Company 
Aire  Rat/ IgG1κ  
5H12 
Alexa Fluor 488 1:100 eBioscience, 
ThermoFisher Scientific 
Fezf1/2 Rabbit/F441 - 1:200 IBL 
ERTR5 Rat/IgM - 1:5 W.van Ewijk  
Leiden University 
CD11c  Armenian 
Hamster/ 
IgG HL3 
Biotin 1:200 BD 
CD8  Rat/ IgG2b 
53-6.7 
Biotin 1:200 eBioscience, 
ThermoFisher Scientific 
CD4 Rat/GK1.5 Alexa Fluor 647 1:200 Biolegend 
IgG(H+L)  Goat FITC 1:100 Southern Biotech 
Anti-rabbit IgG  Donkey/IgG Alexa Fluor 594 1:1000 ThermoFisher Scientific 
Anti-Rat IgM Goat/IgM Alexa Fluor 
647/488 
1:200 Thermofisher, Scientific 
Streptavidin  Goat/IgG Alexa Fluor 
555/488 
1:1000 Thermofisher, Scientific 
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2.5.3 Confocal Quantitation 
WT, Ltbr-/-, Foxn1Cre, LtbrTEC thymi were obtained, frozen and sectioned as detailed in 2.5.1. 
For quantitation, 3-4 sections were taken throughout the whole thymus at differing depths. 
There was staining of these sections for CD11c and ERTR5 (detailed in 2.5.2, Table 2.7) 
before visualization on the Zeiss 780 Zen microscope.  Five pictures were taken per section 
per mouse of both the medullary and cortex areas of the thymus at a x40 magnification.  
Within each image, the region of cortex or medulla randomly selected filled the whole image 
area. From this, the total number of CD11c+ cells were then counted and distribution of these 
within the cortex or medullary area was noted such that the division anatomically regarding 
dendritic cell positioning could be determined.  
2.6 Stimulations of Cell Cultures 
Total thymus was obtained and prepared through the teasing method described in section 
2.3.2. Cells were then subsequently prepared and counted. If cells were being analysed for 
activation status of dendritic cells following stimulations, 2x106 cells were placed in each well 
of a 24 well-plate (Corning Costar) in a volume of 1ml/well of culture medium DMEM. 10µl 
of 1µg/ul stock solution was added forming a final concentration of 10µg/ml of anti-CD40, 
anti-LTβR or both were added to single cell containing wells, with some wells being left 
unstimulated (DMEM alone). These cultures were left at 37°C, 10% CO2, for two days before 
being harvested.  All cultures upon completion similarly had cells removed from the wells 
and washed into 15ml Falcon tubes. Wells were washed thoroughly with DMEM before being 
centrifuged and resuspended in RF10 medium. Cells could then be transferred into a 96 well 
plate (Thermo Scientific) and re-centrifuged 1400rpm 2mins 4°C. Primary antibodies were 
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then added in a volume of 100µl and if subsequent steps were necessary, they were completed 
following washes. Cells were finally washed and resuspended to be analysed on the Fortessa.  
2.7 Kidney Capsule Transplant 
In order to investigate how alterations in the thymic microenvironment in Ltbr-/- mice affected 
the colonisation of dendritic cell populations in comparison to that of WT controls, the kidney 
capsule transplant (KCT) system was used. This allowed transfer of E15 FTOC that had been 
set up 5-7 days prior to surgery in dGuo, depleting haematopoietic cells (detailed in 2.3.4), 
and leaving a thymic stromal casing that could be inserted under the kidney capsule of mice. 
After a period of 8 weeks, grafts were harvested and subsequent presence of host cells 
identified.  
For this process, WT host mice were used aged 7-10weeks. Mice had to weigh above 17g to 
undergo surgery and weights ensured that the correct dose of Buprenorphine (Tamgesic, 
Animal Care UK) was administered subcutaneously at least 1 hour before surgery.  Mice were 
anaesthetised with 4% Isoflurane (May and Barker, Dagenham UK) using oxygen as carrier 
fluid. Following induction of the anaesthesia, the change to a breathing pattern to a deeper 
and slower pace indicated a level of unconsciousness. Mice were then quickly shaved on the 
back left-hand side of the spine, wiped with Hibitane solution – an antiseptic solution, and 
transferred to a fitted facemask. In this set up, mice laid on their chest on a heat pad with their 
face fitted to the mask through which 2% Isoflurane was administered and maintained during 
surgery. Pedal reflex was checked prior to surgery to ensure no reaction and an unconscious 
state.  
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For surgery, all tools used were sterile and had been autoclaved prior to use and were 
maintained as sterile throughout surgery, with storage on sterile disposable drapes. An 
incision was made in the shaved region of the mouse on the left hand side in the area of the 
kidney.  This exposed the peritoneum, which was then cut also and widened with blunt 
scissors. The incision was held open with needle and suture (Vicryl 16mm) attached to needle 
holders. The kidney was lifted onto the skin surface by forceps that gripped onto kidney fat to 
avoid any direct damage to the kidney itself. The kidney was kept hydrated when outside of 
the body cavity by the repeated application of PBS soaked gauze.  
Using a dissection microscope, a small incision was made on the kidney capsule using forceps 
to allow an opening for thymus transfer. E15 FTOC thymic lobes were then carefully placed 
one at a time under the kidney capsule – a maximum of two lobes were placed under one 
kidney capsule. After confirmation that the lobes were in place, the kidney was encouraged 
back into the body cavity before suturing up the peritoneum and skin separately. The skin was 
then additionally secured with metal clips to ensure it would not open if sutures were to fall or 
be pulled out. Saline was administered subcutaneously to restore any fluid loss and mice were 
transferred to a warming box in the recovery room and monitored until they regained 
consciousness. Checks were regularly completed by BMSU staff following this point.  
2.8 Irradiations of Mice 
Mice were sometimes required to have treatment of irradiation either in preparation for Bone 
Marrow Chimera Generation (Section 2.9) or for a sub-lethal irradiation used as a model for 
damage. Prior to all irradiation models, mice were placed on Baytril for 7 days; this was 
additionally maintained for 1 week after the irradiation start date. For Bone Marrow 
Chimeras, mice were given a lethal dosage of irradiation that was split over two days.  When 
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mice were C57/BL6 in background, a single dosage of 500 rads of irradiation (CIS BIO 
International, Cedex, France) was given at the start of the protocol (day one) and again
repeated on the morning of day two. On the afternoon of day two mice were reconstituted 
with bone marrow with 5x106 cells transferred into each mouse. For sublethal irradiations, 
mice were Balb/c in background and given a dosage of 1x425 rad on the morning of day one 
of the protocol. 
2.9 Generation of Bone Marrow Chimeras 
Bone Marrow Chimeras (BMC) were used to identify which compartment; haematopoietic or 
stromal, was responsible for any defects in dendritic cell populations seen in knockout mouse 
models. However in addition, competitive mixed bone marrow chimeras were used to identify 
a possible cell-intrinsic role for CCR7 in regulating the presence of dendritic cell populations 
in the thymus by placing CCR7 deficient bone marrow in competition with WT bone marrow.  
Chimeras were generated through the removal of the tibia and femur bones from sacrificed 
donor mice. Bones were then cleaned to remove excess skin and fat before being cut above 
and below the knee joint in a sterile laminar flow hood to open up the ends of the bone and 
allow a needle to be able to be used to access bone marrow. A sterile needle 25g (Terumo 
Agani) and syringe (BD Plastipak) filled with MACs was then used to flush the bone marrow 
out into a 95mm petri dish (Sterilin). A 1ml pipette containing sterile MACs was used to 
break up any clumps of bone marrow within the petri dish before being transferred through 
sterile mesh into 50ml falcon tubes (Corning Centristar). Suspensions were centrifuged at 
1400rpm, 4°C for 10 minutes. Supernatants were removed and pellets lysed with 2mls RBC
lysis buffer Hybri-max (Sigma Aldrich) for 10 minutes at room temperature before being 
neutralised by an equivalent volume of sterile MACs and centrifuged. Samples were 
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resuspended and counted (as in section 2.3.1) before undergoing removal of mature T-cells 
from the bone marrow to reduce graft vs host disease complications upon transfer. Removal 
of T-cells used a CD3 based approach with anti-CD3 antibody (Table 2.6) being used to stain 
the samples, followed by anti-PE microbeads (Miltenyi Biotech) which were incubated with 
samples at 4°C for 20 minutes having been thoroughly vortexed. Miltenyi MACs column 
depletion was used with samples being passed through LS columns held in the QuadroMACs 
magnets, which were then washed several times with MACs buffer. This allowed CD3+ cell 
removal, which was checked through the proportional presence of CD3 PE positively stained 
cells in post-depletion samples compared to pre-depletion samples on the LSR fortessa. 
Counts were also completed post-depletion to allow for the correct numbers of cells to be 
resuspended in PBS without magnesium or calcium (Sigma Aldrich) for transfer into host 
mice. Host mice had previously undergone irradiation in accordance with section 2.8. A total 
of 5 million cells were transferred intravenously into the host mouse in a carrier volume of 
200µl. Baytril was maintained for a week post-transfer of bone marrow to minimise any 
infections until the haematopoietic compartment was reconstituted. Mice were then left for 8 
weeks prior to sacrifice and tissue harvest.   
2.10 Autoimmunity Analysis 
All autoimmunity analysis was completed in collaboration with M. Carvalho-Gaspar, 
University of Birmingham.  
To provide an alternative and direct read-out of autoimmunity in mouse strains (section 2.1), 
two methods were used – one of cellular infiltrates into tissues and one of autoantibody 
detection.  
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2.10.1 Cellular Infiltrates 
For analysis of cellular infiltrates, multiple tissues from host mice were examined; liver, 
stomach, kidney and salivary glands. Upon schedule one, tissues were harvested and washed 
in PBS (Sigma Aldrich) and slowly frozen down in liquid nitrogen to preserve the tissue. 
Samples were stored at  -80°C prior to use. When required, tissues were removed and kept on 
dry ice to be cut on the cryostat at -20°C as detailed in 2.6.1. Frozen sections were cut at 6-
7µm thickness at 3-5 different layers (30 – 35µm apart) throughout the whole tissue. Sections 
were left to dry overnight and placed in cold acetone for 10 minutes the next day. After this 
sections were then left to dry again at room temperature for 2 hours and then stored at -80°C 
until needed or stained. For this analysis of cellular infiltrates, a simple Haematoxylin and 
Eosin (H&E) staining was used (PFM Medical). Haematoxylin - a basic dye with a positive 
charge and therefore reacts with negatively charged nucleic acids staining them blue. Eosin, 
due to its acidic properties and negative charge reacts with positively charged proteins in the 
cell and stains the cytoplasm and extracellular matrix of cells a pink colour. The process for 
staining was composed of a series of steps of PBS washes, Eosin (1%) and Haematoxylin 
(Harris) stain washes followed by several different alcohol stages at a gradient from 70-100% 
to dehydrate the tissue. Sections were then placed in Xylene to prepare the tissue for the 
Xylene based mounting medium. Tissue was then mounted using DPX Mountant (Sigma 
Aldrich) to preserve the colouring and covered with a glass coverslip.  
2.10.2 Autoantibody Detection  
Blood was obtained from experimental mice for use in autoantibody detection via cardiac 
punctures. For this process, mice were anaesthetised using 4% Isoflurane (May and Barker, 
Dagenham UK) along with the carrier oxygen which fed into a chamber that the mice were 
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singularly held in until a state of unconsciousness was reached. Mice were then transferred to 
a facemask on their backs, chest upright, with isoflurane maintained at 4%. Blood was 
obtained using a sterile needle 25g (Terumo Agani) and syringe (BD Plastipak) then
transferred and held in an eppendorf. Mice were then culled by schedule one.  Samples were 
then left at room temperature until blood had sufficiently clotted. Samples were then 
centrifuged and the remaining serum was removed as the supernatant and stored in 
eppendorfs at -20°C until required.  
To detect autoantibodies, multi-composite slides (INOVA Diagnostics) that contained WT 
Rat Liver, Kidney and Stomach were used – alternatively stored at -4°C prior to use. Goat 
serum (10% diluted in PBS, Sigma) was added initially to sections to prevent non-specific 
binding of the secondary antibody. This was incubated in a humidified chamber in the dark at 
room temperature for 30 minutes before being tipped off the slides. Each sample serum was 
serially diluted using PBS (Sigma Aldrich) to generate a range of dilution factors that could 
be applied to the same slides to determine if autoantibodies could still be detected. The greater 
the level of autoantibodies, the higher the dilution factor required to dilute them such that the 
autoantibodies could no longer be detected. Sections were then incubated with the serum of 
required dilution factor, in a dark humidified chamber for 30 minutes before being washed in 
PBS. Goat F(ab’)2 anti-mouse IgG(H+L) FITC secondary antibody (Southern Biotech) was 
then added and incubated for 30 minutes in a humidified chamber in the dark. The secondary 
antibody recognises IgG, IgA, IgM and therefore acted to detect the presence of 
autoantibodies in the serum sample that bound to the tissue section. Slides were then washed 
in a PBS bath for 5 minutes before counterstaining with 4',6-diamidino-2-phenylindole 
(DAPI) stain was applied and left for 10 seconds before slides were again washed in PBS. 
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Slides were mounted with a coverslip (as in 2.6.2) and ready to be visualised. All images were 
taken using the Leica DM6000 microscope.  
2.11 Statistical Analysis 
GraphPad Prism 6.0 software was subsequently used to generate all graphical representation 
of data. Statistical analysis was also completed using this program whereby unpaired student 
two-tailed T tests were used for most analysis. However analysis comparing more than two 
species for one parameter used a one-way ANOVA, which have been noted in figure legends. 
P values only below 0.05 were noted as being significant.  The significance was noted as: 








LTβR MEDIATED REGULATION OF DC IS 




DC in the thymus have a close association with mTEC, which was originally determined by 
the identification of MHC expressing hematopoietic cells within thymic medullary areas 
(Barclay and Mayrhofer, 1981). These were later directly determined as being DC with their 
medullary positioning shown to be necessary for their functional role in central tolerance 
(Herbin et al., 2016). mTEC have been reported to support the efficient localisation of DC 
with a strong influence upon the regulation of the cDC1 population in particular. Studies have 
shown that Aire expressing mTEC direct cDC1 into medullary areas through XCL1 
production, with the corresponding expression of XCR1 by the cDC1 population (Lei et al., 
2011).  
Functionally, mTEC present tissue restricted antigens (TRAs) on their cell surface due to the 
expression of Aire and Fezf2, which are necessary to regulate this process. Therefore once in 
the medulla, DC can support central tolerance through mTEC interactions, which allows them 
to cross present these TRAs to screen developing thymocytes. This is thought to help optimise 
the availability of self-antigen in the thymus for both negative selection and T-Regulatory cell 
generation (Mouri et al., 2014, Herbin et al., 2016, Perry et al., 2014, Bonasio et al., 2006). As 
a result, the regulation of medullary areas therefore appears to be somewhat vital to ensure 
that there is the correct provision of an environment with the capacity to support dendritic cell 
function and localisation.  
Regulation of the medulla has previously been linked to lymphotoxin beta receptor (LTβR) as 
it was shown that mTEC require LTβR signals in thymic stroma for the correct formation of 
medullary areas (Boehm et al., 2003). Subsequent analysis has also identified a role of LTβR 
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signalling in the correct development of the mTEC sub-populations (Lkhagvasuren et al., 
2013, White et al., 2010). As a result, due to the association between mTEC and DC, it will be 
questioned if DC may utilise the same mechanisms of regulation as mTEC populations with 
investigation into the possible control of DC through LTβR. Considering this, the possibility 
of LTβR mediated regulation of DC has previously been suggested to occur in the periphery. 
This stemmed from a study that focused on mechanisms regulating the conventional DC2 
populations (cDC2) in the spleen and demonstrated that there is a cell intrinsic requirement 
for signalling through LTβR in the regulation of the homeostatic proliferation of cDC2 
(Kabashima et al., 2005, Wang et al., 2005). These studies are important as they show that 
LTβR signals can directly regulate peripheral DC. Whether this process also occurs in the 
thymus is unknown, and will be investigated through this chapter.   
 
In addition, analysis of Ltbr-/- mice illustrated that an absence of LTβR led to fragmentation of 
the medulla and disrupted mTEC populations (Boehm et al., 2003). Furthermore this was 
shown to result in a direct breakdown in central tolerance with the development of T-cell 
driven autoimmunity (Venanzi et al., 2007, Zhu et al., 2007). In such studies, this defective 
central tolerance induction was attributed to the disruption of mTEC. In addition a more 
recent study puts forward the idea that the breakdown in tolerance seen in Ltbr-/- mice may 
also involve dysregulation of the LTβR mediated transcription factor Fezf2 causing a lack of 
Fezf2 associated TRA presentation in thymus (Takaba et al., 2015). As a result, these ideas 
combine to suggest that there is a necessity for a fully formed and functioning medulla to 
maintain central tolerance within the host.  However, whether this breakdown in central 
tolerance is a direct result of medullary disruption, or rather directly attributable to alterations 
in the closely associated DC populations, was unknown. As a result this chapter will also use 
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LTβR absence as a tool to dissect the requirement for an intact medulla for effective central 





3.2.1 Defining DC Pools In Thymus and Spleen 
In order to begin examination of the possible regulators of dendritic cell (DC) populations, 
DCs were firstly isolated from the thymus. This was done through enzymatic digestion of the 
thymus to obtain a single cell suspension that could be antibody stained for DC detection via 
flow cytometric analysis.  DC could be identified in the thymus of adult WT mice (Figure 
3.1A) with cDC referring to conventional DC including subsets cDC1 and cDC2 as well as 
the detection of plasmacytoid DC (pDC).  
To determine how DC development alters with age, an ontogeny series was subsequently 
generated in the thymus of WT mice with the isolation of thymi from mice at differing ages 
and timed matings being set up for the retrieval of E18 WT thymus lobes. This ontogeny 
showed that with age there was a steady increase in total thymus cellularity (Figure 3.1 B), as 
would be expected until around seven weeks of age, from which there appeared to be a slow 
decline in thymus size as involution of the thymus begins. Interestingly total thymic DC 
followed a similar trend, with increases until seven weeks of age and then a corresponding 
decline (Figure 3.1 B). Within the DC compartment, at early stages of development, 
conventional DC (cDC) dominated with pDC only contributing around 20% of the entire DC 
population (Figure 3.1 C). However with age, there was an influx of pDC until around two 
weeks at which point pDC were then 60% of the total DC population. This contribution was 
statistically significant compared to the pDC population at the one week and five week 
timepoint. After five weeks however, pDC began to decrease again with consequentially 
increased cDC seen. Eventually at around seven weeks of age, equilibrium develops with a 






Dendritic Cells Can Be Identified In The Thymus and Change With Age  
 
A) The gating strategy used for the identification of dendritic cell populations within thymus. 
Lineage (Lin) gate included NK1.1, CD19 and CD3, which were all excluded prior to CD11c 
and PDCA-1 gating. cDC1 refers to conventional dendritic cells 1, cDC2 - conventional 
dendritic cells 2 and pDC - plasmacytoid dendritic cells. 
 
All data points for the rest of the figure are representative of different numbers of samples; 
E18 (n=7), d5 (n=14), 1 week (n=6), 2 weeks (n=8), 5 weeks (n=7), 7 weeks (n=6), 9 weeks 
(n=8), 11 weeks (n=6) whereby all are from at least two independent experiments.  
 
B) Scatter plots illustrating changes in total thymus cellularity (left panel) and total thymic 
dendritic cells (right panel) with developmental age. 
 
C) Population percentages obtained through absolute number analysis. For the left hand 
graph, absolute numbers of cDC1 and cDC2 were added to determine the cDC total, this was 
then added to pDC to obtain the whole DC population per mice. Relative proportions of the 
cDC and pDC compartment were then calculated from the total absolute number of dendritic 
cells.  Similarly for the right hand graph, cDC1 and cDC2 absolute numbers were added per 
mouse and proportions that each population contributed to the total cDC compartment was 
calculated and plotted.  
 
D) Total thymic DC absolute number changes with age are plotted for the breakdown in the 
dendritic cell populations. cDC1 (black line), cDC2 (blue line) pDC (red line).  
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dominant cDC population with 90% of cDC being cDC1 at E18 which dropped to a lowest 
level of 70% between five to seven weeks of age; highlighting that this population remained 
fairly consistent within the thymus during development (Figure 3.1 C). Further this data was 
plotted to see if proportional trends were supported by absolute number analysis of total DC 
subsets, which indeed clearly correlated (Figure 3.1 D). This data further confirms that from 5 
weeks onwards, cDC1 are the dominant DC subset in the thymus.  
Similarly, the DC populations in the spleen were assessed following enzymatic digestion of 
freshly isolated splenic tissue, cell suspension and surface antibody staining for DC 
identification (Figure 3.2 A). From this, it was decided to determine how DC populations in 
the spleen altered with age and therefore a corresponding ontogeny series was generated. The 
spleen size was shown to change during age with an increase until seven weeks, which then 
appeared to have variation from that point but generally tended to decrease in size (Figure 3.2 
B). Similarly the trend in total DC population numbers mirrored this pattern (Figure 3.2 B) 
The spleen differed significantly from the thymus in early ontogeny as pDC constituted 
around 70% of the total DC population (Figure 3.2 C), with cDC only slowly increasing until 
five weeks of age from which point cDC then contributed towards 80% of total splenic DC. In 
addition the cDC compartment was predominately cDC1 in early ontogeny (Figure 3.2 C) at 
around 90% of the total cDC which reduced with increased age as cDC2 increased, plateauing 
at five weeks to constitute around 70% of cDC. This change was significant between two to 
five weeks of age. Furthermore it appeared that in absolute number analysis of the DC 
ontogeny (Figure 3.2 D) there was an increase between two to five weeks of age in cDC2, 






Dendritic Cells Within The Spleen Alter With Age 
 
All data points are representative of the following sample numbers; E18 (n=7), d5 (n=14), 1 
week (n=6), 2 weeks (n=8), 5 weeks (n=7), 7 weeks (n=6), 9 weeks (n=8), 11 weeks (n=6) 
whereby all are from at least two independent experiments.  
 
A) The gating strategy used for the identification of dendritic cell populations within Spleen. 
Lineage (Lin) gate again included NK1.1, CD19 and CD3, which were excluded prior to 
CD11c and PDCA-1 gating. cDC1 refers to conventional dendritic cells 1, cDC2 - 
conventional dendritic cells 2 and pDC - plasmacytoid dendritic cells. 
 
B) Proportional bar graphs of the dendritic cell compartment; left graph showing the 
contribution of the cDC and pDC to the dendritic cell population. These were calculated using 
absolute numbers of cDC1 and cDC2 for total cDC, combined with pDC for the whole DC 
pool number. Proportions of cDC and pDC to the whole DC population were then calculated 
and plotted.  Similarly in the right panel contributions of cDC1 and cDC2 to the conventional 
DC pool were calculated on a per mouse basis through the sum of absolute numbers of cDC1 
and cDC2 totaling the whole cDC population and then proportion of cDC1/total cDC and 
cDC2/total cDC calculated and plotted.  
 
C) Individual changes in the dendritic cell populations absolute numbers through ontogeny is 
plotted. cDC1 (black line), cDC2 (blue line) and pDC (red line).  
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As a result, this shows that the spleen differs from the thymus (Figure 3.1 D) with the cDC2 
population numerically being the most abundant DC subset maintained throughout adulthood.  
To determine if phenotypically DCs in the thymus differed from those seen in the spleen, their 
activation status was compared through flow cytometric analysis (Figure 3.3 A) with 
activated DCs defined as expressing high levels of CD86 and MHCII. Quantitation of the 
proportions of MHCIIloCD86lo DC expressing subsets showed significantly higher 
proportions were present in the spleen for cDC1 and cDC2 than the thymus (Figure 3.3 B) 
and also in the reciprocal MHCIIhiCD86hi proportional analysis, there were increased 
proportions of cDC1 and cDC2 with an activated phenotype in the thymus compared to the 
spleen; again of significance. Therefore this data suggests that DCs acquire a greater level of 
activation in the thymus compared to the spleen.  
To assess how DCs acquired this activation in thymus, it was decided to analyse their 
expression of CD40 and LTβR as previous studies suggest that signalling through these 
receptors stimulates upregulation of MHC and CD86 (Spidale et al., 2014, Kabashima et al., 
2005, De Trez, 2012, Summers-DeLuca et al., 2007). Expression of CD40 and LTβR was 
determined through flow cytometry with comparisons to fluorescence minus one samples or 
isotypes, for all DC subsets (Figure 3.4 A). Data showed that all DC subsets had the capacity 
to express CD40 and LTβR with a shift in the positive staining profile compared to controls. 
The ability of DC to respond through these receptors was determined through in vitro cultures 
of total thymus with anti-CD40 or anti-LTβR compared to unstimulated controls (Figure 3.4 
B). Samples were obtained following enzymatic digestion and transferred into a culture 
medium to undergo stimulation for a two-day period at 37°C with 10µg/ml of the stimulant 
added. Interestingly, culture alone caused some upregulation of DC activation with higher  
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Figure 3.3: 
Dendritic Cells in Thymus Are More Activated Than Those In Spleen 
A) Left panel shows summary plots of cDC1, cDC2 and pDC in the thymus when split on the
basis of MHCII and CD86 to identify MHCIIhiCD86hi and MHCIIloCD86lo. Similarly this was
done in the spleen in the right panel.
B) Quantitation to show the relative FACs percentages of MHCIIhiCD86hi and
MHCIIloCD86lo within the different dendritic cell populations. Comparisons are made for
each dendritic cell population for the MHC/CD86 phenotype between the thymus (black bar)
and the spleen (white bar). Data is from three independent experiments where n=9 for
thymus, n=10 spleen.
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. 
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Figure 3.4: 
Stimulation Of Dendritic Cells Through CD40 Supports A More Activated Dendritic 
Cell Phenotype In Thymus 
A) Expression of CD40 (blue line) for each DC population in WT adult mice is plotted in the
top panel against a sample stained without CD40 (grey plot). The lower panel shows LTβR
expression (blue line) in thymic dendritic cells against the isotype control staining (grey plot).
B) Representative FACs plots of DC populations in thymus stained for CD86 and MHCII
following total thymus cell suspension that were previously cultured with either culture
medium alone (unstimulated), with anti-CD40 (middle panel) or with anti-LTβR (lower
panel).
C) Quantitative analysis of the relative proportions of MHCIIhiCD86hi following different
culture conditions with unstimulated (black bar), anti-CD40 (white bar) anti-LTβR (dark grey
bar), or anti-CD40 in combination with anti-LTβR (pale grey bar). Results are representative
of three independent experiments n=3.
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. 
B 
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proportions of MHCIIhiCD86hi cells than is usual in WT adult analysis. Stimulation with anti-
CD40 however saw further upregulation of MHCII and CD86 expression for cDC2 activation 
and an increase was seen in cDC1 MHCIIhiCD86hi proportions. However, with anti-LTβR 
treatment, there was no proportional DC activation increase. Quantitation of the proportions 
of MHCIIhiCD86hi cells under culture stimulations (Figure 3.4 C), mirrored trends that could 
be seen in FACs analysis, with a significant increase in activation of cDC2 under anti-CD40 
stimulation and a trend towards increased activation of cDC1. Additionally anti-LTβR 
treatment remained comparable to unstimulated controls with no synergistic effect with anti-
CD40 and anti-LTβR (Figure 3.4 C).  
 
3.2.2 Requirement For LTβR In The Regulation and Development of Thymic DC 
Populations  
Due to the requirement for LTβR in the development of the medullary areas that are occupied 
by thymic DC along with the expression of LTβR by thymic DCs and previous reports 
suggesting a role for LTβR signalling in splenic DC populations (Kabashima et al., 2005, 
Lkhagvasuren et al., 2013), we explored how DCs in thymus may be affected by an absence 
of LTβR. To do this, we initially looked at the ontogeny of thymic DC in LTβR heterozygous 
(Ltbr+/-) mice compared to LTβR deficient (Ltbr-/-) mice that were littermate controls (Figure 
3.5 A); again taking mice at specified ages following birth to examine dendritic cells. 
Analysis appeared to highlight that the LTβR heterozygous controls were comparable to the 
WT mice used in previous ontogeny analysis (Figure 3.1). Thymus cellularities between 
Ltbr+/- and Ltbr-/- mice were comparable throughout ontogeny (Figure 3.5 A left panel). 
However analysis of thymic DCs with age, indicated total numbers of DC were relatively 
distinct between mice strains from five weeks of age with significant reductions in total DC in 
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Ltbr-/- mice compared to Ltbr+/- control mice, with this maintained further into adulthood with 
another significant difference still seen at 9 weeks of age (Figure 3.5 A right panel). When 
this ontogeny variation was broken down more specifically into the DC populations (Figure 
3.5 B), the reduced DC population at 5 weeks onwards correlated to reductions in both the 
cDC1 and pDC populations in adulthood. Plots showed that infact that cDC1 population had 
slowly increased with age until two weeks where from this point, cDC1 in Ltbr-/- mice then 
failed to continue increasing and instead went into a decline phase with significantly reduced 
cDC1 numbers seen at five and nine weeks of age. pDC in Ltbr-/- mice were similarly greatly 
increased in absolute numbers, following the trend of Ltbr+/- mice until two weeks of age 
from which point pDC absolute numbers fell greatly and this reduction was maintained at 
significance even at nine weeks of age.  cDC2 on the other hand, had comparable total DC 
numbers throughout ontogeny to the control Ltbr+/- mice. Therefore this ontogeny suggests 
that LTβR may be regulating the maintenance of thymic DC populations, especially in the 
adult where cDC1 and pDC populations appear to be subsequently reduced.  
Building on from this, we reassessed LTβR expression on DC and thymic stromal populations 
in adult mice. This was done through digestion of thymi, which differed according to the cell 
type being identified (specified in Methods), but was necessary to obtain optimal cell 
suspensions of target populations for surface staining with antibodies and analysis of LTβR 
expression by flow cytometry. When compared to the anti-LTβR isotype control antibody, 
there was expression of LTβR by all populations of both DC and thymic stroma with shifts in 
the expression profile  (Figure 3.6 A). As a result, this allowed us to further explore the 
possible regulation of DCs by LTβR signalling as data suggested regulation could be possible  
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Figure 3.5: 
Dendritic Cell Populations Are Altered During Development In LTβR Deficient Mice 
All experimental timepoint analysis corresponds to the following sample numbers; Ltbr+/- E18 
(n=6), d5 (n=7), 1 week (n=10), 2 weeks (n=7), 5 weeks (n=9), 7 weeks (n=4) Ltbr-/- E18 
(n=8), d5 (n=13), 1 week (n=5), 2 weeks (n=3), 5 weeks (n=7), 7 weeks (n=6). All data points 
are from at least two experimental replicates.  
A) Changes in total thymus cellularity during ontogeny (left panel). Alterations in absolute
numbers of total thymic DC populations during ontogeny (right panel). LTβR+/- (red)
compared to LTβR-/- (blue).
B) Breakdown of the total DC population into the cDC1, cDC2 and pDC for changes in
absolute numbers across ontogeny analysis. Significant differences between Ltbr+/- (red)
compared to Ltbr-/- (blue) are highlighted.
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LTβR Is Expressed By Dendritic Cells and Stromal Cells In Thymus   
 
A) Expression of LTβR by different dendritic cell populations (top panel) and expression of 
LTβR by stromal cell populations; total stroma (CD45-), thymic epithelial cells (TEC CD45-
EpCAM-1+), mesenchymal cells (CD45-EpCAM-1-Ter119-PDPN+CD31-), endothelial cells 
(CD45-EpCAM-1-Ter119-PDPN-CD31+). Expression of LTβR by WT (blue line) compared to 
WT samples stained with LTβR isotype (grey). Results are representative of 3 n=4 across a 
minimum of 2 independent experiments.  
 
  














within the thymus directly via LTβR on DC cell-intrinsically or alternatively on thymic 
stromal cell populations in turn potentially regulating DC populations. 
 
As a result, it was decided to focus on 8-12 week old adult mice deficient for LTβR (Ltbr-/-) as 
during adulthood there was a marked reduction in thymic cDC1 and pDC seen in the 
ontogeny series (Figure 3.1). Therefore 8-12 week old Ltbr-/- mice were compared to WT 
controls for differences in thymic DC (Figure 3.7). FACS analysis of antibody stained thymus 
cell suspensions, showed that in the absence of LTβR there was a loss in total percentage of 
cDC that specifically mapped to reduced cDC1 proportions with a subsequently increased 
cDC2 proportion. Additionally pDC were almost absent from the thymus of Ltbr-/- mice 
(Figure 3.7 A).  Quantitation in Figure 3.7 B showed no difference in the total thymus 
cellularity between the two strains, but there was a significant reduction in total pDC and cDC 
as well as cDC1 in the absence of LTβR. However cDC2 remained unchanged. Splenic 
analysis was also performed (Figure 3.7 C); highlighting initially that the cellularity of Ltbr-/- 
mice was far greater than WT controls which was attributable to their lack of lymph nodes 
(Figure 3.7 C). Furthermore, splenic analysis saw a reduction in total cDC that differentially 
mapped to cDC2 as well as pDC of Ltbr-/- mice also being reduced compared to WT controls 
(Figure 3.7 C). As a result, these findings from the adult mouse highlight a requirement for 
LTβR in the thymus to support the cDC1 and pDC populations but also that LTβR regulation 
of DC populations in the spleen is distinct from thymus mediated regulation. 
 
However, whether this reduced DC phenotype was the consequence of reduced proliferation 
of the DC populations was unknown. As a result, BrdU incorporation was used as a measure 










LTβR Controls The Intrathymic Dendritic Cell Pool 
 
A) Representative FACs plots showing alterations in the distribution of the dendritic cell 
populations in the thymus under the absence of LTβR (right panel) compared to WT controls 
(left panel). Lineage discrimination included the exclusion of CD3, CD19 and NK1.1 
positively stained cells.  
 
B) Absolute number analysis of total thymic cellularity and dendritic cell populations in 
thymus with WT (black bar) compared to LTβR-/- (white bar) mice.  Data was obtained from 
at least 3 independent experiments with n=11 for WT and 12 for Ltbr-/- mice. 
 
C) Splenic absolute number analysis of total cellularity and dendritic cell populations in WT 
(black bar) compared to Ltbr-/- (white bar). Data was again obtained from a minimum of three 
independent experiments, WT (11) and Ltbr-/- (12). 
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The Proliferation Capacity of Dendritic Cells Is Unaffected Under LTβR absence 
 
A) FACs plots to demonstrate the relative proportions of BrdU+ thymic dendritic cell 
populations in WT (top panel) and Ltbr-/- mice (bottom panel). 
 
B) Proportional analysis of the dendritic cell populations in WT (black bar) were compared to 








































































































































































































intraperitoneally into experimental mice and mice were sacrificed 18 hours later for tissue 
harvest and analysis. Proportions of BrdU positive cells were used for analysis due to Ltbr-/- 
mice having defective numbers of thymic DC. The proliferation of thymic DCs was analysed 
in WT mice (Figure 3.8 A) with FACs plots showing the relative proportions of proliferating 
DC subsets. The split in the DC populations that were BrdU positive and therefore 
undergoing proliferation in WT mice remained at around 30% for WT cDC1 and cDC2 and 
slightly lower at around 10% for pDC populations. Ltbr-/- mice proportionally were shown to 
have comparable levels of DC proliferation to those recorded for WT (Figure 3.8 A). 
Quantitation of this confirmed that the proportion of proliferating DCs remained unchanged in 
Ltbr-/- mice compared to WT controls (Figure 3.8 B). Therefore this was suggestive that the 
defective DC populations seen in Ltbr-/- mice was not due to reduced DC proliferative 
capacity. 
 
To further compartmentalise the effect of LTβR signalling on thymic DC populations, bone 
marrow chimeras were generated (Figure 3.9). Firstly, Ltbr-/- or WT T-cell depleted bone 
marrow was transferred into lethally irradiated WT host mice. After 8 weeks, the spleen and 
thymus were harvested for analysis of dendritic cell populations. In this situation, the 
phenotype seen in the spleen of the germline LTβR deficient mice (Figure 3.7 C) was 
recapitulated, with reduced total cDC and a significant cDC2 reduction in the spleen of the 
host post reconstitution. However, in the thymus of these chimeras, there was no significant 
reduction in any of the DC populations. This suggests that there is no cell intrinsic 
requirement for LTβR signalling in thymic DCs (Figure 3.9 A), as cDC1 and pDC that were 











The Defect In Dendritic Cells In Ltbr-/- Mice Maps To LTβR Signals on Thymic Stroma 
 
A) Generation of bone marrow chimeras with WT bone marrow reconstituting WT hosts 
(black bar) and Ltbr-/- bone marrow reconstituting WT hosts (white bar). Analysis of total 
cellularity and then dendritic cell populations in spleen (top panel) and thymus (bottom 
panel).  Data is representative of a minimum of three independent experiments WT bone 
marrow (n=9) Ltbr-/- bone marrow (n=10). 
 
B) Bone marrow chimeras were generated with WT bone marrow into either a WT host 
(black bar) or an Ltbr-/- host (white bar). Subsequent numerical analysis of total cellularity and 
dendritic cells is shown in spleen (top panel) and thymus (bottom panel). Data represents at 
least three independent experiments with WT host (n=15) and Ltbr-/- host (n=10). 
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The reverse bone marrow chimeras were therefore generated with Ltbr-/- or WT host mice 
being reconstituted with WT bone marrow following lethal irradiation exposure. In these 
chimeras, the spleen was comparable to control WT transfers, with regards to cDC2 although 
pDC were reduced (Figure 3.9 B). However the thymus of Ltbr-/- host mice reconstituted with 
WT bone marrow had a severe total cDC, cDC1 and pDC reduction which mirrored the 
germline mice. As a result this data is suggestive that the maintenance of thymic DC subsets 
is occurring through an indirect LTβR signalling mechanism on a stromal cell population 
within the thymus. 
 
To further investigate the role of LTβR in thymic DC development, a kidney capsule 
transplant model was used. In this model, embryonic thymus lobes were treated with 2-
deoxyguanosine to remove all hematopoietic cells (Figure 3.10 A). WT and Ltbr-/- cultured 
thymus lobes were transferred into host mice under the kidney capsule and left for 8 weeks. 
The corresponding reconstitution of grafted thymi by host cells was determined following 
this, with quantitation of the DC populations following graft retrieval and digestion for flow 
cytometric analysis (Figure 3.10 B). Where thymic stroma was Ltbr-/-, there was a defect in 
DCs with total cDC, cDC1 and pDC being significantly reduced compared to WT controls. 
Therefore all of these models highlight the requirement for LTβR on thymic stroma to support 
the maintenance of thymic cDC1 and pDC.  
 
3.2.3 Targeting of LTβR Deletion In Thymic Epithelial Cells  
Due to the close association of thymic DCs with the medulla of the thymus, and their 
coordinated role in establishing central tolerance, there was questioning as to whether 










Kidney Capsule Transplants With LTβR Deficient Grafts Highlight Stromal 
Requirement for LTβR in Intrathymic Dendritic Cell Regulation  
 
A) Illustration of the set up for Kidney Capsule Transplant (KCT) and graft retrieval for 
analysis.  
 
B) Absolute number analysis of the grafted thymi.  WT hosts were grafted with WT grafts 
(black bar) or Ltbr-/- grafts (white bar) which are compared for the total cellularity and 
absolute numbers of dendritic cells. Data is representative of at least three experimental 
repeats with WT (n=9) an Ltbr-/- mice (n=10).  
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reason for the defect in thymic DC (Boehm et al., 2003). To address this directly, mice were 
generated with LTβR specifically absent from thymic epithelial cells (Figure 3.11 A). These 
mice were generated by crossing Foxn1Cre mice (Gordon et al., 2007) with Ltbrfl/fl mice 
(Wang et al., 2010b), to generate Foxn1Cre x Ltbrfl/fl mice. In all cases, Foxn1Cre mice were 
used as controls and going forward the resultant Foxn1Cre x Ltbrfl/fl mice will be known as 
LtbrTEC. The deletion of LTβR from the thymic epithelial populations in the thymus of the 
LtbrTEC model was checked (Figure 3.11 B) and LtbrTEC expression of LTβR reflected the 
germline Ltbr-/- mouse; with positive expression shown in the Foxn1Cre, used as a positive 
control. As a result, this proves that this model is functional and therefore can be used to 
address the impact of LTβR deficiency from thymic epithelial cells on thymic DC 
maintenance and the process of tolerance.  
 
Further characterisation of these mice was necessary to analyse the impact of LTβR deletion 
from thymic epithelial cells. For this, visual comparisons were made between the control WT 
and Foxn1Cre mice and the deletional germline Ltbr-/- and LtbrTEC mice (Figure 3.12 A). H&E 
analysis was conducted following freezing and sectioning of thymic tissue from the 
corresponding mice. Subsequent H&E staining showed that Ltbr-/- and LtbrTEC mice had the 
same structural appearance with disrupted and broken medullary areas spread throughout the 
cortex, compared to controls. Additional analysis was completed with confocal microscopy 
using antibodies to CD8 (to highlight the cortex areas) and mTEC specified by ERTR5 
positive staining to highlight the medullary areas (Figure 3.12 B).  Results suggest that the 
WT and Foxn1Cre mice sections showed normal thymic architecture but in Ltbr-/- and LtbrTEC 
mice, numerous small medullary satellite areas could be seen. This data indicates that the 











LTβR Deletion from Thymic Epithelial Cells Using Mouse Models Is Effective 
 
A) Model of mouse crosses used to delete LTβR from thymic epithelial cells by generating 
LtbrTEC mice. 
 
B) LTβR expression on thymic epithelial cells (CD45-EpCAM-1+) from Foxn1Cre control 
mice (solid line) with Ltbr-/- mice (grey fill) and LtbrTEC mice (dashed line). Data is 
representative of Foxn1Cre mice (n=9) Ltbr-/- and LtbrTEC mice (n=10) across three 
independent experiments.  
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Absence of LTβR Causes Disruption of Medullary Areas 
 
A) H&E staining of Foxn1Cre, LtbrTEC, WT and Ltbr-/- thymus sections. Scale bar is equivalent 
to 500µm. 
 
B) Confocal staining of thymus sections from Foxn1Cre, LtbrTEC, WT and Ltbr-/- mice. 
Staining for CD8 (green) highlights cortical areas and ERTR5 (red) highlights mTEC areas. 
Data is typical of at least n=3 mice per strain for which three individual sections were taken 





























study the impact of other cellular regulators of tolerance whereby thymic structure is 
specifically disorganised through absence of LTβR on TEC. 
 
The disrupted thymic stromal populations in both Ltbr-/- and LtbrTEC mice raised the question 
as to whether and how the whole mTEC compartment was disrupted following TEC specific 
deletion of LTβR. Therefore Ltbr-/- and LtbrTEC adult mice were analysed for TEC populations 
(Figure 3.13 A). The corresponding proportions of mTEC subdivided on MHCII and CD80 
showed that in the absence of LTβR, a shift in these mTEC subpopulations occurred with an 
increase in mTEChi to the detriment of the mTEClo population (Figure 3.13 A). Additionally 
absolute number analysis of WT and Ltbr-/- TEC (Figure 3.13 B) showed total thymus 
cellularity was unchanged between the WT and Ltbr-/- mice; but a reduction was seen in total 
TEC populations. There was however a reduction in total cortical thymic epithelial cells 
(cTEC), suggesting a role for LTβR regulation of the TEC compartment as a whole. When 
mTEC populations were broken down in Ltbr-/- mice, all subsets were reduced significantly 
with the reduction seen in the mTEClo and in particular the CCL21 expressing mTEClo 
population. Further quantitation of the ratio of the mTEClo:mTEChi saw that this was reduced 
in Ltbr-/- mice compared to WT control mice; suggesting a large reduction in the mTEClo with 
increased mTEChi compared to corresponding WT controls. Therefore this data highlights that 
in Ltbr-/- mice, disruption of the medulla is accompanied by defects in TEC populations 
suggesting a role for LTβR in mechanisms that control medullary structure (Figure 3.13 B).   
 
To see whether a similar thymic disruption occurred when LTβR was specifically absent from 
TEC, FACs analysis was conducted in LtbrTEC thymi (Figure 3.14). Here it was clear that the 
distribution of the mTEC compartment, again related to an increase in the mTEChi 
	115 
MHCIIhiCD80hi expressing population in LtbrTEC mice when compared with Foxn1Cre control 
mice (Figure 3.14 A). Interestingly at an absolute number level the same trend could be seen 
to the germline Ltbr-/- mice, with no difference in total thymus cellularity but reduced total 
TEC, reduced mTEC and mTEC subpopulations (Figure 3.14 B). In LtbrTEC mice mTEClo and 
CCL21+mTEClo populations were predominately reduced against Foxn1Cre control mice. The 
ratio when calculated to compare the mTEClo to the mTEChi compartment indicated the loss 
of the mTEClo population to the advantage of the mTEChi population. As a result this data 
mirrors the main trends in mTEC alteration seen in the germline Ltbr-/- mice (Figure 3.13), 
highlighting a cell intrinsic signalling requirement for LTβR on TEC for mTEC development.  
 
3.2.4 Thymic Absence Of LTβR and Its Impact on Tolerance 
Considering the medullary disruption that follows under the absence of LTβR on TEC, 
(Figure 3.13, 3.14), it remained unknown as to the consequence of this. This is of interest 
given the DC reduction in the Ltbr-/- mice and the role of the medulla in negative selection 
and T-Regulatory cell generation. To consider this, mice were investigated for autoantibodies 
and inflammatory infiltrates.  
 
To begin with, infiltrates were investigated in the liver of WT, Foxn1Cre, Ltbr-/- and LtbrTEC 
mice with livers being freshly isolated and frozen in liquid nitrogen before being sectioned for 
analysis. H&E staining was used to identify infiltrates within the tissue through microscope 
visualization. Infiltrates were determined and clusters of more than 25 cells were counted as a 
cellular infiltrate (Figure 3.15 A). Quantitation of cellular infiltrates/cm2 of each section 











Thymic Epithelial Cells Are Reduced Under LTβR Absence 
 
A) Plots to show the distribution of mTEChi and mTEClo populations separated based upon 
MHCII and CD80 expression following previous mTEC gating (CD45-EpCAM-1+Ly51-
UEA-1+). 
 
B) Absolute number analysis of thymus in WT and Ltbr-/- mice with total cellularity and TEC 
populations. Comparing WT mice (black bar) with Ltbr-/- mice (white bar). WT mice (n=12) 
and Ltbr-/- mice (n=11) from three experimental repeats. Work for this was completed in 
collaboration with Kieran James.  
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LtbrTEC Mice Have Reduced Thymic Epithelial Cell Populations 
 
A) FACs plots representative of the mTEC (CD45-EpCAM-1+Ly51-UEA-1+) distribution 
between mTEChi (MHCIIhiCD80hi) and mTEClo (MHCIIloCD80lo) compartments in Foxn1Cre 
and LtbrTEC mice.  
 
B) Analysis of thymus total cellularity and absolute numbers of TEC populations in Foxn1Cre 
control mice (black bar) and LtbrTEC mice (white bar); n=12 for both groups performed from a 
minimum of three independent experiments. Work for this was completed as collaboration 
with Kieran James.  
 































































































































































































































































































Absence of LTβR Results In An Autoimmune Phenotype That Doesn’t Map To A 
Thymic Stromal Requirement For LTβR 
 
A) Analysis of cellular infiltrates in the liver of the four mouse groups. Representative infiltrate 
images (left panel) with quantitation seen in the right panel. This was calculated as mean cellular 
foci/cm2 of tissue section with at least 5 sections cut per tissue per mouse; Ltbr-/- (black bar),  
LtbrTEC mice (white bar),  Foxn1Cre mice (dark grey bar) and WT mice (light grey bar). Ltbr-/- 
(n=4), LtbrTEC (n=3), Foxn1Cre (n=3) and WT (n=3). 
 
B) Stomach autoantibody analysis with representative plots at 1:80 dilution (left panel). Arbitrary 
scores were assigned based on intensity of fluorescence per image, correlating to the level of 
autoantibodies detected (green staining) with a DAPI counterstain (red). Scores were assigned 
from 0-6 with 0 being no infiltrates detected and 6 being most infiltrates seen (right panel). Ltbr-/- 
mice (black bar),  LtbrTEC mice (white bar),  Foxn1Cre mice (dark grey bar) and WT mice (light 
grey bar).  Ltbr-/- (n=6), LtbrTEC (n=5), Foxn1Cre (n=5) and WT (n=5). 
 
C) Segmented plots indicate autoantibody presence in the stomach, liver and kidney of the 
four mouse groups. A black segment represents autoantibodies detected at a 1:20 dilution 
factor and a grey segment indicates no autoantibodies; each segment is an individual mouse.  
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clusters of infiltrates were seen in representative plots shown in Figure 3.15 A in Ltbr-/- mice.  
Furthermore, analysis into the presence of autoantibodies was conducted with serum from 
these mice obtained prior to sacrifice and applied to tissue sections to determine the level of 
autoreactive antibodies. This could be visualised through fluorescent tagging of bound 
autoantibodies to tissue sections with staining against the stomach (shown as green staining), 
detected in the germline Ltbr-/-mouse serum (Figure 3.15 B). This was quantitated through an 
arbitrary score system (detailed in the methods) with a higher score given to a greater 
intensity of autoantibody detection, correlating to a higher level of green staining in sections.  
The presence of autoantibodies in Ltbr-/- mice was shown with higher arbitrary scores 
awarded compared to controls and LtbrTEC mice.   
 
Additional autoantibody analysis was completed at a 1:20 dilution of serum which was added 
to sections of kidney and liver as well as the stomach as previously shown and analysed in 
Figure 3.15 C. Here segmental plots have been shown, with each segment representing 
analysis in one mouse. Ltbr-/- mice had autoantibodies detected in all mice (9/9) for the 
stomach, 5/9 mice for the kidney and 7/9 suffered from autoantibodies in the liver. However, 
in LtbrTEC mice, one mouse had autoantibodies detected in the stomach, with all other mice 
analysed failing to show any autoantibodies. As a result this data appears to reveal that there 
is autoimmune manifestation in mice that are germline knockout for LTβR only. From this, 
LtbrTEC mice appear to support a normal phenotype with regards to autoimmunity despite the 
disruption in the medullary compartment, separating the so far identical phenotype between 
LtbrTEC and Ltbr-/- mice.  
 
	120 
To address what may be responsible for tolerance breakdown in Ltbr-/-mice, it was decided to 
look at the presence of transcriptional regulators in the thymus of the four mouse strains. This 
was necessary as the transcriptional regulators Fezf2 and Aire have been shown to be required 
to drive expression of tissue restricted antigens (TRAs) in the thymus, which in turn are 
presented on the cell surface of mTEC for the screening of developing thymocytes and central 
tolerance induction (Takaba et al., 2015, Anderson et al., 2002). Analysis for this was done 
through confocal microscopy (Figure 3.16) to look at Aire and Fezf2 transcription factor 
expression on frozen thymus sections. Aire expression was shown as green staining and Fezf2 
expression through red staining, both stained along with ERTR5 (blue) to highlight medullary 
areas of the thymus through mTEC recognition.  Analysis appeared to show that expression of 
Aire and Fezf2 was unperturbed in Ltbr-/- and LtbrTEC mice with comparable levels of positive 
cells seen to WT and Foxn1Cre control mice with high magnification (x40) (Figure 4.16 A). 
Similarly when looking at a low magnification (x10), the distribution of these positive cells 
appeared to again remain comparable between the strains (Figure 4.16 B). This highlights that 
the presence of transcriptional regulators of self-antigen expression remain comparable, 
which is fundamental for central tolerance. It therefore argues against the idea that lack of 
transcription factor expression under absence of LTβR is the reason for the autoimmunity 
seen in the germline Ltbr-/- mice. 
 
However, the autoimmunity seen in the Ltbr-/- but not LtbrTEC mice, despite normal 
transcriptional regulator expression, still highlights that an additional mechanism remains 
disrupted to result in autoimmunity in these germline mice. To further consider this, T-
Regulatory cells were analysed as they develop intrathymically but act to suppress 












Absence of LTβR Does Not Cause Alterations In The Presence Of Transcriptional 
Regulators Fezf2 and Aire 
 
A) Confocal images of thymus from WT, Ltbr-/-, Foxn1Cre, LtbrTEC mice. Staining in the far 
left panel for Aire (green) and the mTEC marker ERTR5 (blue), middle panel Fezf2 (red) and 
ETR5 (blue), right panel is a merge of Aire (green), Fezf2 (red) and ERTR5 (blue). Images 
taken at high magnification x40 with 2.3x zoom (A). 
 
B) Confocal images again from the thymus of the four mice strains, but this time at a high 
power magnification x40 with a 1x zoom. Comparing Aire (green) and ERTR5 (blue) in the 
























autoimmune manifestations. T-Regulatory populations were identified in the thymus of WT 
and Ltbr-/- mice as thymus tissue was freshly isolated and disaggregated to obtain thymocyte 
suspensions for analysis by FACs (Figure 3.17 A). T-regulatory populations were further 
subdivided upon CCR7 expression into newly generated (CCR7+) and those recirculating 
from the periphery (CCR7-). This was conducted as it has previously been shown that 
acquisition of CCR7 expression directly correlates to newly generated T-cells through 
Rag2GFP models and further heterogeneity within the T-regulatory cell pool could be 
distinguished by CCR7 expression to discount recirculating CCR7- T-regulatory cells (Cowan 
et al., 2016). The representative FACs distribution of T-Regulatory cells through this division 
was similar between WT and Ltbr-/- mice (Figure 3.17 A). Quantitative analysis confirmed no 
difference in absolute numbers of T-Regulatory cells between WT and Ltbr-/- mice at a total 
level or under CCR7 subdivision (Figure 3.17 B).  Similar analysis in the LtbrTEC mice and 
Foxn1Cre controls showed that proportions of T-Regulatory cells and the breakdown on CCR7 
expression were alike between these mice (Figure 3.17 C). When absolute numbers were 
analysed (Figure 3.17 D), there was no significant difference in total T-Regulatory cells and 
there was a comparable split based upon CCR7 expression also. As a direct result, there is no 
requirement for LTβR signalling either totally or specifically on TEC to drive development of 
T-Regulatory cells in thymus. 
 
3.2.5 Thymic Absence Of LTβR and Consequential Impact on Thymic DC and Negative 
Selection 
Having considered TEC disruption, transcriptional regulators, T-Regulatory populations and 
showing comparability in these areas between Ltbr-/- and LtbrTEC mice, the reasoning for 










T-Regulatory Cells Develop Intrathymically Independently Of LTβR 
 
A) Representative FACs plots illustrating proportions of Treg (left plot) for both WT and Ltbr-
/- mice pre-gated on CD4+TCRβhi expression. Treg are then identified as being CD4+TCRβhi 
Foxp3+CD25+ then split on expression of CCR7 (right plot).  
 
B) Absolute number analysis of thymus from WT (black bar) and Ltbr-/- (white bar) for total 
Treg, and then subsequently those that were CCR7 expressing or not. Data was obtained from 
three independent experiments WT mice (n=9) and Ltbr-/- mice (n=9).  
 
C) Representative FACs plots as in (A) but looking at Foxn1Cre and LtbrTEC mice for Treg 
populations. 
 
D) Absolute number analysis of the thymus of Foxn1Cre (black bar) and LtbrTEC (white bar) 
mice for total Treg and CCR7+/- subpopulations. All data was from three independent 
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remaining aspect related to central tolerance that was necessary to investigate was thymic 
DCs. It had already been shown that under the absence of LTβR there was a reduction in 
cDC1 and pDC (Figure 3.7), and it was in this germline analysis that tolerance appeared to be 
broken (Figure 3.15). However to correlate these two findings together it was firstly important 
to rule out that altered DC populations were not seen in LtbrTEC mice which may contain 
alternative compensatory mechanisms preventing the break of tolerance in this model (Figure 
3.18). For this, freshly isolated thymi were prepared for flow cytometric analysis to identify 
DC populations. FACs analysis highlighted that all DC populations could be identified in the 
thymus of LtbrTEC mice, equivalently to Foxn1Cre controls (Figure 3.18 A). Analysis of 
absolute numbers from this showed no difference in thymus cellularity or in cDC1 or pDC 
that had been reported to be altered in the germline Ltbr-/- mice. However there was an 
increase in cDC2 in the LtbrTEC mice compared to Foxn1Cre controls. Splenic analysis showed 
that by FACs the DCs could again be identified and equivalent proportions were seen between 
the two strains (Figure 3.18 C). Absolute number analysis showed no effect on any peripheral 
DC populations. This data as a result emphasises that the absence of LTβR from TEC does 
not disrupt DC populations; despite the obviously altered medullary architecture and reduced 
mTEC numbers which appear to be distinct from DC regulation in this analysis (Figure 3.14).  
However despite the lack of any DC numerical reductions in LtbrTEC mice, we questioned if 
the disrupted medulla was indeed capable of still having some impact on proliferation of DC, 
causing functional abnormalities in LtbrTEC mice. To assess this, BrdU incorporation was used 
with LtbrTEC mice and Foxn1Cre control mice injected with BrdU intraperitoneally, before 
being harvested 18 hours later for thymic analysis of DC populations by flow cytometry. 
Proportions of BrdU positive DCs remained comparable to one another between LtbrTEC and 









Dendritic Cells In Thymus Are Unaffected In LtbrTEC mice 
 
A) Representative FACs plots illustrating the dendritic cell populations in the thymus in 
Foxn1Cre and LtbrTEC mice. Lineage again includes the exclusion of CD19, CD3 and NK1.1. 
 
B) Analysis of absolute numbers for thymus cellularity and thymic dendritic cell populations 
in Foxn1Cre control mice (black bar) and LtbrTEC mice (white bar). Data is representative of 
three experiments where n=10. 
 
C) Representative FACs plots of the splenic dendritic cell populations in Foxn1Cre and LtbrTEC 
mice. Similarly lineage excludes CD19, CD3 and NK1.1. 
 
 
D) Splenic absolute number analysis of total cellularity and dendritic cells. Foxn1Cre mice 
(black bar) and LtbrTEC mice (white bar). Data is representative of three experiments where 
n=10.  
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LTβR Absence From Thymic Epithelial Cells Fails To Affect Dendritic Cell Proliferation  
 
A) FACs plots showing the relative proportions of BrdU+ thymic dendritic cell populations in 
Foxn1Cre mice (top panel) compared to LtbrTEC mice (bottom panel). 
 
B) Proportion of dendritic cells and pre-cDC in thymus that were BrdU positive with Foxn1Cre 
mice (black bar) compared to LtbrTEC mice (white bar). Data is from two independent 
experiments, Foxn1Cre mice (n=5) and LtbrTEC mice (n=5).  
  




































































































































































































































those seen in WT and Ltbr-/- analysis (Figure 3.8). Quantitation confirmed this trend with no 
significant difference seen in proliferative proportion of DCs in the thymus of LtbrTEC and 
Foxn1Cre mice. As a result, this confirmed absence of LTβR from TEC was unable to disturb 
functioning of thymic DC. 
 
However, despite the proliferation of DC being shown to be comparable between WT, Ltbr-/-, 
Foxn1Cre and LtbrTEC mice, the positioning of the DCs in this disrupted medulla was unknown 
and could correlate to defective activity of DC in negative selection, as this requires 
medullary positioning. To assess this, confocal quantitation of DCs was conducted on freshly 
frozen and sectioned thymi which were stained for ERTR5 (green) to highlight medullary 
areas of the thymus, with absence of ERTR5 staining reflecting cortical areas and CD11c 
(red) to identify DC positioning (Figure 3.20). Firstly WT and Ltbr-/- mice sections were 
compared and the distribution of thymic DC remained predominately localised to the medulla 
in the Ltbr-/- mice despite smaller medullary areas being found (Figure 3.20 A). This was 
shown graphically (Figure 3.20 B) from which there was therefore no difference in the 
proportion of DCs localised to cortex or medulla for the WT compared to Ltbr-/- mice. The 
same analysis was completed in LtbrTEC and Foxn1Cre mice with confocal plots (Figure 3.20 
C) showing distribution of thymic DCs localised to the medullary areas. Furthermore, 
quantitation also showed that the localisation of DC within the LtbrTEC and Foxn1Cre mice was 
comparable with no distributional difference (Figure 3.20 D). Therefore disrupted mTEC 
populations in LtbrTEC and Ltbr-/- mice does not alter the localisation of thymic DCs, which 








Intrathymic Dendritic Cells Remain Correctly Positioned Despite LTβR Absence 
 
A) Confocal graphs of the position of dendritic cells in the thymus of WT (left panel) 
compared to LTβR deficient mice (right panel) with ERTR5 (green) defining mTEC and 
CD11c (red) defining dendritic cells. 
 
B) Quantitation of the proportion of total CD11c+ cells counted in 3-4 sections per thymus per 
strain. Five images were randomly taken per section for both medullary and cortical areas. 
The CD11c+ cells within these areas were recorded for both cortex and medulla; WT mice 
(black bars) or Ltbr-/- mice (white bars). Data was obtained from three individual samples per 
WT/ Ltbr-/- mouse. 
 
C) Confocal plots showing the positioning of dendritic cells (CD11c+, red) in the thymus of 
Foxn1Cre and LtbrTEC. ERTR5 defines mTEC populations. 
 
D) Quantitation of the proportion of total dendritic cells within 3-4 thymus sections taken for 
both Foxn1Cre and LtbrTEC mice. Within these sections five randomly selected areas for both 
the cortex and medulla had CD11c+ cells counted and recorded; Foxn1Cre control mice (black 
bar) and LtbrTEC mice (white bar). Data was from three individual thymus samples for both 























































































The total numerical reduction in DCs in Ltbr-/- mice (Figure 3.7) indicates this may be a 
reason for tolerance breakdown. Yet why reduced DC may result in a break in tolerance in 
Ltbr-/- mice remained unanswered. Given the role of thymic DCs in central tolerance, we 
examined if reduced DCs were causing altered negative selection. To answer this, expression 
of Caspase-3 was assessed (Figure 3.21) to identify dead/dying cells which could then be 
separated into those triggered to undergo death during negative selection (CD5+CD69+) or 
rather death by neglect (CD5-CD69-) (Stritesky et al., 2013). Subsequently all four mouse 
strains were analysed by flow cytometry for these parameters, with representative FACs 
shown (Figure 3.21 A). This analysis suggested that WT, Foxn1Cre and LtbrTEC mice, all had 
similar proportions of cell death and negative selection yet the proportion of Caspase-3 
positive cells was reduced in Ltbr-/- mice compared to controls with a further reduction 
specifically in cells undergoing negative selection (Figure 3.21 A). Absolute number analysis 
was conducted to quantify the reduction in negative selection in the absence of LTβR. This 
analysis highlighted that the total number of Caspase-3 positive cells was significantly 
reduced in Ltbr-/- mice compared to WT control mice, whereas LtbrTEC and Foxn1Cre control 
mice were comparable (Figure 3.21 B). When Caspase-3+ cells were divided into CD5+CD69+ 
negatively selected cells, Ltbr-/- mice had reduced number of cells undergoing negative 
selection compared to WT control mice; with LtbrTEC and Foxn1Cre mice remaining 
comparable. Finally those negatively selected cells that were CD4+ thymocytes 
(CD5+CD69+CD4+) were significantly reduced in the Ltbr-/- mice compared to WT with no 
difference between LtbrTEC and Foxn1Cre control mice. Therefore this emphasises that the 
breakdown in tolerance seen in Ltbr-/- mice correlates with reduced negative selection; 










Negative Selection Becomes Reduced In Germline LTβR Deficient Mice 
 
A) FACs plots illustrating how cells undergoing death and then subsequently death by neglect 
or negative selection were identified for analysis with their relative proportions in the thymus 
of WT, Ltbr-/-, Foxn1Cre and LtbrTEC mice shown.  
 
B) Absolute number analysis of Caspase-3+ cells as well as those undergoing negative 
selection (Caspase+CD5+CD69+) and CD4 SP negatively selected cells 
(Caspase+CD5+CD69+CD4+). WT mice (black bar), Ltbr-/- mice (white bar), Foxn1Cre mice 
(dark grey bar) and LtbrTEC mice (light grey bar). Data was obtained from at least two 
independent experiments; n=8. 
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3.3 Discussion 
3.3.1 Development of Thymic DC Populations 
The thymus is known to contain DC populations that are implicated in central tolerance 
induction. However the ability of the thymus to regulate these populations still requires 
greater investigation. Ontogeny analysis shows that intrathymic DC populations increase as 
thymus size increases, indicating that DC are regulated by the thymus directly. This may 
relate to a larger thymus containing increased thymic niches and therefore being able to 
support greater numbers of DC. This can be suggested in the spleen also where the same trend 
was observed. However as well as regulation of DC numbers, the thymus also acts to 
differentially alter the DC phenotype as it promotes increased activation, which is itself 
necessary to support DC function in thymocyte interactions and tolerance induction (Proietto 
et al., 2008b, Li et al., 2009). Furthermore, this increased activation of thymic DC has been 
linked to CD4 or CD8 single positive thymocytes as analysis of TCRα-/- mice showed that 
cDC have a less activated phenotype and that this was due to a requirement for CD40L 
provision by T-cells (Spidale et al., 2014). However in culture experiments using anti-CD40 
stimulation, cDC2 activation was selectively increased. Considering this, in our hands, the 
intrathymic activation of cDC1 and pDC may be governed by factors other than stimulation 
through CD40. Further analysis of pathways regulating cDC1 and pDC activation in the 
thymus focused on LTβR stimulation using in vitro cultures. This was of interest, as it was 
shown in lymph node studies that LTβR signalling on DC through interactions with LTα1β2 
on T-cells increased CD86 expression (Summers-DeLuca et al., 2007). This study 
furthermore proposed that CD40 and LTβR signalling were infact working in combination to 
support the greatest level of DC maturation. Interestingly, however, our in vitro studies 
suggested no effect of LTβR stimulation or any cumulative influence with anti-CD40 on 
thymic DC.  
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This indicates that DC in the thymus may require different signals to promote their activation 
from the mechanisms previously reported to drive peripheral DC activation. This leaves the 
possibility for alternative thymocyte related factors such as RANK to possibly play a role in 
the process of intrathymic DC activation. The RANK/RANKL pathway is known to be active 
intrathymically as it is involved in TEC development and further peripherally it has been 
implicated in the regulation of DC populations (Desanti et al., 2012, Rossi et al., 2007).  In 
lymph nodes, T-cell/DC (RANKL/RANK) interactions have been shown to drive increased 
B-cell lymphoma XL (Bcl-xL) and Bcl-2 expression to support survival of DCs, with a similar 
mechanism utilised also in bone marrow (Josien et al., 2000, Williamson et al., 2002). 
Additionally, under in vitro blockade of OPG, a decoy receptor for RANKL, free RANKL 
availability increased and as a consequence was shown to support greater survival of bone 
marrow derived DC (Chino et al., 2009). As a result, this research on RANK and DC 
maintenance in various tissues in the periphery brings into question whether this mechanism 
may be potentially responsible for DC maturation in the thymus and is something that would 
be interesting to explore in more detail. Furthermore the thymic stromal populations that DC 
are closely associated to may support DC activation through factors such as thymic stromal 
lymphopoietin, as this is already known to prime DC for T-regulatory cell induction in 
thymus (Watanabe et al., 2005, Hanabuchi et al., 2010).  
 
The thymus also appears to regulate the general composition of the DC compartment, with 
variation occurring with age in turn suggesting that mechanisms regulating DC in the thymus 
must correspondingly alter with age. This could also be said for splenic regulation of DC 
populations. Intrathymically, a visible transition in DC proportions took place between 2-5 
weeks of age suggesting that this time point marks a switch in factors regulating DC 
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maintenance or recruitment in early ontogeny, from those seen later in development and 
throughout adulthood. This ‘change over period’ saw increased populations such as pDC and 
cDC2 entering into the thymus, which we hypothesise, may relate to a requirement for an 
increased repertoire of antigens for greater T-cell selection earlier in development (around 2-5 
weeks). This was supported by a recent study, showing that negative selection was inefficient 
in early ontogeny but efficiency of tolerance induction increased with age, corresponding to 
increased cDC2 and pDC influxing into the thymus (Kroger et al., 2016). cDC2 in particular 
were shown to provide greater antigen processing capacity to assist in effective negative 
selection. As a result, the altered composition in DC populations in the adult thymus therefore 
appears to occur in order to support the function of the thymus in negative selection and to 
possibly prevent the reduced T-cell clonality seen through thymic involution later in life.  
 
3.3.2 LTβR and Thymic DC Regulation 
Mechanisms regulating intrathymic DC were revealed through analysis of LTβR deficient 
mice for a similar ontogeny sequence. This suggested that the later phases of ontogeny 
concerning cDC1 and pDC were dependent on LTβR mediated regulation as there was only 
comparability between Ltbr+/- control and Ltbr-/- mice until the transitional phase of 2-5 weeks 
of age. From which point, these strains diverged with cDC1 and pDC being reduced in Ltbr-/- 
mice. Interestingly, it was apparent through the ontogeny series as well as by adult analysis of 
DC in Ltbr-/- mice compared to WT controls, that cDC2 were developing in the thymus 
independently of LTβR. This was surprising to find as peripherally it has been shown that 
cDC2 require LTβR signalling cell intrinsically to support their maintenance in the spleen 
(Kabashima et al., 2005, Wang et al., 2005). This was confirmed in adult analysis, with 
reduced splenic cDC2 in Ltbr-/- mice compared to WT control mice along with bone marrow 
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chimera analysis supporting a cell intrinsic signalling requirement for LTβR on splenic cDC2. 
Therefore, it appears that LTβR mediated regulation of DC subsets differs upon both 
anatomical localisation and the DC subset being regulated. It is possible that mechanisms 
regulating the alternative DC subsets vary in order to ensure the maintenance of some DC in 
the thymus even under conditions of LTβR absence, given the known requirement for DC in 
tolerance induction (Ohnmacht et al., 2009).  
 
As a result of the above findings, it was decided to focus upon the regulation of thymic cDC1 
and pDC by LTβR in the thymus. Consequently regulation of thymic DC was shown to be 
dependent upon stromal mediated LTβR signals, through bone marrow chimera and kidney 
capsule graft generation. However, due to LTβR being implicated in thymic medulla 
formation and DC subsequently localising to these sites, it could be suggested that these 
disrupted medullary areas may in turn be indirectly modulating DC in thymus (Boehm et al., 
2003). Exploration of this was possible through the generation of LtbrTEC mice in which 
Foxn1Cre mice were crossed with Ltbrfl/fl mice. This initially revealed that the disruption of the 
medullary areas within Ltbr-/- and LtbrTEC mice was due to a cell intrinsic requirement for 
LTβR signalling on TEC populations to support their persistence in the thymus. This novel 
finding builds upon previous work and furthermore supports a recent publication using an 
alternative TEC-specific LTβR deletional model, which confirmed our finding (Boehm et al., 
2003, Wu et al., 2017). This disrupted development of the medullary areas was further 
suggested to occur due to the prevention of LTβR dependent mTEC progenitors (Cld3,4 
SSEA-1+) from developing into mTEC, an aspect that we did not investigate in our studies 
(Wu et al., 2017). Therefore our findings, supported by recent research, suggest LTβR is cell 
intrinsically required to maintain mTEC in the thymus and that this further may be at the level 
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of medullary progenitor development. It would therefore be interesting to uncover in future 
experiments exactly how an absence of LTβR may affect mTEC progenitor populations as 
LTβR signals from mature T-cells have already been implicated in the later stage terminal 
development of mTEC (White et al., 2010). This may be investigated through alternative 
models of disrupted medullary structure such as Tcrα-/- mice. Here, it is possible that medullas 
are disrupted because the absence of single positive thymocytes leaves them unable to supply 
the LTβR signals that could be necessary for development of mTEC. Therefore the 
supplementation of LTβR ligands in these models would to be interesting to consider to 
determine if it is through this axis that medullary development may have become limited. 
However as smaller medullary areas are still able to form in Ltbr-/- mice, it is clear that there 
are other mechanisms independent of LTβR that support medullary formation to compensate 
at least partially for this LTβR absence – another area that would be interesting to explore.  
 
Nonetheless, despite the factors regulating mTEC development requiring further research, 
whether the DC population defect in Ltbr-/- mice resulted from these disrupted mTEC 
populations was unknown. However it is possible this could be responsible for disrupted DC 
as there is a fundamental requirement for the medulla in the maintenance of thymic DC. 
Studies using Relb-/- mice, or aly/aly mice with a natural mutation in the NIK gene, both 
suffer from almost a total loss of mTEC, and have dysregulated DC populations (Wu et al., 
1998, Mouri et al., 2014). Recent analysis showed that absence of RelB specifically from 
mTEC caused a significant loss of mTEC populations and this correlated directly to the cDC1 
and pDC population being reduced in the thymus due to the alterations in mTEC themselves 
(Riemann et al., 2017, Briseno et al., 2017). This emphasises that the medulla is absolutely 
required to be present for thymic cDC1 maintenance, however the level of medulla necessary 
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to support DC was somewhat questioned following our findings. Through analysis of LtbrTEC 
mice, we found that the medulla itself is not required to be fully formed and further mTEC 
can be rather quantitatively reduced, whilst still remaining competent at regulating normal DC 
populations intrathymically. Considering this and the reduced DC seen in total medullary 
absence, it puts forward the idea of a threshold of mTEC being necessary in thymus to 
maintain normal DC numbers. Further, considering bone marrow chimeras which suggested 
stromal mediated regulation of the cDC1 and pDC, this finding of normal DC populations in 
LtbrTEC mice shows that LTβR mediated regulation of TEC is dispensable for intrathymic DC 
maintenance and supports that indirect medullary disorganisation is not responsible for the 
DC defects seen in Ltbr-/- mice. Furthermore, it emphasises that the reduced cDC1 and pDC 
seen in Ltbr-/- mice rather relates to an LTβR dependent process that must be occurring on an 
alternative non-TEC stromal population.  
 
In addition, the inability of the medulla to fully form in Ltbr-/- and LtbrTEC mice was shown to 
further be insufficient to prevent the correct localisation of the thymic DC populations. This 
shows that the quantitative reduction in the number of Aire expressing mTEC that remained 
in these mice were still sufficient to be able to produce the Aire-dependent chemokine XCL1 
to attract the XCR1+ cDC1 which are predominately medullary localised (Lei et al., 2011). 
However the levels of XCL1 production in these models was not investigated but it would be 
interesting to determine whether they remained equivalent in the Ltbr-/- and LtbrTEC mice. 
Additionally, the proliferation of these DC populations was unchanged in Ltbr-/- and LtbrTEC 
mice. This was itself surprising as administration of agonistic LTβR antibody in vivo led to 
increased splenic DC proliferation through cell intrinsic LTβR signals that overrode the 
inhibitory herpesvirus entry mediator- B and T lymphocyte attenuator (HVEM-BTLA) 
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pathway normally acting to suppress DC proliferation (De Trez et al., 2008). Yet in the 
thymus of the Ltbr-/- and LtbrTEC mice, DC may utilise alternative mechanisms than LTβR 
signalling to support their homeostatic proliferation. This also puts forward the idea that 
reduced mTEC in the thymus in LtbrTEC mice are still sufficient to support medullary function 
in the thymus for normal DC regulation with regards to positioning and proliferation. As a 
result it reinforces that the reduced cDC1 and pDC populations seen in Ltbr-/- mice rather 
relate to a requirement for LTβR signalling on non-TEC stroma and that this reduction occurs 
independently of medullary disorganisation in this model as determined through comparisons 
to equally disrupted LtbrTEC mice.  
 
3.3.3 LTβR and Central Tolerance 
As well as the role of the medulla in DC regulation, it is also absolutely essential for the 
process of central tolerance as studies of Relb-/- mice, with an absence of medullary areas, 
portray a phenotype of autoimmunity (Wu et al., 1998, Weih et al., 1995). Original studies 
used this finding in Relb-/- mice to suggest that defects in central tolerance in Ltbr-/- mice arose 
from defective medullary areas. It was further previously suggested that these altered 
medullas in Ltbr-/- mice were reduced in their ability to produce CCL19/CCL21 expression, 
which in turn prevented the migration of CCR7 expressing newly selected single positive 
cells into the medulla, inhibiting tolerance induction (Zhu et al., 2007). Considering this, 
analysis of LtbrTEC mice with disrupted mTEC populations that are identical to in Ltbr-/- mice, 
would be expected to have the same mislocalisation of single positive thymocytes and failure 
to induce negative selection if this theory was true. However the correct induction of central 
tolerance in the LtbrTEC mice despite reduced CCL21 expressing mTEC numbers and 
disrupted mTEC, acts to disprove this theory. This therefore highlights that the process of 
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negative selection that is reported to be altered in Ltbr-/- mice does not relate solely to 
mislocalisation of single positive thymocytes causing an inability of these cells as a result to 
undergo negative selection. Rather it correlates to alterations in the alternative regulators of 
central tolerance other than mTEC which are responsible for the tolerance breakdown. In 
addition, the dysregulation of the medullary areas seen in Ltbr-/- mice is itself insufficient to 
directly drive the break in tolerance reported in these mice. 
 
Importantly from this, analysis of Ltbr-/- and LtbrTEC mice further brought into question the 
regulation of the machinery that is necessary to support TRA expression for thymocyte 
screening and tolerance induction. Aire expression was expected in Ltbr-/- and LtbrTEC mice, as 
previous research has shown that Aire is regulated by RANK signalling in mTEC and not by 
LTβR associated mechanisms (Venanzi et al., 2007, Martins et al., 2008). However LTβR had 
previously been reported to be essential for Fezf2 expression in the thymus – but our findings 
with confocal microscopy, highlight that there is still a clear presence of Fezf2 in the thymus 
in Ltbr-/- and LtbrTEC mice; thus rather bringing in to question if LTβR is the key regulator of 
Fezf2 (Takaba et al., 2015).  Furthermore the sustained and equivalent presence of this 
machinery in Ltbr-/- and LtbrTEC mice, despite reduced mTEC, suggests that TRA expression 
alterations is not responsible for the break in tolerance seen in the Ltbr-/- mice. Additionally 
this highlights that LTβR is dispensable for Fezf2 expression and therefore suggests 
alternative regulators in this process that need to be investigated.  
 
Additionally it seems that the intact medulla is also dispensable for the generation of T-
regulatory cells implicated in tolerance, which was surprising as it had previously been shown 
through kidney capsule transplant experiments of Relb-/- thymic lobes that there was a 
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requirement for an intact medulla for the generation of T-regulatory cells (Cowan et al., 
2013). As a result, the normal generation of Treg in the LtbrTEC mice suggests that the medulla 
is able to provide sufficient TRAs for antigen cross presentation through normal numbers of 
DC, to support Treg generation. Furthermore and perhaps more interestingly, when the cDC1 
and pDC populations were reduced along with mTEC in the Ltbr-/- mice, there still remained 
to be sufficient TRA presentation to not perturb Treg development – despite DC and mTEC 
being shown to be pivotal regulators of Treg induction (Tai et al., 2013, Perry et al., 2014). 
The lack of Treg disruption in Ltbr-/- mice could relate to cDC2 being normally maintained 
under LTβR absence, as cDC2 have previously been suggested to be the main DC subset 
involved in intrathymic Treg induction and so may be supporting Treg generation in these 
mice (Proietto et al., 2008b).  Therefore the maintenance of alternative central tolerance 
regulators in the Ltbr-/- mice in comparable levels to the LtbrTEC mice emphasises that as cDC1 
and pDC populations are the only differing factor between these mice, their maintenance in 
the thymus directly correlates with the correct induction of central tolerance through the 
process of sustained negative selection (shown in summary Figure 3.22).  
 
Considering this chapter as a whole, it questions how intact the medullary compartment needs 
to be to effectively carry out its role in central tolerance, with a substantial quantitative loss of 
mTEC still having no detrimental effect on tolerance induction. Furthermore, the regulation of 
the medullary compartment by LTβR is distinct from the role of LTβR in the regulation of 
thymic DC – again segregating the association between the medulla and thymic DC 
regulation. This chapter further identifies that the breakdown in tolerance previously reported 
in Ltbr-/- mice, is not due to medullary disruption itself or by this disruption directly impacting 















Summary Diagram For LTβR Mediated Regulation Of Thymic DC 
 
A) Summary diagram of the regulation of thymic tolerance in the four different mouse models 
used in this chapter. The thymic structure with regards to medullary architecture is depicted in 
the left hand panel with relative DC and mTEC proportional populations shown in the central 
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requirement for LTβR-dependent signalling on non-TEC stromal cells to in turn indirectly 
support the maintenance of cDC1 and pDC that are vital regulation of effective negative 
selection for the prevention of autoimmune disease. This poses the question as to whether the 
maintenance of thymic DC is possibly more pivotal for the prevention of autoimmunity than 
that of mTEC, with potentially only a threshold level of mTEC being necessary to support 









PRE-CDC ENTRY INTO THE THYMUS IS 




Of the three DC populations within the thymus, the conventional DC subset cDC1 are the 
only subset thought to develop intrathymically from a progenitor (pre-cDC) that is recruited 
from the bone marrow. Whilst the precursor product relationship during DC development is 
not yet fully clear, a pre-cDC has been described with a Lin-MHCII-CD11c+Flt3+Sirpαint 
phenotype in the bone marrow and spleen (Liu et al., 2009). In this study, pre-cDC were 
shown to be generated in the bone marrow and actively divide before migrating in the blood 
and into lymphoid tissues. Pre-cDC isolated from the bone marrow and spleen were 
adoptively transferred into host mice and shown to give rise to both cDC1 and cDC2 
populations. In contrast the availability of these cells in thymus has not been assessed, 
although it is known that cDC2 arise from a peripherally mature population that migrates in to 
the thymus (Baba et al., 2009, Li et al., 2009). Research in the thymus concerning cDC1 
progenitors infact previously determined pre-cDC as CD8α+CD172α- cells, with the 
suggestion that these progenitors contribute towards the DN1c subset of thymic settling 
progenitors (Luche et al., 2011). Purified transfers of CD8α+CD172α- pre-cDC cells in this 
study additionally indicated that this pre-cDC population could be detected in the thymus and 
ultimately gave rise to cDC1. Therefore it is initially important in this chapter to establish 
consistent identification of the pre-cDC (Lin-MHCII-CD11c+Flt3+Sirpαint) population between 
both the periphery and the thymus to allow for effective comparisons between these different 
compartments in the study of pre-cDC.  
 
Following on from this, further investigations will consider the mechanisms that may be 
affecting the recruitment of pre-cDC into the thymus. This is important as in contrast to the 
known recruitment of pDC and cDC2 DC subsets via CCR9 and CCR2 expression, the factors 
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that are regulating pre-cDC remain undetermined (Hadeiba et al., 2012, Baba et al., 2009). 
Therefore possible regulators of pre-cDC will be considered in this chapter. To begin with, 
the previous chapter indicated that cDC1 were regulated by LTβR signalling on thymic 
stromal cells and the cDC1 population is the direct progeny of pre-cDC. This raises the 
question as to whether pre-cDC recruitment is in turn LTβR dependent. As a result, the 
correlation of the cDC1 reduction with alterations in thymic pre-cDC will be investigated in 
this chapter with regards to the potential role of LTβR in the regulation of pre-cDC.  
 
Furthermore if LTβR absence is shown to affect pre-cDC, the mechanisms by which this may 
be occurring will additionally be considered with the use of different mouse models to dissect 
this process. For example, a possible role for LTβR in pre-cDC recruitment may involve 
LTβR mediated chemotaxis. This should be considered as pre-cDC may enter into the thymus 
via similar mechanisms of recruitment to ETP, for which recruitment is dependent upon 
exposure to certain chemokines. Indeed, ETP recruitment has been suggested to occur through 
the chemokines CCR7 and CCR9 as CCR7/CCR9 expressing ETP have been shown to 
become attracted to CCL19/CCL21 and CCL25, produced within the thymus (Lkhagvasuren 
et al., 2013, Seach et al., 2008, Ueno et al., 2004, Zhu et al., 2007). As a consequence, mouse 
models that were Ccr7-/- indeed demonstrated a detrimental decline in ETP presence in the 
thymus (Krueger et al., 2010, Misslitz et al., 2004, Zlotoff et al., 2010). As a result, the 
potential for the CCR7 axis to be implicated in pre-cDC recruitment will also be examined in 





4.2.1.Regulation of cDC1 Progenitors Through LTβR  
To begin to address the role of LTβR in the regulation of pre-cDC, firstly the development of 
pre-cDC in steady state conditions was assessed. The development of the DC populations 
themselves is known to depend upon a progressive developmental pattern from upstream 
progenitor populations, which have a distinct anatomical localisation. Therefore, upstream 
progenitors were identified to be restricted to the correct sites (Figure 4.1 A). For this, bone 
marrow was retrieved from hind legs of WT mice (detailed in methods) along with spleen and 
thymus, which were freshly isolated and disaggregated to obtain cells for flow cytometric 
analysis. Representative FACs plots show the Macrophage Dendritic Cell Progenitor (MDP) 
and Common Dendritic Cell Progenitor (CDP) were restricted to the bone marrow and absent 
from the spleen and thymus (Figure 4.1 A). This could further be seen in quantitation of 
FACs proportions with MDP and CDP only detected in the bone marrow (BM) samples 
(Figure 4.1 B). The downstream development of pre-cDC (Lin-MHCII-CD11c+Flt3+Sirpαint) 
was also confirmed to occur in the bone marrow through similar cell preparations, with the 
identification of progenitors through FACs analysis (Figure 4.1 C). Further quantitation 
showed that these progenitors could also be seen in the spleen and thymus as they migrate 
into these tissues for their development (Figure 4.1 C). Quantitation of numbers of pre-cDC 
show that they can be abundantly found in the bone marrow and then become less frequent in 
spleen and further in thymus. Therefore the localisation of the DC progenitors in WT adult 
mice appears to correlate with the previous literature, with MDP and CDP being bone marrow 










Dendritic Cells and Their Progenitors Are Correctly Localised  
 
A) The gating strategy used to identify the myeloid dendritic progenitors (MDP) and common 
dendritic cell progenitors (CDP) in bone marrow, spleen and thymus. Prior gating again 
included lineage discrimination, which excludes all cell expressing CD19, CD3, B220, 
Ter119, NK1.1.  
 
B) FACs plots of MDP and CDP in bone marrow (BM), spleen and thymus. Data is 
representative of two independent experiments with n=6. 
 
C) Gating strategy used to identify pre-cDC populations within the bone marrow, thymus and 
spleen. Lineage dump channel included NK1.1, CD19, CD3, B220, Ter119 with positively 
stained cells excluded prior to onward gating. Staining is representative of that seen in the 
bone marrow. Subsequent plots for the final identification of pre-cDC are shown with 
quantitation of absolute numbers in each tissue. Results were compiled from 3 independent 
experiments where n=11.  
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Pre-cDC can give rise to cDC1 as they undergo recruitment from the bone marrow to the 
thymus. Considering this and the previous chapter whereby LTβR signalling was shown to 
regulate the cDC1 population of DC, whether the pre-cDC population was affected under 
LTβR absence was therefore investigated. As a result, WT, Ltbr-/-, LtbrTEC and Foxn1Cre 
mouse strains were analysed for pre-cDC populations to determine if there were any 
alterations in this pre-cDC population. To begin with Ltbr-/- mice were analysed for pre-cDC 
through flow cytometric analysis in the bone marrow, spleen and thymus which were all 
freshly isolated from adult mice (Figure 4.2 A). The proportions of pre-cDC in WT and Ltbr-/- 
mice were comparable as shown in representative FACs plots for the bone marrow and spleen. 
However there was a loss of the pre-cDC population in the Ltbr-/- thymus compared to WT 
control mice. This was confirmed by absolute number quantitation with comparable numbers 
of pre-cDC in the bone marrow and spleen, but a reduction in pre-cDC in thymus of Ltbr-/- 
mice compared to WT control mice  (Figure 4.2 A right panel).   
 
This phenotype raised the question of whether this defect in pre-cDC was occurring at the 
level of LTβR signalling on thymic stromal cells. Therefore, bone marrow chimeras were 
generated whereby T-cell depleted bone marrow from either Ltbr-/- or WT mice was 
transferred into lethally irradiated WT hosts (pre-cDC would be lacking LTβR) and left for 8 
weeks before being sacrificed for pre-cDC absolute number analysis (Figure 4.3 A). When 
analysed by flow cytometry, results showed that numbers of pre-cDC in the bone marrow, 
thymus and spleen remained comparable between control WT and Ltbr-/- bone marrow 
transfers; further with no significant difference seen.  The reverse chimeras were also 
generated with lethally irradiated Ltbr-/- or WT host mice being reconstituted with WT bone 









Pre-cDC Are Reduced In Thymus Under LTβR absence 
 
A) Identification of pre-cDC (Lin-MHCII-CD11c+Flt3+Sirpαint) with Lin referring to CD19, 
B220, Ter119, NK1.1 and CD3. These were identified in bone marrow, spleen and thymus of 
WT and Ltbr-/- mice.  Absolute number analysis is shown in the right panel with the WT 
(black bar) and Ltbr-/- (white bar). Data is representative of three independent experiments 
with a sample number of 11 per strain, per tissue.  
 



































































LTβR Absence From Stroma Maps To Pre-cDC Defect But Not Specifically to Thymic 
Epithelial Cells 
 
Pre-cDC were all identified as Lin-MHCII-CD11c+Flt3+Sirpαint with Lin including the 
exclusion of CD19, B220, Ter119, NK1.1 and CD3. 
 
A) Generation of bone marrow chimeras with WT bone marrow transferred into a WT host 
(black bar) or Ltbr-/- bone marrow into a WT host (white bar). Mice were analysed 8 weeks 
post reconstitution for pre-cDC, across three independent experiments where n=10 for both 
chimeras. 
 
B) Generation of bone marrow chimeras with host thymus analysis following an 8 week 
period of reconstitution; WT bone marrow into WT host (black bar) and WT bone marrow 
into Ltbr-/- host (white bar). Graphs indicate absolute number analysis of cDC1 progenitors in 
bone marrow, spleen and thymus. Data represents five independent experiments WT host (15) 
and Ltbr-/- (10).  
 
C) Generation of LtbrTEC mice. Absolute number analysis of pre-cDC in Foxn1Cre (black bar) 
and LtbrTEC (white bar) mice under steady state analysis. Data was obtained across three 
experiments with n=13 per sample, per strain. 
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Deletion of LTβR on TEC x	 x	
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that absolute numbers were comparable between WT and Ltbr-/- hosts in the bone marrow and 
spleen. However a reduction was seen in pre-cDC in the thymus of WT bone marrow 
reconstituted Ltbr-/- host mice when compared to WT reconstituted controls. Therefore when 
thymic stroma was deficient in LTβR, cDC1 progenitors became defective within the thymus, 
but remained unaffected in alternative tissues. Additional analysis then questioned if the 
requirement for LTβR signalling on thymic stroma for pre-cDC regulation mapped to any 
difference in LtbrTEC mice compared with Foxn1Cre controls (Figure 4.3 C). In this analysis, 
pre-cDC were unchanged in the bone marrow, spleen and thymus between the LtbrTEC and 
Foxn1Cre mice, with no absolute number difference; suggesting no role for LTβR signalling 
on TEC in pre-cDC recruitment to the thymus.  
 
From this, we tried to address whether the alternative stromal populations of thymic 
mesenchyme and endothelial cells were necessary to support pre-cDC recruitment via LTβR 
signalling, with these populations previously shown to express LTβR (Figure 3.6). Therefore, 
LTβR deletion on these cells was targeted through the generation of mice in a similar manner 
to LtbrTEC, using a similar Cre/flox system. To target endothelial cells for LTβR deletion, 
initially the endothelial marker Tie2 was used, which forms part of the cell surface 
angiopoietin receptor required to bind angiopoietin. From this, Tie2Cre mice (Kisanuki et al., 
2001) were crossed with the Ltbrfl/fl mice (Wang et al., 2010b), generating Tie2CreLtbrfl/fl mice 
(Figure 4.4 A). When the thymus of the Tie2CreLtbrfl/fl mice was enzymatically digested 
following fresh isolation and prepared to examine endothelial cells by flow cytometry, the 
level of deletion of LTβR from the endothelial cells was incomplete, with the expression 
pattern spanning both the Ltbr-/- and Tie2Cre control mice (Figure 4.4 A). The same mice were 








LTβR Deletion From Endothelial Populations Is Incomplete In This Model 
 
A) Generation of endothelial cell specific LTβR deletion model. Analysis in the lower panel 
indicates level of deletion with isotype for Ltbr-/- (grey fill), Tie2cre (black solid line) and 
Tie2creLtbrfl/fl (dashed line).  
 
B) Quantitative analysis of dendritic cell populations in thymus. Tie2cre (black bar line) and 
Tie2creLtbrfl/fl (white bar). Data was obtained from at least two independent experiments 
(n=6). 
 
C) Pre-cDC analysis of bone marrow, thymus and spleen in Tie2cre (black bar line) and 
Tie2creLtbrfl/fl (white bar). Analysis is representative of n=6 from at least 2 independent 
experiments.  
 
All data was obtained in collaboration with Kieran James.  
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compared to Tie2Cre control mice, but there were no changes in any other dendritic cell subset 
(Figure 4.4 B). In addition, pre-cDC analysis in isolated bone marrow, spleen and thymus 
samples from Tie2CreLtbrfl/fl mice, showed no difference compared to controls. Therefore a 
partial deletion failed to achieve the same phenotype as the germline Ltbr-/- mice.  
 
Subsequently, an alternative endothelial marker was selected, with the use of the Flk1Cre 
mouse model (Motoike et al., 2003), with Flk1 being a receptor for Vascular Endothelial 
Growth Factor (VEGF). These mice were crossed to Ltbrfl/fl mice (Wang et al., 2010b) to 
generate Flk1CreLtbrfl/fl mice (Figure 4.5 A). The deletion of LTβR on these mice was then 
assessed to check whether there would be due to successful deletion from endothelial cells. 
This was shown through FACs analysis following preparation of thymus samples with 
enzymatic digestion, anti-CD45 MACs bead depletion and antibody staining for endothelial 
cell identification (CD45-EpCAM-1-Ter119-gp38-CD31+)  (Figure 4.5 A). Deletional analysis 
showed that LTβR was successfully deleted from the endothelial cells in the Flk1CreLtbrfl/fl 
mice with levels of LTβR mapping to the Ltbr-/- control mice; positive staining for LTβR 
expression was only seen on the Flk1Cre control mice. Subsequently, FACs analysis was also 
performed to assess the impact on thymic DCs in Flk1CreLtbrfl/fl mice, with similar thymus 
digestion upon isolation and antibody staining but for DC identification. This highlighted that 
cDC were unchanged, and pDC were reduced by half compared to Flk1Cre control mice 
(Figure 4.5 B). Furthermore, this unchanged cDC1 population was supported by no difference 
in pre-cDC, which were identified by flow cytometry in bone marrow, spleen and thymus of 










Alternative Model For LTβR deletion From Endothelial Cells Yields Complete Deletion 
 
A) Model of LTβR deletion from endothelial cells. The lower panel highlights the level of 
deletion in this system with staining for Ltbr-/- (grey fill), Flk1Cre (black solid line) and 
Flk1CreLtbrfl/fl (dashed line). Representative of two independent experiments n=6. 
 
B) Absolute number analysis of thymic dendritic cell populations; representative of two 
independent experiments with Flk1cre (black bar) n=6 and Flk1creLtbrfl/fl (white bar) n=4.  
 
C) Pre-cDC absolute number analysis in the bone marrow, spleen and thymus. Pre-cDC are 
identified as Lin-MHCII-CD11c+Flt3+Sirpαint with Lin referring to the exclusion of CD19, 
B220, Ter119, NK1.1 and CD3. Flk1creLtbrfl/fl (white bars), Flk1cre controls (black bars). Data 
is representative of two independent experiment with Flk1cren=6 and Flk1creLtbrfl/fl n=4.  
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Furthermore, mesenchymal cells were then targeted for LTβR deletion, which was initially 
investigated through PDGFRβCre mice (Foo et al., 2006) that were crossed with Ltbrfl/fl mice 
(Wang et al., 2010b), generating PDGFRβCreLtbrfl/fl mice (Figure 4.6 A). Platelet derived 
growth factor receptor β (PDGFRβ), is expressed by mesenchymal cells and therefore was a 
good target for mesenchymal deletion of LTβR. However when PDGFRβCreLtbrfl/fl mice, were 
analysed for the deletion of LTβR from mesenchymal cells that were retrieved from thymus, 
there was incomplete deletion with LTβR expression on PDGFRβCreLtbrfl/fl mice overlapping 
with PDGFRβCre mice as a positive staining control (Figure 4.6 A). Therefore this highlighted 
incomplete deletion once again. However again, DC were analysed to determine if any 
phenotype may subsequently be achieved with this partial deletion. Yet following this, DC 
populations in PDGFRβCreLtbrfl/fl mice were comparable to PDGFRβCre controls (Figure 4.6 
B) and in addition analysis of pre-cDC again highlighted no difference between these mice in 
bone marrow, spleen or thymus (Figure 4.6 C).  
 
From this, it was decided to try again to generate alternative versions of these mice to obtain 
deletion of LTβR from mesenchymal cell populations. Therefore Wnt1Cre mice (Lewis et al., 
2013) were crossed with the Ltbrfl/fl mice (Wang et al., 2010b) to generate Wnt1CreLtbrfl/fl mice 
to drive deletion of LTβR on mesenchymal cells which are of neural crest origin and present 
within the thymus (Figure 4.7 A) (Foster et al., 2008, Muller et al., 2008). Analysis of the 
deletion of LTβR from mesenchymal cells in Wnt1CreLtbrfl/fl mice was conducted via flow 
cytometry. This showed that there was partial deletion, with Wnt1CreLtbrfl/fl mice having a 
shifted expression of LTβR compared to the Wnt1Cre control mice, but failing to completely 
overlap with the Ltbr-/- negative control. Therefore it appears to have some level of successful 









LTβR Deletion From Mesenchymal Populations Is Incomplete In This Model 
 
A) Generation of a model for LTβR deletion from mesenchymal cells. Lower panel highlights 
level of LTβR deletion with Ltbr-/- (grey fill), PDGFRβCre (black solid line) and 
PDGFRβCreLtbrfl/fl (dashed line).  
 
B) Quantitative analysis of dendritic cell populations in thymus. PDGFRβCre (black bar line) 
and PDGFRβCreLtbrfl/fl (white bar). Data was obtained from at least two independent 
experiments (n=5). 
 
C) Pre-cDC absolute number analysis from bone marrow, spleen and thymus of PDGFRβCre 
(black bar line) and PDGFRβCreLtbrfl/fl (white bar) mice. Data was obtained from two 
independent experiments, n=5.  
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Generation of An Alternative Mesenchymal LTβR Deletional Model Fails To Yield 
Complete Deletion 
 
A) Mechanism of generation of the Wnt1CreLtbrfl/fl mice. Lower panel shows deletional 
analysis obtained from LTβR expression analysis on CD45-EpCAM-1-Ter119-CD31-gp38+ 
mesenchymal cells with Ltbr-/- (grey fill), Wnt1Cre (black solid line) and Wnt1CreLtbrfl/fl 
(dashed line) mice. This deletion was repeated across three independent experiments where 
n=8 
 
B) Corresponding absolute number analysis of thymic dendritic cells with Wnt1Cre (black bar) 
and Wnt1CreLtbrfl/fl (white bar) mice obtained from three independent experiments n=7/8 
respectively. 
 
C) Analysis of absolute numbers of pre-cDC in the bone marrow, thymus and spleen of 
Wnt1Creand Wnt1CreLtbrfl/fl mice (black and white bars respectively). Data is again 
representative of three individual experiments with n=7 for Wnt1Cre and n=8 for 
Wnt1CreLtbrfl/fl mice.   
 
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. 
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Subsequent analysis of these Wnt1CreLtbrfl/fl mice with thymic preparation and intrathymic DC 
identification by flow cytometry showed that the partial deletion was sufficient to cause a 
phenotype with regards to thymic DC (Figure 4.7 B). Absolute number quantitation showed 
that when the Wnt1Cre and Wnt1CreLtbrfl/fl mice were compared, total cellularities, total cDC 
and cDC2 were comparable in the thymus. However, the partial deletion seen in 
Wnt1CreLtbrfl/fl mice was sufficient to generate a phenotype of cDC1 and pDC reduction 
compared to Wnt1Cre control mice (Figure 4.7 B). Additionally when the bone marrow, spleen 
and thymus were isolated and analysed for pre-cDC populations, there was no reduction seen 
in pre-cDC in the bone marrow or spleen but a reduced population in the thymus of 
Wnt1CreLtbrfl/fl mice compared to control Wnt1Cre mice (Figure 4.7 C). As a result, this 
suggests that the partial deletion seen in these Wnt1CreLtbrfl/fl mice is sufficient to support a 
pre-cDC reduction in thymus and a corresponding cDC1 reduction most similar to the 
phenotype reported in the Ltbr-/- germline model.  
 
4.2.2 Alternative Mechanisms For Recruitment of cDC1 Progenitors 
It was apparent at this stage, that the dissection of the stromal population signalling through 
LTβR to impact pre-cDC recruitment to the thymus for subsequent cDC1 development was 
suggestive of a role for thymic mesenchyme. As a result, it was decided to investigate the 
contribution of possible chemokines to this process of pre-cDC recruitment as they have 
previously been implicated in recruitment of mature dendritic cell populations (cDC2 and 
pDC) into the thymus (Baba et al., 2009, Hadeiba et al., 2012). Further due to the association 
between LTβR and CCR7 ligand production in the thymus, the potential role for CCR7 in the 
regulation of pre-cDC populations was explored (Lkhagvasuren et al., 2013, Krueger et al., 
2010).  
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As a result, expression of CCR7 by the DC populations was initially assessed (Figure 4.8 A). 
This was completed with isolation of thymic tissue and enzymatic digestion for DC retrieval. 
Antibody staining was then completed to identify the DC subpopulations but further whether 
they expressed CCR7 on their surface as detected by flow cytometry. FACs analysis, using a 
CCR7 isotype (Figure 5.8 A), showed positive staining on cDC1, pre-cDC and cDC2, but that 
pDC for the most part, had no CCR7 expression. Considering this positive result for cDC1 it 
was possible that CCR7 signalling may be implicated in the regulation of the cDC1 
population.  
 
From this, there was analysis of Ccr7-/- mice to determine if under the absence of CCR7 
expression, dendritic cell populations, in particular the cDC1 and their progenitors were 
defective. However, due to CCR7 ligands being required in development of mTEC 
populations, it was decided to firstly check that TEC compartments were intact in Ccr7-/- 
mice, so that if any difference was reported in thymic DC analysis, it was not the result of a 
bystander effect of altered TEC populations. TEC were therefore analysed through enzymatic 
digestion of freshly isolated adult thymic tissue prior to flow cytometric analysis of WT 
control and Ccr7-/- mice. Representative FACs plots showing WT compared to Ccr7-/- thymi 
for all TEC populations suggested that proportions of TEC populations were unchanged 
between these mice including Aire expressing and CCL21 expressing mTEC, which remained 
largely comparable (Figure 4.9 A).  Absolute number analysis in the thymus was completed 
and similarly, TEC populations remained comparable between WT and Ccr7-/- mice (Figure 


















CCR7 Is Expressed by Some Dendritic Cell Populations  
 
A) Expression of CCR7 on different thymic DC populations. This was determined by FAC 
with positive staining (blue line) detected against a CCR7 isotype (grey filled). Representative 
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CCR7 Deficient Mice Have Comparable Thymic Epithelial Cell Analysis to WT 
Controls 
 
A) FACs plots show the proportional make up of TEC populations within a WT and Ccr7-/- 
thymus. It also clearly highlights the gating strategy used in the identification of these 
populations. 
 
B) Absolute numbers of TEC populations were calculated in the thymus of WT (black bars) 
and Ccr7-/- (white bars) mice with total thymus cellularity also shown. Data is representative 
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Therefore due to these unaltered TEC populations, analysis of the intrathymic DC 
compartment in WT compared to Ccr7-/- mice could be conducted to see if there was a direct 
effect on these DC populations following CCR7 absence.  
 
Firstly, DCs were identified in the thymus of WT and Ccr7-/- mice through flow cytometric 
analysis and representative plots showed that under the absence of CCR7, proportions of total 
cDC and cDC1 and pDC were reduced (Figure 4.10 A). Quantitation from this highlighted a 
significant reduction in total cDC which correlated in particular to reduced cDC1 as cDC2 
remained unchanged (Figure 4.10 B). Additionally pDC were reduced to a significant level. 
Therefore this data is suggestive of a potential requirement for CCR7 to coordinate cDC1 and 
pDC in the thymus. Splenic analysis was also completed to rule out any peripheral alterations 
in DC in Ccr7-/- mice and data showed no effect compared to WT control mice (Figure 4.10 
C). Furthermore pre-cDC were identified by flow cytometry in the bone marrow, spleen and 
thymus and absolute numbers showed that WT controls were comparable to Ccr7-/- mice in 
the bone marrow however reduced pre-cDC were seen in the spleen and a more significant 
reduction was seen in the thymus of Ccr7-/- mice compared to WT control mice (Figure 4.10 
C). Therefore this suggests a possible requirement for CCR7 to be present to support 
recruitment of pre-cDC and cDC1 development.  
 
Considering this possibility, whether there was a direct requirement for CCR7 signalling on 
the CCR7 expressing DCs themselves was not shown. This was therefore investigated 
through the generation of CCR7 mixed bone marrow chimeras. For this, WT mice that had 










Ccr7-/- Mice Have Reductions In Dendritic Cell Populations 
 
A) FACs plots show the distribution of dendritic cells in WT and Ccr7-/- mice.  
 
B) The lower panel shows corresponding absolute number analysis generated following FACs 
with total thymus cellularities and dendritic cell populations highlighted. WT (black bar) is 
representative of n=14 and Ccr7-/- (white bar) n=14 in the thymus obtained from four 
independent experiments. 
 
C) Absolute number analysis of splenic dendritic cell populations in WT (black bar) is 
representative of n=14 and Ccr7-/- (white bar) n=14 obtained from four independent 
experiments.  
 
D) Pre-cDC analysis in bone marrow, spleen, thymus in WT (black bar) and Ccr7-/- (white 
bar). Pre-cDC were Lin-MHCII-CD11c+Flt3+Sirpαint with Lin excluding CD19, B220, Ter119, 
NK1.1 and CD3 positive cells. Data was obtained from three independent experiments where 
n=10.  
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CD45.2+ bone marrow in equal proportions. Experimental mice contained WT and Ccr7-/- 
bone marrow co-transfers whereas controls contained WT:WT bone marrow.  This allowed 
analysis concerning the ability of CCR7 deficient bone marrow to compete with WT for the 
development of DCs in the thymus as well as their ability to support pre-cDC (Figure 4.11).  
 
By gating on the DC populations first, the proportion of the DC subsets that were 
reconstituted by CD45.1 expressing WT or CD45.1 lacking (CD45.2+) Ccr7-/- or WT bone 
marrow could be determined. Proportional analysis appeared to show roughly equivalent 
reconstitution of CD45.1+ or CD45.1- compartments of DC in WT:WT transfers. However 
WT:Ccr7-/- bone marrow transfers had proportional differences, shown in representative 
FACs plots (Figure 4.11 B) in the cDC1 and pre-cDC populations compared to WT controls.  
 
This was quantitated through proportional analysis for the contribution of CD45.1 or CD45.2 
to the DC (Figure 4.11 C).  The relative proportions of WT:WT transfers remained reasonably 
equal in all populations however comparisons between WT:WT and WT:Ccr7-/- transfers for 
the relative CD45.1/2 proportion, identified differences in cDC1. The WT population in the 
WT:Ccr7-/- transfers contributed more to the cDC1 population as it outcompeted the Ccr7-/- 
proportion making up 75% and 25% of the cDC1 population as a whole respectively. This 
was shown to be particularly skewed when compared to the relative WT:WT controls, which 
reconstituted at roughly 50%, 50%. Therefore a significant increase could be seen between 
the WT CD45.1+ compartment from WT:Ccr7-/- transfers when compared with the WT 
CD45.1+ compartment in WT:WT transfers for cDC1. Also a reduction could be seen for the 
CD45.2+ Ccr7-/- proportion from the WT: Ccr7-/- transfers when compared to the WT CD45.2+ 







cDC1 Require Cell Intrinsic Signalling Through CCR7 For Thymic Persistence 
 
A) Model used for WT and Ccr7-/- bone marrow transfer into WT congenically distinguished 
hosts. Representative FACs plots show the method used to identify the dendritic cell 
populations and their make-up with regards to differently labelled reconstituting 
compartments. Pre-cDC are also shown for the final CD45.1 discrimination rather than 
population identification. Pre-cDC were Lin-MHCII-CD11c+Flt3+Sirpαint with lineage 
excluding CD19, CD3, B220, NK1.1 and Ter119.  
 
B) Control chimera generation with WT:WT bone marrow placed  equally into an irradiated 
WT host utilising congenic markers to distinguish each population.  The lower panel shows 
dendritic cell identification from different CD45 compartments. Pre-cDC proportions of 
CD45.1+/- were included and identified as in A. 
 
C) Analysis of host thymus following bone marrow reconstitution. Analysis is all proportional 
with the left bar of each graph representing the WT:WT bone marrow reconstituted WT host. 
Within this, the black part of the bar correlates to WT CD45.1 and the white part being WT 
CD45.2. The right bar of each graph represents WT:Ccr7-/- bone marrow used to reconstitute 
the WT host with the black section referring to the WT CD45.1 bone marrow derived cells 
and the white being CD45.2 Ccr7-/-. Data is obtained across two independent experiments 
n=8. For pre-cDC data is from two independent experiments n=6.  
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analysis, highlighting reduced ability for Ccr7-/- progenitor derived cells to persist against WT 
control cells. Therefore there is a reduced ability of CCR7 deficient bone marrow derived 
cDC1 and pre-cDC to compete with WT counterparts; highlighting a requirement cell 
intrinsically for CCR7 expression on cDC1 and cDC1 progenitors for their thymic 
maintenance.  
 
Confirming the requirement for CCR7 signalling, it was decided to look at mice deficient for 
CCR7 ligands – these being plt/plt mice, which lack CC19 and CCL21 expression. plt/plt 
mice were examined for DC populations in the thymus and spleen with flow cytometric 
analysis compared to WT controls. Representative FACs plots following analysis showed a 
switch in the cDC1/cDC2 proportions in plt/plt mice compared to WT mice with a pDC 
reduction also seen (Figure 4.12 A). When absolute numbers were calculated, there was no 
total thymus cellularity difference but a reduction in total cDC that specifically mapped to 
cDC1 and a pDC reduction was also seen in plt/plt mice. Splenic analysis showed no 
difference in cDC but a slight pDC reduction was seen (Figure 4.12 C). Furthermore pre-cDC 
were analysed following preparations of bone marrow, splenic and thymic cells for flow 
cytometric analysis and showed that there was a reduction in pre-cDC in the thymus of plt/plt 
mice, but no alteration seen in the bone marrow or the spleen of plt/plt mice compared to WT 
controls (Figure 4.12 D). This data suggests similarly to the Ccr7-/- mouse analysis that pre-
cDC may require CCR7 and signalling through CCR7 by its ligands in a cell intrinsic manner 
for maintenance of cDC1 in the thymus.  
 
Which ligand, CCL19 or CCL21 was specifically necessary for the phenotype seen linking 








Mice Lacking CCR7 Ligands Suffer Dendritic Cell Defects 
 
A) FACs plots to illustrate identification of the dendritic cell populations within WT and 
plt/plt mice which lack CCR7 ligands.  
 
B) Absolute number analysis in the thymus for total cellularity and dendritic cell populations 
is within the lower panel. WT (black bar) and plt/plt (white bar). DC data was obtained from 
four independent experiments WT (n=13) and plt/plt (n=14).  
 
C) Splenic absolute number analysis for total cellularity and DC populations within WT 
(black bars) and plt/plt (white bars) is shown graphically, with n=13 and 14 respectively 
across four independent experiments.  
 
D) Analysis of pre-cDC defined as Lin-MHCII-CD11c+Flt3+Sirpαint with Lin referring to the 
exclusion of CD19, B220, Ter119, NK1.1 and CD3. Pre-cDC absolute numbers were 
analysed for bone marrow, thymus and spleen in WT (black bars) and plt/plt (white bars) with 
n=12 and 11 respectively across three independent experiments.  
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addressed. This was possible through analysis of Ccl19-/- or Ccl21α-/- mice which were both 
obtained from collaborators with for Ccl19-/- mouse thymus tissue shipped for analysis and 
Ccl21-/- mouse thymic analysis being conducted by the collaborators in Japan. Firstly Ccl19-/- 
mice were analysed for thymic DC populations and showed through representative FACs 
plots that the proportional distribution of thymic DC populations was maintained between 
mouse strains (Figure 4.13 A). Further absolute number analysis confirmed this distribution 
with absolute numbers being comparable for all parameters; total cellularity, total cDC, 
cDC1, cDC2 and pDC as well as pre-cDC remaining unaffected. Furthermore, this suggests 
that there may not be a role for CCL19 in the regulation of thymic DC populations. As a 
result this highlights CCL21 as a possible regulator. This was investigated through thymic 
preparations of WT and Ccl21α-/- mice for flow cytometric analysis of DC populations in 
thymus and showed that all populations could be identified within the thymus (Figure 3.13 
B). Representative plots showing DC proportions appeared to suggest that there was a 
reduction in the cDC population as a whole which specifically mapped to cDC1, whereas 
pDC appeared little affected. Additional analysis of absolute numbers showed that under the 
absence of CCL21, there was a corresponding reduction in total cDC and cDC1 linking 
directly to a significant loss of pre-cDC that was also seen in the Ccl21a-/- thymus, whereas 
cDC2 and pDC remained unaltered. From this it appears that there is a requirement for CCR7 
ligands, in particular CCL21, in the regulation of pre-cDC recruitment to the thymus to allow 









CCL21 Is Responsible For The Pre-cDC Recruitment To Thymus For cDC1 
Development 
 
A) FACs plots showing representative distribution of dendritic cell populations in WT and 
Ccl19-/- mice. The lower panel shows the absolute number analysis with total cellularity and 
dendritic cell populations highlighted as well as the pre-cDC (Lin-MHCII-
CD11c+Flt3+Sirpαint) population. The WT is indicated by the black bar and Ccl19-/- the white 
bar. Data is from two independent experiments where WT n=9 and Ccl19-/- n=10. Data was 
obtained in collaboration with Sanjiv Luther (Switzerland).  
 
B) FACs plots to illustrate the dendritic cell populations in Ccl21+/- controls and Ccl21-/- 
hosts. The lower panel quantitates the differences between these mice with regards to absolute 
number analysis. Data was preliminarily obtained from 9 independent experiments n=9. Data 
was obtained in collaboration with Yousuke Takahama (Japan). 
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4.3.1 LTβR Mediated Regulation of Pre-cDC and pDC Recruitment 
The previous chapter revealed that there were thymic reductions in cDC1 in Ltbr-/- mice, 
while BrdU analysis suggested that this was not due to a difference in proliferative status of 
cDC1. Thus reduced cDC1 in Ltbr-/- mice may be due to altered recruitment of cDC1 
progenitors to the thymus; a focus of this chapter. Previous research suggested that a 
CD11c+MHCII-Flt-3+Sirpαint pre-cDC population could give rise to cDC in the periphery. It 
was also suggested that cDC1 progenitors migrate into the thymus to contribute towards the 
DN1c subset for intrathymic cDC generation (Luche et al., 2011, Liu and Nussenzweig, 
2010). Therefore this peripherally defined pre-cDC population was analysed as a cDC1 
progenitor in bone marrow, spleen and thymus. Collectively data suggested that pre-cDC 
could exit the bone marrow and migrate into the spleen normally, but were reduced in 
numbers in the thymus of Ltbr-/- mice. This indicates that the thymus employs different 
recruitment mechanisms to those seen in the spleen and further that thymic pre-cDC 
recruitment depends to some extent upon LTβR. In turn, this was shown to be necessary at the 
level of the thymic stroma. To break this requirement down further, Cre/flox model systems 
were used to determine which stromal compartment was mediating pre-cDC regulation and in 
turn cDC1 maintenance.   
 
The Flk1CreLtbrfl/fl mice, with their successful deletion of LTβR from endothelial cells, 
appeared to suggest that LTβR signalling on endothelium was dispensable for pre-cDC 
recruitment. Therefore, when considering that LtbrTEC mice also showed no pre-cDC 
alteration, it suggests a role for thymic mesenchyme in recruitment of pre-cDC to thymus or 
further cooperation between multiple cell compartments. Yet the partial deletion in both the 
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PDGFRβCreLtbrfl/fl mice and the Wnt1CreLtbrfl/fl mice makes it a challenge to correlate these 
ideas. Despite this, the level of deletion appeared to be more effective in the Wnt1CreLtbrfl/fl 
mice compared to PDGFRβCreLtbrfl/fl mice and this was associated with a phenotype of 
reduced pre-cDC. As this partial deletion is sufficient to cause a pre-cDC reduction, it 
suggests that mesenchymal LTβR signals regulate thymic pre-cDC recruitment. Therefore, 
mechanistically, LTβR mediated modulation of mesenchymal cells may influence 
mesenchymal activation that could be necessary for pre-cDC recruitment. Analysis of the 
phenotype of mesenchymal cells in the various Ltbr-/- mouse strains may provide insight into 
how this population can become defective, in turn identifying factors that may support pre-
cDC recruitment.   
 
In addition, analysis of pDC showed a reduction in the Wnt1CreLtbrfl/fl mice which suggests 
that LTβR signals on thymic mesenchyme may influence pDC recruitment. However in 
addition, the Flk1CreLtbrfl/fl mice also showed a reduction in pDC to a similar extent to the 
germline Ltbr-/- mice. This was suggestive that pDC are being regulated by LTβR signalling 
on thymic endothelium potentially more so than signals on mesenchyme – however 
mesenchyme may be additionally implicated. Considering this, recruitment of pDC to the 
thymus from the periphery requires a multistep adhesion cascade with a series of tethering, 
rolling, firm adhesion to allow for subsequent transmigration of pDC into the thymus 
(Alvarez et al., 2008). Thymic endothelial cells have been shown to express VCAM-1, 
ICAM-1 and P-selectin which support the recruitment and entry of cells into the thymus 
(Lepique et al., 2003, Sultana et al., 2012). P-selectin has been suggested to interact with (P-
selectin glycoprotein ligand 1) PSGL-1 expressed on migratory DC for rolling on the 
endothelium, with firm adhesion associated with endothelial VCAM-1 in turn binding to 
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VLA-4 on DC for entry into the thymus (Bonasio et al., 2006). This questions whether LTβR 
may regulate these molecules on thymic endothelium to influence pDC entry into the thymus.  
 
From this, RT-PCR analysis of mesenchyme and endothelial cell sorted populations showed 
that the expression of ICAM-1 and VCAM-1 was regulated by LTβR, with significant 
reductions in adhesion molecule expression in the absence of LTβR (Lucas et al., 2016). 
Therefore it would be interesting to further determine if LTβR dependent regulation of 
ICAM-1 and VCAM-1 expression on endothelium or mesenchyme in the thymus may be 
responsible for altered pDC recruitment. However, analysis of P-selectin expression failed to 
show the same trend as ICAM-1, VCAM-1 and P-selectin expression in WT and Ltbr-/- mice 
showed no difference by RT-PCR (Lucas et al., 2016). Yet interestingly, P-selectin may still 
be involved in pDC recruitment as it was shown that although P-selectin is expressed in Ltbr-/- 
thymus, lack of LTβR led to the loss of a CD31+CD45-EpCAM-1+Ly6C-P-selectin+ subset of 
thymic endothelium (Shi et al., 2016). The lack of this population was shown to abrogate 
recruitment of T-cell progenitors into the thymus. Therefore, if the homing process of cells 
into the thymus is relatively conserved, it is possible that loss of the Ly6C-P-selectin+ 
endothelial population could in turn impact upon thymic pDC recruitment. These ideas 
combine to suggest that LTβR mediated regulation of adhesion molecules on endothelial and 
or mesenchymal cells may be necessary for successful pDC recruitment and this warrants 
further investigation. Despite this, pDC were slightly reduced in splenic analysis of Ltbr-/- 
mice, causing additional confirmation that pDC do not require LTβR for their normal 
development in the bone marrow to be necessary. This would allow direct correlation of 
reduced pDC in thymus with reduced recruitment, rather than altered production or 
availability.  
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4.3.2 CCR7 Mediated Regulation of Pre-cDC and pDC Recruitment 
While work from Cre/flox models indicate mesenchyme as the stromal population required to 
support pre-cDC entry into the thymus via LTβR signals, the persistence of a proportion of 
pre-cDC in Ltbr-/- mice is suggestive of alternative regulatory mechanisms. From this, CCR7 
was investigated as an alternative regulator given its implication in thymic progenitor homing 
(Zlotoff et al., 2010, Krueger et al., 2010). However it was important to confirm that there 
was no difference in the stromal compartment of the thymus in Ccr7-/- mice compared to WT 
mice in terms of TEC populations, to directly correlate any altered pre-cDC finding to 
reduced recruitment rather than indirectly to altered TEC. This was particularly relevant, as in 
the absence of CCR7 mice are known to have smaller medullary areas that are increased in 
frequency (Misslitz et al., 2004, Ueno et al., 2004). Additionally, using quantitative analysis 
we showed that the absolute numbers of different TEC compartments were unaltered in WT 
and Ccr7-/- mice, despite this changed organisation.  
 
Therefore, following this, further analysis of Ccr7-/- mice with reduced cDC1 and pre-cDC, 
showed that pre-cDC may be utilising CCR7 mediated migration to enter the thymus and give 
rise to the cDC1.  This was shown through mixed bone marrow chimeras to be necessary at a 
cell intrinsic level with an absence of CCR7 leading to a reduced ability of pre-cDC and 
cDC1 to compete with WT counterparts to gain entry into the thymus. Therefore this further 
rules out a non-cell autonomous requirement for CCR7 expression and suggests that TEC are 
supporting CCR7 ligand production that is directing these CCR7 expressing pre-cDC into the 
thymus (Lkhagvasuren et al., 2013). The correlation of plt/plt mice with the defect seen in the 
Ccr7-/- mice confirms a requirement for CCR7 ligands in signalling via CCR7 for pre-cDC 
recruitment and cDC1 maintenance in thymus. Furthermore, it was apparent that this 
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reduction in the thymus correlated to a tissue specific requirement for CCR7-CCR7L 
mediated recruitment, as both the bone marrow and the spleen in plt/plt mice had equivalent 
numbers of pre-cDC populations.  In addition the requirement for CCR7 ligands in this pre-
cDC recruitment process was directly correlated to CCL21 as Ccl21a-/- mice suffered reduced 
pre-cDC, while Ccl19-/- mice were not affected.  
 
Interestingly, in analysis of Ccr7-/- mice, pDC appeared to also be affected and this is 
somewhat harder to unravel given our inability to detect CCR7 expression on pDC. 
Supporting this, despite migration of pDC to the thymus being linked to the CCR9/CCL25 
axis, lymph node studies using isolated pDC showed through transwell migration assays that 
pDC could migrate towards CCR7 ligands, supporting an ability of pDC to be influenced by 
CCR7 ligands (Hadeiba et al., 2012, Seth et al., 2011). Yet despite this being feasible, further 
experiments with our mixed bone marrow chimera analysis argue against a requirement for 
CCR7 expression by pDC for their recruitment to the thymus, as pDC lacking CCR7 
expression were able to compete with WT pDC and be represented equally in the thymus. 
Therefore, the reductions in thymic pDC in Ccr7-/- mice and additionally in plt/plt mice 
proposes that CCR7 signalling may be necessary for pDC to be recruited to the thymus but 
via an indirect intermediate population. There appeared to be a requirement further for both 
CCL19 and CCL21 in this process as an absence of either of these ligands did not affect pDC, 
suggesting that these ligands are able to compensate for one another for pDC recruitment to 
the thymus. Therefore, overall, this suggests CCR7 mediated regulation of an intermediate 
population, which is perturbed in Ccr7-/- mice, is necessary to indirectly regulate the 
recruitment of pDC into the thymus. It will be interesting to determine which intermediate 
cell type this may be as many cells in the thymus are dependent upon CCR7 signalling for 
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their regulation such as thymocytes that require CCR7 signals for cortex to medulla migration 
(Kurobe et al., 2006, Ueno et al., 2004).  
 
In conclusion, this chapter highlights the requirement for LTβR in the recruitment of pre-cDC 
and subsequently cDC1 maintenance in the thymus. Despite inefficiency of Cre/flox animal 
models, Wnt1CrexLtbrfl/fl mice hint towards a role for mesenchyme in this process. 
Furthermore this chapter emphasises that CCR7 is also involved in the recruitment of pre-
cDC to the thymus, specifically via CCL21 exposure on pre-cDC in a cell intrinsic manner. 
This suggested process is shown in a summary diagram Figure 4.14. Additionally pDC were 
considered in this chapter and were shown to be regulated predominately by LTβR signalling 
on endothelial cells, although mesenchymal cells appeared to also have a role. How this 
works mechanistically remains unknown but it may be suggested to occur through alterations 
in adhesion molecules necessary for pDC recruitment. 
 
Considering the two parts of this chapter, CCR7 ligand production in the thymus is indeed 
known to be due to LTβR signalling on TEC (Lkhagvasuren et al., 2013, Seach et al., 2008). 
As a result, the possibility for the observation of reduced pre-cDC and cDC1 in Ltbr-/- mice to 
be linked to reductions in CCR7 ligands is possible. This process further has been suggested, 
through work in this chapter, to relate to mesenchymal cells. However CCL21 is not produced 
by mesenchyme, leaving the production of CCL21 by TEC to be required subsequently for 
presentation by mesenchyme. Furthermore, this is a possibility as mesenchyme has been 
shown to present CCL21 in the thymus as it binds to podoplanin (Fuertbauer et al., 2013). In 
addition, studies of mesenchymal cells in lymph nodes showed that their activation was 
affected under the absence of LTβR with reduced VCAM-1 and ICAM-1 expression and 
reduced immunocompetency of these cells (Chai et al., 2013). Therefore this information 
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combines to suggest the possibility of LTβR mediated maturation of mesenchymal cells to 
support mesenchymal presentation of TEC produced CCL21. This in turn may support the 
recruitment of pre-cDC and cDC1 into the thymus. This hypothesis requires further 
confirmation, potentially by proving the ability of mesenchyme in WT mice to present CCL21 
and further determine whether Wnt1CrexLtbrfl/fl mice have altered mesenchymal activation that 














Summary Diagram For Pre-cDC Regulation By CCL21 In Thymus  
 
A) Model to show the proposed process of pre-cDC recruitment into the thymus. 1) TEC 
produce CCL21. 2) CCL21 is presented by mesenchyme cells that mature through LTβR 
signalling. 3) Pre-cDC expressing CCR7 are attracted to the CCL21 presented on 
mesenchyme in the thymus. 4) Recruited pre-cDC enter into the thymus attracted by CCL21 























CHAPTER FIVE:  







The thymus medulla is classically known as a home for mature SP thymocytes. In addition, as 
described in previous chapters, the thymus medulla contains important hematopoietic 
elements, namely DC that play vital roles in thymus function. Interestingly, it has also been 
reported to contain multiple other hematopoietic cells, whose functions are perhaps less clear. 
These include cells of the adaptive immune system, such as B-cells as well as a wide range of 
innate immune cells including iNKT cells, macrophages and eosinophils.  
 
Eosinophils are thought to enter into the thymus through their expression of CCR3, being 
attracted towards eotaxin (CCL11) which is readily detectable within the thymus and localises 
eosinophils to the medullary areas (Matthews et al., 1998). Current research suggests a 
possible role for eosinophils in the thymus for the clearance of apoptotic cells that arise 
following negative selection and death by neglect processes (Kim et al., 2010). This study 
suggested that when apoptosis was induced through γ irradiation there was an increase in 
TUNEL+ cells which coincided with increased infiltration of eosinophils into the thymus and 
clearance of dying cells. This clearance was less effective under eosinophil absence and 
therefore eosinophils were suggested to have a role in the thymus in apoptotic cell clearance. 
Interestingly, other studies suggest that eosinophils potentially contribute towards the process 
of negative selection itself in the thymus through antigen cross-presentation (Throsby et al., 
2000). Despite these studies, the role of eosinophils in thymus function is poorly understood, 




Importantly, and in addition to their influence on immune system function, eosinophils have 
been shown to support the recovery of multiple tissues following damage. To begin with, 
upon damage to the liver, it had previously been reported that a rapid type 2 immune response 
was consistently initiated and originally this was suggested to relate to macrophages that were 
thought to be responsible for the repair of damaged tissue barriers (Allen and Wynn, 2011, 
Palm et al., 2012). However through a model of injury using carbon tetrachloride, the role of 
eosinophils in this regeneration process was uncovered (Goh et al., 2013). Following damage, 
a huge influx of eosinophils were seen into the liver correlating to an increase in hepatocyte 
proliferation. Analysis of the eosinophil deficient model, dblGATA mice, illustrated that this 
repair process was impaired and therefore highlighted a role for eosinophils in the repair of 
liver tissue (Goh et al., 2013). A similar study was carried out in muscle, showing again that 
upon muscle damage, large numbers of eosinophils were recruited to the damaged site, which 
in turn supported muscle regeneration. Again, in the absence of eosinophils, this recovery was 
hindered (Heredia et al., 2013). Mechanistically, both studies concluded that eosinophils were 
functioning to repair tissue through their production of IL-4. In hepatocytes, this triggered 
entry into cell cycle to recover liver cell numbers post damage (Goh et al., 2013), whereas in 
muscle IL-4 was shown to induce the differentiation and conversion of fibro/adipocyte 
progenitors into myofibres to support muscle regeneration (Heredia et al., 2013).  
 
Therefore it appears that eosinophils have a vital role in tissue repair. Whether they possess 
this role in the thymus remains completely uninvestigated. Considering this, regeneration of 
the thymus has gained extensive interest due to thymic involution which occurs with age as 
well as following damage such as irradiation therapy; both causing the thymus, in turn, to be 
immunologically inefficient (Aw et al., 2007, Lynch et al., 2009, Steinmann et al., 1985). As a 
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result much research has been focused on mechanisms regulating the process of thymus 
regeneration with an emphasis on regenerating the TEC compartment to support enhanced 
thymus reconstitution. Current techniques include, administration of Fibroblast growth factor 
7 (FGF7) to trigger TEC expansion (Erickson et al., 2002, Dooley et al., 2007) as well as 
insulin like growth factor and IL-7 administration to enhance T-cell development (Mackall et 
al., 2001, Bolotin et al., 1996, Chu et al., 2008). An additional study highlighted that there 
may be a role for intrathymic IL-22 production by lymphoid tissue inducer (LTi) cells 
following damage in the regeneration of TEC and this is currently being explored in clinical 
trials (Dudakov et al., 2012). As a result, this chapter will focus on preliminarily addressing 
whether thymic eosinophils may be capable of supporting recovery of the thymus post 
damage and if so, then it will begin to hypothesise and address potential mechanisms through 




5.2.1 Phenotypic Analysis Of Thymic Eosinophils 
To examine the possibility of eosinophils supporting the process of thymic regeneration, they 
firstly required further identification and characterisation in the thymus. To identify 
eosinophils, fresh thymus and splenic tissues were prepared by enzymatic digest. Antibody 
staining was then performed and eosinophils were identified as CD45+CD4-CD8-TCRβ-
Ter119- cells that co-expressed CD11b and Siglec-F (Figure 5.1 A). The population of 
eosinophils identified in the thymus and spleen has been shown with representative plots 
(Figure 5.1 B). Proportions of eosinophils between the thymus and spleen were further 
compared with increased proportions of eosinophils in thymus. Eosinophil populations were 
then compared between the thymus and spleen for subsequent phenotypic analysis of mean 
fluorescent intensity by flow cytometry for Siglec-F and CD11b expression. This was 
conducted as such markers directly correlate to an activated phenotype, allowing the relative 
activation status of eosinophils in the thymus to be compared to those in the spleen. A 
significant difference was noted between thymic and splenic eosinophils upon this analysis, 
suggesting that eosinophils in the thymus represent an activated population (Figure 5.1 C).  
 
Despite the presence of eosinophils in the thymus, little is known about their emergence 
during life.  Therefore, a developmental ontogeny series looking at the presence of 
eosinophils in the thymus was generated; with WT mice harvested at specified time points 
and further timed matings established to look at embryonic stages in development (Figure 
5.2). As previously seen in Chapter 3 with regards to DC ontogeny, as mice increased in age, 
the total thymus cellularity correlated with an initial growth phase from E18 to around three 










Eosinophils Are Present In The Thymus and Spleen of WT mice 
 
A) FACs plots to show the gating strategy that was employed to identify eosinophil 
populations. This was common to thymus and spleen. Final eosinophils were identified as 
CD45=CD4-CD8-TCRβ-Ter119-CD11b+Siglec-F+. 
 
B) Representative FACs plots to illustrate the presence of eosinophils identified in thymus 
and spleen.  Quantitation of FACs percentages of eosinophils in the right hand panel for 
thymus compared to spleen. Thymus (n=10), spleen (n=10).  
 
C) Analysis of Siglec-F and CD11b mean fluorescence intensity (MFI) representative of 
activation status n=10. Thymus and spleen are compared to one another for these markers 
with the black bar representing thymic data, and the white bar referring to splenic.   
 





































































































































Eosinophils In Thymus Alter With Ontogeny 
 
Ontogeny series data was representative of the following sample numbers; E18 2x(6 lobes 
pooled per repeat), 1 week (n=8), 3 weeks (n=9), 5 weeks (n=7), 7 weeks (n=13), 9 weeks 
(n=8). All samples were analysed freshly upon isolation.  
 
Analysis of total thymus cellularity with development (A) and corresponding numbers of 
thymic eosinophils (B). Thymic eosinophils (B) are shown on a per mouse basis (left panel) 
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decline with a significant drop from three to five weeks before continuing to decrease in size 
with the onset of involution of the thymus through adulthood life, between seven to nine 
weeks of age (Figure 5.2 A). Following thymus analysis for total size, the presence of 
eosinophils was examined by flow cytometry and a population of eosinophils was 
distinguishable from E18 in the thymus of WT Balb/c mice (Figure 5.2 B). The trend in 
eosinophil numbers mirrored the thymus size, with increases until around five weeks of age 
from which point numbers began to decline again from five to nine weeks, coordinating with 
changes in total thymus cellularity. This could be seen on a per mouse basis (Figure 5.2 B top 
panel) as well as in a summary analysis with average numbers of eosinophils calculated 
(Figure 5.2 B bottom panel). Therefore this data series shows that thymic eosinophils persist 
throughout the thymus, independent of thymic age and are very much in synchrony with the 
thymic size. 
 
As eosinophils are thought to be localised in medullary areas, we questioned if there was a 
requirement for the medulla to regulate thymic eosinophils (Matthews et al., 1998, Throsby et 
al., 2000). To address this, the presence of eosinophils in the thymus was initially investigated 
under circumstances where the thymic medulla and further the thymic architecture was 
disrupted. For this, Tcrα-/- mice, which lack single positive thymocytes and therefore as a 
result, due to the reciprocal requirement for single positives to promote mTEC development, 
suffer from disrupted mTEC populations and disorganised medullary structure, were analysed 
to see if the eosinophil populations were resultantly altered (Figure 5.3)(Desanti et al., 2012, 
Palmer et al., 1993). Firstly, thymi from Tcrα-/- adult mice were digested enzymatically along 
with WT controls and eosinophils were identified through antibody staining for detection by 







Eosinophils Are Reduced In Mice Lacking Single Positive Thymocytes 
 
A) FACs plots showing the identification of thymic eosinophils (CD45+CD4-CD8- TCRβ-
Ter119-CD11b+Siglec-F+) in the left hand plot and eosinophil identification in the right hand 
plot through CD45+CD11b+Siglec-F+ which separates eosinophils more so based upon 
activation status for WT and Tcrα-/- mice.  
 
B) Quantitation of total thymus cellularity is shown in the left plot, Facs% of eosinophils 
(middle plot) and eosinophil absolute numbers (right plot) for WT and Tcrα-/- mice. Data is 
representative of three independent experiments (n=10). 
 
C) FACs plots showing eosinophils (CD45+CD4-CD8- TCRβ-Ter119-CD11b+Siglec-F+) in the 
spleen in the left hand plot and eosinophil identification based upon activation in the right 
hand plot for WT and Tcrα-/- mice. 
 
D) Absolute number analysis with total splenic cellularity, eosinophil FACs% and eosinophil 
absolute numbers in WT and Tcrα-/- mice. Data was obtained from three independent 
experiments with (n=10).  
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vast reduction in proportion in Tcrα-/- thymus compared to WT control mice (Figure 5.3 A). 
Furthermore when eosinophils were identified and separated based upon their levels of 
Siglec-F expression, linked with increased activation; there was downregulation of Siglec-F 
by eosinophils in the Tcrα-/- mice compared to WT mice (Figure 5.3 A). Additional analysis at 
an absolute number level of the total number of eosinophils showed that they were almost 
completely absent from Tcrα-/- mice (Figure 5.3 B). Therefore this data suggests a requirement 
for the medulla in the regulation of thymic eosinophils and furthermore a possible 
requirement for single positive cells in thymic eosinophil maintenance.  
 
Building upon this, splenic eosinophil populations were identified in WT and Tcrα-/- mice 
following isolation and splenic tissue preparation.  Upon analysis, proportionally eosinophils 
appeared to be slightly reduced compared to WT controls (Figure 5.3 C). Activation analysis 
suggested that eosinophils may also be less activated in the spleen of Tcrα-/- mice, with a loss 
of the highest expressing Siglec-F population when compared to WT mice. Absolute number 
analysis showed no difference in total splenic cellularity and no significance was seen in 
proportional eosinophil analysis either, whereas total eosinophil numbers were significantly 
reduced in the spleen of Tcrα-/- mice (Figure 5.3 D). Therefore this data suggests that there 
could be a peripheral requirement for αβT cells in the maintenance of the splenic eosinophil 
populations.  
 
5.2.2 Analysis of Eosinophil Deficient dblGATA Mice Under Steady State Conditions  
To begin to address the possible thymic role of eosinophils, we utilised a model of eosinophil 
deficiency: dblGATA mice, on a Balb/c background. These mice have a deletion of the high 
affinity double Gata binding site in the Gata-1 promoter, which is required to drive the 
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development of eosinophils and have been shown to lack eosinophils (Yu et al., 2002).  
Thymuses from 8-12 week old WT and dblGATA mice were digested and stained for 
eosinophil specific cell markers including Siglec-F and CD11b to define eosinophils. Figure 
5.4 A shows that while detectable in the WT thymus, eosinophils were markedly absent from 
thymus of dblGATA mice. To examine whether eosinophils impact upon steady state thymus 
formation and/or development, fresh thymi were isolated from WT and dblGATA mice. The 
physical structure of the thymus as a whole remained unaltered upon isolation with the gross 
size remaining comparable between WT and dblGATA mice (Figure 5.4 B). Further some of 
these thymi were snap frozen before being sectioned and stained with antibodies for confocal 
microscopy. In this analysis, thymocytes were identified through CD4(red) and CD8(blue) 
with this staining highlighting single positive (CD4+ or CD8+) and double positive 
(CD4+CD8+) thymocytes in the thymus. Medullary areas were further highlighted with the 
staining of ERTR5 (green) as a medullary marker (Figure 5.4 C). Double positive thymocytes 
were shown to be correctly positioned in the cortex and single positive thymocytes were 
present in the medullary regions of the dblGATA thymi, with comparable staining to WT 
controls.  
 
Next, in-depth analysis of TEC was conducted to determine if there was correct development 
of the thymic stromal structure in the absence of eosinophils. For this, thymus samples were 
enzymatically digested and FACs analysis was performed. Representative plots have been 
shown (Figure 5.5 A) of the proportions of TEC populations in the steady state between WT 
and dblGATA mice. This further highlights the gating strategy used for TEC population 
identification which as a whole were classified as CD45-EpCAM-1+ cells. Subpopulations of 










dblGATA Mice Are A Model Of Successful Eosinophil Absence 
 
A) FACs analysis verifying the model of dblGATA mice by highlighting how the dblGATA 
mice suffered from an effective loss of eosinophils compared to WT controls. Plots are 
identifying eosinophils as (CD45+CD4-CD8- TCRβ-Ter119-CD11b+Siglec-F+). Absolute 
numbers are also shown. Data is representative of two independent experiments where n=6.  
 
B) Visual representation of thymic size in WT and dblGATA adult mice from age and sex-
matched mice. 
 
C) Confocal analysis of the thymus of dblGATA mice showing CD4 staining (red), CD8 
staining (blue) and ERTR5 (green). 
 
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. 
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Steady State TEC Development Is Unchanged In Eosinophil Deficient Mice 
 
A) FACs analysis of Thymic Epithelial Cell (TEC) populations between WT and dblGATA 
including mTEC subpopulations indicating the corresponding gating strategy used for 
identification such as mTEChi (EpCAM-1+UEA-1+Ly51-MHCII+CD80+) and mTEClo 
(EpCAM-1+UEA-1+Ly51-MHCII-CD80-) shown in the top panel. 
 
B) Analysis of weight and total thymus cellularity between WT and dblGATA mice. Data is 
representative of two independent experiments WT (n=5) dblGATA (n=7) shown by the 
black and white bars respectively.  
 
C) Corresponding absolute number analysis of TEC populations identified in A, performed 
from two independent experiments with WT (n=5) dblGATA (n=7), all adult mice. Black bar 































































































































































































































































mTEC then subdivided into MHCII+CD80+ mTEChi and MHCII-CD80- mTEClo cells. The 
weight of the thymus was also equivalent between WT and dblGATA mice in steady state 
conditions, supported by no difference in total thymus cellularity (Figure 5.5 B). Following 
from this, absolute number analysis reflected the lack of difference in TEC proportions 
(Figure 5.5 C lower panel). These findings suggest that TEC development is unaffected in 
dblGATA mice, indicating that eosinophils are not required for TEC development.  
 
T-cell development in steady state WT and dblGATA mice was additionally conducted to 
determine quantitation of thymocyte populations. Isolated steady state thymi were 
disaggregated to release thymocytes for identification by flow cytometry. Representative 
FACs plots of thymocytes are shown in WT and dblGATA mice (Figure 5.6 A) where 
proportions of CD4+ cells appeared comparable, with further gating for mature single positive 
CD4+TCRβhi cells also remaining proportionally comparable even at the level of Treg 
(CD4+TCRβhiCD25+Foxp3+). Additionally, the maturation status of the CD4+TCRβhi 
population was assessed and showed that the most mature CD62L+CD69- population in 
dblGATA thymi was again similar proportionally to the WT mice. However, interestingly, 
CD4-CD8+ thymocytes were reduced in dblGATA mice, which mapped to reduced 
populations of the most mature CD62L+CD69- subset. Absolute number analysis supported 
these representative proportions and concluded that total thymus cellularities, CD4+CD8+ 
double positive and CD4+TCRβhi populations including T-Regulatory cells were comparable 
to WT mice (Figure 5.6 B). Furthermore no defect was seen in CD4+TCRβhi maturation 











T-cell Development Is Comparable Between WT and dblGATA Mice 
 
A) Representative FACs plots illustrating the gating strategy for T-cell analysis and 
identification of CD4SP and CD8SP T cell populations as well as their subsequent subsets 
including T-Regulatory CD4+TCRβ+CD25+Foxp3+ and the splitting of CD4SP upon CD69 
and CD62L to highlight the most mature CD69-CD62L+ and immature CD69+CD62L- 
subsets.  
 
B) Absolute number quantitation of T-cell populations in WT Balb/c and adult dblGATA 
mice. Data is for n=6 across two independent experiments. WT (black bar), dblGATA (white 
bar). CD4+ and CD8+ cells have also been subdivided based upon expression of the 
maturation markers CD69 and CD62L to separate the mature (CD69-CD62L+) from the 
immature (CD69+CD62L-).  
 





























































































































































































result, this steady state analysis highlights that overall T-cell development occurs normally in 
dblGATA mice with the exception of a slight reduction in CD8+TCRβ+ cells.  
 
5.2.3 Sub-lethal Irradiation Damage of Eosinophil Deficient dblGATA Mice 
As thymus development in the steady state of dblGATA mice is comparable to WT mice (all 
8-12 weeks old and female only), we next examined if under conditions of thymic damage a 
potential role for eosinophils could be unveiled. To begin with, we decided to induce thymic 
damage by employing a model of sub-lethal irradiation (SIR) whereby mice were exposed to 
a single dose of 425 rad level of irradiation at the day 0 time point. Subsequently the recovery 
of the thymus from this initial exposure could be addressed upon sacrifice and compared 
between WT and dblGATA mice. Initially we assessed if following SIR, the extent of thymic 
damage was similar between WT and dblGATA mice. To do this, we chose an early time 
point day four (d4) post SIR and compared TEC damage between WT and dblGATA mice 
(Figure 5.7). Initial analysis of thymus weight showed a slight reduction in dblGATA mice 
but this was not of significance. However when total cellularity was compared, dblGATA 
mice had reduced overall cell numbers correlating directly to the reduction seen in CD45+ 
thymocytes (Figure 5.7 A). Further, following isolation of thymi at the d4 timepoint, thymi 
were digested and alternatively stained with TEC specific antibodies to assess TEC 
populations by flow cytometry. This showed that TEC populations were comparable between 
WT and dblGATA mice at d4 post SIR (Figure 5.7 B). Similarly, when absolute numbers of 
TEC populations were quantified, there was no significant difference seen between WT and 











dblGATA Mice Have Comparable TEC To WT Controls At d4 Post Sub-lethal 
Irradiation  (SIR) 
 
A) Weights, cellularities and numbers of thymocytes (CD45+) in the thymus of sub-lethally 
irradiated (SIR) WT were compared to sub-lethally irradiated eosinophil deficient mice at day 
four following damage. Data is of WT (n=6) and dblGATA (n=7) with black bars and white 
bars respectively obtained from two independent experiments.  
 
B) Representative FACs plots of Thymic Epithelial Cell (TEC) analysis with mTEC 
subpopulation gating shown (EpCAM-1+UEA-1+) in WT and dblGATA irradiated mice at d4 
post irradiation harvest. Typical proportional plots are shown for the two strains. 
 
C) Quantitation of TEC analysis with further breakdown of TEC subsets for comparison 
between WT black bars and dblGATA white bars. The mTEC population is subdivided into 
mTEChi (EpCAM-1+UEA-1+Ly51-MHCII+CD80+) and mTEClo  (EpCAM-1+UEA-1+Ly51-
MHCII-CD80-) for quantitation and comparison. WT (n=6), dblGATA (n=7) across two 
independent experiments.  
 































































































































































































































































































Continuing on to a day seven (d7) time point following SIR, thymi between WT and 
dblGATA mice were examined to assess the ability of the thymus to carry out mechanisms of 
recovery, as it had previously been shown that the thymus begins recovering from this time 
point following damage (Figure 5.8) (Dudakov et al., 2012). For this, sub-lethally irradiated 
thymi from WT and dblGATA mice were similarly prepared with isolation, enzymatic 
digestion for TEC retrieval and flow cytometric analysis to identify TEC populations. What 
was apparent to begin with, was that there was a marked reduction in thymus weight in 
dblGATA mice, supported by reduced cellularity from around 6x106 cells seen in the WT 
mice down to a reduced 2x106 cells in dblGATA mice (Figure 5.8 A). This coincided with a 
similar fractional reduction in thymocytes that was further of significance. Interestingly, 
subsequent analysis of TEC populations demonstrated that all populations were present in WT 
and dblGATA mice with the proportions of these further being comparable when gated in an 
identical manner (Figure 5.8 B). However, absolute number analysis saw a large reduction in 
total TEC in dblGATA mice when compared to WT sub-lethally irradiated control mice 
(Figure 5.8 C). The reduction in total TEC was due to a significant decrease in all TEC 
populations, with mTEChi being the most significantly affected.  As a result, this highlights 
that dblGATA mice have perturbed thymic recovery following SIR.  
 
The experiments described above indicating reduced recovery of dblGATA thymi following 
sub-lethal irradiation (SIR) were performed using dblGATA (dblGATA-/-) mice and WT 
controls that were not littermate controls. Next littermate controls of dblGATA+/- and 
dblGATA-/- mice were generated for comparison to confirm if the trend mirrored that seen 
between the non-littermate WT and dblGATA-/- mice previously assessed. It allowed also for 








Eosinophil Deficient Mice Fail To Recover To The Level of WT Controls Following Sub-
lethal Irradiation at a d7 Timepoint 
 
A) Analysis of weights of thymus, total thymus cellularities and number of thymocytes 
(CD45+) at d7 post sub-lethal irradiation (SIR) of dblGATA mice (white bar) compared to 
WT controls (black bar). Data was obtained from three experiments with a sample number of 
7.  
 
B) FACs plots showing TEC populations in WT compared to dblGATA mice d7 post sub-
lethal irradiation. Proportions were representative of the populations and illustrate how the 
gating was completed.  
 
C) Absolute number analysis of the TEC populations, mTEC being defined as EpCAM-
1+UEA-1+Ly51- and cTEC as EpCAM-1+UEA-1-Ly51+, mTEChi (EpCAM-1+UEA-1+Ly51-
MHCII+CD80+) and mTEClo (EpCAM-1+UEA-1+Ly51-MHCII-CD80-) seen in (B). Data is 
from three independent experiments (n=7). Black bar represents WT and white bar is 
dblGATA analysis.  
 







































































































































































































































































































comparability. The presence of thymic eosinophils in WT and dblGATA+/- mice along with 
relative absence from dblGATA-/- mice confirmed the phenotype was correct (Figure 5.9 A). 
There appeared to be a proportional reduction in eosinophils in the thymus of dblGATA+/- 
compared with WT controls, and a further reduction between dblGATA+/- and dblGATA-/- 
mice with dblGATA-/- having a complete absence of eosinophils detectable by FACs. When 
this was quantitated however, there was no statistical difference between WT and dblGATA+/- 
mice for eosinophil number. But a significant reduction was seen when dblGATA-/- mice 
were compared to both WT and dblGATA+/- controls.  
 
Additional analysis was then completed to assess TEC populations (Figure 5.9 B). Thymi 
were isolated from age-matched mice and digested enzymatically for TEC analysis. There 
was no difference in the steady state for any of the TEC populations between the littermate 
control dblGATA+/- and dblGATA-/- mice. Furthermore, the WT non-littermate controls were 
also equivalent with regards to absolute numbers of TEC to the dblGATA+/- littermate 
controls. This highlights in the steady state that there is no difference in the development of 
TEC and that the WT mice remain comparable to dblGATA+/- littermate control mice. 
Development of T-cell populations was also addressed, with isolated thymus samples being 
disaggregated to release thymocytes for analysis by flow cytometry. FACs analysis and 
absolute number quantitation was conducted and showed that total thymus cellularity was 
comparable between the three mouse strains (Figure 5.9 C). Furthermore all of the T-cell sub-
populations were comparable to one another with similar levels of double positive 
(CD4+CD8+), CD4+TCRβhi mature single positive CD4 T-cells and T-Regulatory cells. 










Littermate Heterozygous Controls for dblGATA Mice Are Comparable To WT Mice In 
Steady State Analysis 
 
A) Eosinophil staining in steady state mice WT, dblGATA heterozygous (Het) and dblGATA 
knockout (KO) mice with representative plots for the final identification of eosinophils shown 
as CD45+CD4-CD8-TCRβ-Ter119-CD11b+Siglec-F+. Absolute numbers of eosinophils is 
quantified in the right panel graph. Data was obtained from two independent experiments 
where n=6.  
 
B) Absolute number analysis highlights TEC analysis in the steady state of littermate controls 
for dblGATA compared to WT. WT (black bar), Het (grey bar), dblGATA KO (white bar).  
Data was obtained from one independent experiment with n=4.  
 
C) Absolute number analysis in the steady state of T-cell populations within the thymus of 
littermate controls for dblGATA Het/KO (white bar/ dark grey) and comparison to WT (black 
bar). Data was obtained from one independent experiment where n=3. 
 
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. Comparisons were 
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dblGATA+/- and finally dblGATA-/- mice. As a result, there was comparability between WT 
and dblGATA+/- mice also for T-cell development in the steady state level.  
 
The response of WT and dblGATA+/- mice to SIR at d7 was assessed next. We therefore 
irradiated the littermate control dblGATA+/- and dblGATA-/- mice along with non-littermate 
WT mice for comparison, with one dose of 425 rad of irradiation, and harvested the mice 
seven days following damage induction. TEC analysis was completed with representative 
FACs plots shown for TEC populations, which were clearly identifiable and comparable 
(Figure 5.10 A). Additional numerical analysis showed comparability between WT and 
dblGATA+/- mice at d7 post SIR in total cellularity, total thymocytes and total TEC. But a 
significant reduction was maintained when WT and dblGATA+/- mice were individually 
compared to dblGATA-/- mice for all parameters (Figure 5.10 B). Therefore it appears that 
WT non-littermate controls again behave the same as the dblGATA+/- mice even when under 
conditions of SIR.  
 
5.2.4 Long Term Recovery of dblGATA Thymus Post SIR 
Considering the relative comparability of non littermate WT and dblGATA+/- mice in steady 
state and irradiation conditions, with the phenotype of reduced recovery in dblGATA-/- 
(dblGATA) mice previously described (Figure 5.8), we wanted to confirm that the presence 
and persistence of eosinophils in the thymus was the determining factor encouraging recovery 
of WT sub-lethally irradiated thymi and hindering it in dblGATA mice. For this, we decided 
to assess the relative radioresistance of eosinophils in the thymus of WT adult mice. For this, 
SIR WT mice (one dose of 425rad) were compared to unmanipulated controls for the 










dblGATA Littermate Heterozygous Controls Mirror WT Mice At d7 Following Sub-
lethal Irradiations 
 
A) Representative FACs plots of TEC analysis in the three mouse strains; WT, dblGATA 
Heterozygous (Het), dblGATA deficient (KO).  
 
B) Absolute number analysis of total thymus cellularity, thymocytes (CD45+) and total TEC 
(CD45-EpCAM-1+) seen in WT, dblGATA Het or dblGATA KO at d7 following sub-lethal 
irradiations (SIR). Data was obtained from two independent experiments where WT (n=4), 
Het (n=5) and KO (n=6).  
 
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. Comparisons were 
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cellularity calculated (Figure 5.11). Analysis by flow cytometry showed that eosinophils were 
detectable in the thymus even following damage induction and that the relative proportions of 
eosinophils were unchanged in FACs analysis (Figure 5.11 A). By then subdividing 
eosinophils based upon their lack of Gr1 expression but Siglec-F expression, there were a 
greater proportion of eosinophils positioned within the Siglec-F high fraction following SIR 
(Figure 5.11 B). However mean fluorescence intensity (MFI) for the expression level of 
Siglec-F by eosinophils in the thymus failed to be significantly different (Figure 5.11 B). 
Furthermore, thymus cellularity was reduced in WT SIR mice compared to WT 
unmanipulated controls from around 1.5x108 cells to 0.5x108 cells (Figure 5.11 C) as would 
be expected following damage and subsequent thymic involution. However because of this 
loss of total thymus cellularity, the persistence of eosinophils in the thymus numerically 
would be reduced as a consequence. Therefore by calculating the number of eosinophils per 
1x106 thymus cells to compensate for the loss of thymus cells induced following irradiation, 
eosinophils present per 1x106 thymus cells in control steady state mice and sub-lethally 
irradiated WT adult mice were comparable, suggesting that thymic eosinophils may be less 
susceptible to irradiation (Figure 5.11 C).  
 
Given the potential persistence of eosinophils in WT thymi following damage, we continued 
investigating the regeneration of the thymus at later time points (d14 and d35) following SIR 
damage to determine if dblGATA mice recovered eventually to the same level as WT controls 
or were hindered in their ability to recover (Figure 5.12). Upon thymus isolation and analysis, 
at d14, thymus recovery of dblGATA mice was reduced. This continued into analysis of total 
cellularity and also total thymocytes with dblGATA mice having reduced numbers compared 





Thymic Eosinophils Appear Radioresistant Post Exposure To Sub-lethal Irradiation 
  
Mice were irradiated sub-lethally (SIR) and the thymus was compared to WT non-irradiated 
steady state Balb/c mice d7 post irradiation to investigate the relative radio-resistance of 
eosinophils.  
 
A) FACs plots showing identification of the eosinophil population ((CD45+CD4-CD8- TCRβ-
Ter119-CD11b+Siglec-F+) in WT steady state unmanipulated (left panel) and irradiated (right 
panel) and analysed at d7. Proportional analysis of FACs percentages of eosinophil 
populations was also quantified on the far right with steady state (black bar, n=2) and SIR d7 
WT (white bar, n=7).  
 
B) Representative FACs plots show activation of eosinophils (CD45+CD11b+Siglec-F+Gr-1-) 
through relative expression levels of Siglec-F and lack of Gr1 expression comparing WT 
steady state and WT irradiated examined d7 post sub-lethal exposure. MFI of Siglec-F on 
eosinophils was shown in far panel comparing these two conditions; black bar (steady state, 
n=2) and white bar (SIR d7, n=7). 
 
C) Absolute number analysis of thymus cellularity (left panel) in control mice compared to 
those irradiated sub-lethally with analysis day 7 post irradiation. Number of eosinophils (right 
panel) were calculated and corrected in relation to the total cellularity due to the reduction 
seen following irradiation. As a result data shows number of eosinophils per 1x106 total 
thymus cells. Circles represent controls (n=2) and squares represent irradiated mice (n=7). 
Data was obtained across two independent experiments.  
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dblGATA Mice Have Alterations In TEC Recovery At d14 and d35 Timepoints 
Following Sub-lethal Irradiation 
 
A) d14 timepoint post sub-lethal irradiation  (SIR) analysis of thymus weights, cellularity, 
thymocytes (CD45+) and TEC populations; total TEC (CD45-EpCAM-1+) and the 
corresponding subpopulations. WT (black bar) and dblGATA (white bar). Data was obtained 
from two independent experiments (n=7).  
 
B) d35 timepoint following sub-lethal irradiation (SIR). Analysis of weights of thymus, 
cellularity and total thymocytes (CD45+) along with absolute numbers of TEC and 
subpopulations in WT (black bar) compared to dblGATA (white bar). Data was obtained from 
one experiment where WT (n=5) and dblGATA (n=6).  
 


























































































































































































































































































seen statistically within the breakdown of the TEC populations apart from the mTEChi 
population that maintained significance.  
 
When an additional d35 time point was analysed for the same parameters, the differences 
between the WT and dblGATA mice following SIR began to widen once again (Figure 5.12 
B). The weight differences of the thymus were more statistically significant and as were the 
cellularities and total thymocytes – with reductions in dblGATA mice compared to WT 
controls. Surprisingly there was again a difference in TEC population absolute numbers with 
total TEC reductions in dblGATA mice and further this was seen in all populations with the 
mTEChi cells again being the most significantly affected (Figure 5.12 B). As a result, it 
appears that there is a failure for long term recovery of dblGATA mice in the thymus with 
regards to TEC regeneration following injury through SIR.   
 
Based on these observations, a summary time course figure was constructed to highlight the 
long term differences in the recovery of the dblGATA mice compared to WT controls (Figure 
5.13). Firstly, analysis in the steady state of total thymus cellularity highlighted that WT and 
dblGATA mice were comparable with similar total cell numbers. However, upon injury at 
day 0, the thymus damage induced following SIR was greater at day 4 in dblGATA mice 
compared to WT controls with a reduced thymus cellularity seen in dblGATA mice. Further 
analysis at later time points following SIR damage appeared to show that infact this difference 
in thymus size continued to widen between WT and dblGATA mice with a potential 
regression in any apparent recovery that the dblGATA mice may have previously achieved 









dblGATA mice Fail To Recover Their Thymus Cellularity And TEC To The Level of 
WT Mice Following Sub-lethal Irradiation  
 
For all time points data was obtained from a minimum of two independent experiments with; 
d0 (WT n=5, dblGATA n=7), d4 (WT n=5, dblGATA n=7), d7 (WT n=7, dblGATA n=7), 
d10 (WT n=4, dblGATA n=4), d14 (WT n=7, dblGATA n=7), d35 (WT n=5, dblGATA n=5). 
 
A) Total cellularity changes overtime for the thymus following sub-lethal irradiations have 
been plotted with regards to the mean value obtained from replicate experiments for WT 
(black line) against dblGATA (blue line).  
 
B) Total TEC (CD45-EpCAM-1+) absolute numbers have been plotted over time following 
sub-lethal irradiations to allow comparisons between WT (black circles) and dblGATA (blue 
squares).  
 
All significance was noted as: *<0.05, **<0.01, ***<0.001, ***<0.0001. 
  










































0 4 7 0 4 5 
Days after SIR 
0 4 7 0 14 35 













Total TEC analysis additionally showed a similar trend to that seen in total cellularity, with 
WT mice recovering post SIR in a U shaped curve, with the later time points having TEC 
numbers which were approaching those seen prior to damage (Figure 5.13 B). However when 
the dblGATA TEC recovery was examined, it seemed that despite comparable levels of 
damage at day 4 with similar TEC numbers, by day 7 a significant difference had been 
generated between these mice. This partially looked to recover especially at the day 14 time 
point but then at day 35, TEC populations in dblGATA mice had failed to increase from d14, 
leaving the graph to generate more of a plateau shape (Figure 5.13 B). This leaves reduced 
TEC recovery in dblGATA mice suggestive of an inability of the TEC populations to 
subsequently recover fully in dblGATA mice following damage.  
 
5.2.5 Sub-lethal Irradiation Analysis of T-cell Recovery In dblGATA Mice 
Having generated a time series of TEC recovery in dblGATA mice under SIR damage, there 
was then interest into what was happening to the relative T-cell populations. For this, mice 
were similarly irradiated sub-lethally (1x425 rad) and at d7 following damage, T-cell analysis 
through flow cytometry was conducted on harvested thymi.  
 
WT mice showed a profile of T-cell development (CD4vsCD8) that was remarkably different 
from that seen in dblGATA mice (Figure 5.14 A). Firstly and most strikingly, the proportion 
of double positive T-cell populations (CD4+CD8+) was reduced in dblGATA mice at d7 
analysis compared to SIR WT control mice. In addition, a large proportion of CD8+ cells were 
seen in dblGATA mice compared to WT and CD4+ cells also appeared relatively increased. 
But the division of CD4+ and CD8+ on the expression of TCRβ was relatively similar with 
regards to proportions of TCRβhi cells.  Absolute number analysis from this highlighted some 
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interesting findings (Figure 5.14 B). Total thymus cellularity was again significantly reduced 
in dblGATA mice compared to WT mice at d7 post SIR as was expected, but interestingly, 
this appeared when broken down, to be due to the reduction in double positive thymocytes. 
Interestingly results also suggested that there might be a reduction in total CD4+CD8- 
thymocytes.  
 
To see if the same developmental defects in T-cell development were seen when the total 
cellularity was at its most different in dblGATA compared to WT mice following SIR; the 
d35 time point was assessed for T-cell development (Figure 5.15). Interestingly, there was an 
apparent difference in the developmental profile of thymocytes with greatly reduced 
proportions of CD4+CD8+ thymocytes and a consequential increase in the CD4+CD8- 
thymocytes (Figure 5.15 A). In addition, absolute number analysis showed that dblGATA 
mice had a significant reduction in total cellularity compared to WT controls and because of 
this there were subsequently reduced absolute numbers in all thymocyte populations (Figure 
5.15 B).  
 
5.2.6 Mechanisms of Eosinophil Mediated Thymus Recovery Following Sub-lethal 
Irradiation Damage  
Mechanistically, how eosinophils may be acting to repair the thymus post injury as a process 
needs to be considered. In other tissues, eosinophils have been linked to the production of IL-
13 and IL-4 for their recovery following damage. To examine whether a similar axis may be 
operating in thymus we used Il4ra-/- mice (Goh et al., 2013, Heredia et al., 2013). WT and 
Il4ra-/- mice were sub-lethally irradiated, as conducted in WT and dblGATA mice previously, 











T-cell Analysis In dblGATA Is Altered Compared To WT Mice d7 Following Sub-lethal 
Irradiations 
 
A) FACs plots showing the T-cell development in WT mice (top panel) and dblGATA mice 
(lower panel) d7 following sub-lethal irradiations (SIR). T-cell analysis was obtained through 
CD4 and CD8 single positive gating and subsequently dividing this population on TCRβ 
expression. Plots were representative of proportions seen during analysis.  
 
B) Absolute number analysis of T-cell populations in WT (black bar) and dblGATA (white 
bar) d7 following sub-lethal irradiations. Data was obtained from one experiment where n=3.  
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T-cell Analysis In dblGATA and WT Mice d35 Following Sub-lethal Irradiations 
 
A) FACs plots showing T-cell development in WT mice (top panel) and dblGATA mice 
(lower panel) d35 following sub-lethal irradiations. T-cells were identified as expressing 
either CD4 or CD8 and then were divided upon TCRβ expression.  
 
B) Absolute number analysis of T-cell populations in WT (black bar) and dblGATA (white 
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in dblGATA mice at this stage (Figure 5.16). Initial analysis following thymus isolation at d7 
post SIR for thymus weight, cellularity and total thymocytes, showed that there were no 
significant differences between WT and Il4ra-/- mice (Figure 5.16 A). Interestingly it seemed 
that there was a trend for increased numbers of total cells and thymocytes in the Il4ra-/- mice, 
but it was insignificant.  Further TEC analysis following thymi isolation and digestion prior to 
antibody cell surface staining, showed that while all of the TEC populations could be 
identified, total TEC proportions were reduced between WT and Il4ra-/-  mice. The make up 
of the TEC compartment however remained comparable with proportions of TEC 
subpopulations being similar between WT and Il4ra-/- mice (Figure 5.16 B). Absolute number 
analysis showed that although there was a trend towards reduced numbers of TEC in all 
subpopulations including cTEC, mTEC, mTEChi and mTEClo, none of these were statistically 
significant, but some of the p values shown were close to significance.  
 
However, due to dblGATA mice having significantly altered thymocyte populations 
following damage and the profound contribution of thymocytes to total thymus cellularity 
along with their requirement to reciprocally support TEC development, thymocytes in Il4ra-/- 
mice were analysed at d7 following SIR (Figure 5.17 A). Data collected from freshly isolated 
and prepared thymi from WT and Il4ra-/- mice at d7 post SIR showed marked thymocyte 
alterations by flow cytometry. However there was a loss of the CD8+CD4- thymocytes and 
their subsequent TCRβhi subpopulation - a feature of Il4ra-/- mice as eosmesodermin CD8 T-
cells have been shown to be IL-4 dependent (Jameson et al., 2015). Absolute number analysis 
supported the lack of proportional changes seen by FACs, with no population except for that 
of the CD8+ cells being significantly altered when Il4ra-/- mice were compared to WT control 










Il4rα-/- Deficient Mice Have Reduced TEC At d7 Following Sub-lethal Irradiations 
 
A) Thymus weight, total thymus cellularity and absolute number of thymocytes (CD45+) is 
shown for WT (black bar) and Il4rα-/- mice (white bar) d7 following sub-lethal irradiations. 
Data was from three independent experiments WT (n=10) and Il4rα-/- (n=12). 
 
B) FACs plots for TEC analysis in WT and Il4rα-/- mice at d7 following sub-lethal 
irradiations.  
 
C) Absolute number analysis of total TEC (CD45-EpCAM-1+) and TEC subsets in WT (black 
bar) and Il4rα-/- (white bar) d7 post sub-lethal irradiations. Data was obtained from three 
independent experiments with WT (n=10) and Il4rα-/- (n=12). 
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T-cell Analysis Of Il4rα-/- Mice Is Unchanged Compared To Controls For d7 Following 
Sub-lethal Irradiation 
 
A) Representative plots shown for FACs thymic analysis of T-cell development at d7 after 
sub-lethal irradiation; WT (top panel) and Il4rα-/- mice (bottom panel).  
 
B) Absolute number analysis is also shown with total cellularity and thymocyte populations in 
the lower panel. WT (black bar) Il4rα-/- (white bar). Data was obtained from one experiment 
n=4. 
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As dblGATA mice had a great difference in thymus recovery at the d35 timepoint post SIR, 
we conducted a later timepoint for thymocyte analysis of the Il4ra-/- mice at this stage with 
thymus isolation, disaggregation and antibody staining for flow cytometry (Figure 5.18 B). 
Representative FACs plots showed that the proportions of all thymocyte populations were 
comparable between WT and Il4ra-/- mice except for the maintained reduction in CD8+CD4- 
cells. However in absolute number analysis a difference in total cellularity of the thymus and 
CD4+CD8+ (DP), CD4+ and CD4+TCRβhi cells were all reduced in Il4ra-/- mice compared to 
WT control mice following SIR (Figure 5.18 B). This reduction was of significance and 
highlighted that there may be an issue with recovery of Il4ra-/- thymi long term following 
damage. While this does not fully phenocopy that seen in the dblGATA mice, it may provide 
















T-cell Development In Il4rα-/- Mice Is Reduced Compared To Controls At d35 Following 
Sub-lethal Irradiation 
 
A) FACs analysis of thymus for T-cell development, d35 following sub-lethal irradiations; 
WT in top panel and Il4rα-/- mice bottom panel.  
 
B) Absolute number analysis is also shown with WT (black bar) and Il4rα-/- (white bar). Data 
was obtained from one experiment n=4. 
 






















SIR d35 WT 
SIR d35 Il4rα-/- 
























































































































































































5.3.1 Medullary Regulation of Thymic Eosinophils 
The thymus is composed of many different types of accessory cells with distinct roles. 
Intrathymic dendritic cell subsets are associated with central tolerance induction whereas 
macrophages have been related to clearance of apoptotic cells and ILC3 cells have been 
suggested to support thymus regeneration (Gallegos and Bevan, 2004, Dudakov et al., 2012). 
However eosinophils have also been identified in the thymus and previously were suggested 
to aid in apoptotic cell clearance and possibly in negative selection (Guerri et al., 2013, Kim 
et al., 2010). In Relb-/- mice that fail to form an intact medulla, a loss of thymic eosinophils 
has been reported (Throsby et al., 2000). This suggests that thymic microenvironment and the 
medulla in particular directly regulates the intrathymic eosinophil pool. Similarly in Tcrα-/- 
mice, which also possess a disrupted medulla, we reported a corresponding loss of 
eosinophils. This therefore further suggests a requirement for the medulla in the support of 
eosinophils in the thymus. This could relate to the medulla being necessary for the production 
of eotaxin with reduced mTEC leading to a lower concentration of chemokine to recruit 
eosinophils, which would be interesting to determine (Matthews et al., 1998). Furthermore the 
lack of mTEC is likely to also prevent a typical 3D medullary structure being present, which 
may be necessary to support eosinophils in the thymus via survival factor provision.  
 
Interestingly the reduced eosinophil population in the spleen of Tcrα-/- mice implies that there 
may also be involvement of single positive T-cells in eosinophil maintenance. It is known that 
IL-5 is necessary for eosinophil development and release from the bone marrow into the 
periphery, with a study indicating that eosinophil progenitors express IL-5Rα and proliferate 
following IL-5 exposure which increases circulating eosinophil numbers (Iwasaki et al., 
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2005). Considering this, eosinophilia, in infected states such as helminth infections and 
asthma has also been linked to IL-5, with increased IL-5 seen in disease being associated with 
Th2 cells (Gause et al., 2003, Behm and Ovington, 2000, Tomaki et al., 2000). Indeed, T-cells 
are known to home to the bone marrow at naïve, effector or memory stages, allowing the 
presence of these cells in the bone marrow to potentially influence eosinophil development 
(Di Rosa and Pabst, 2005, Mazo et al., 2005). In addition, it has been shown that IFN-γ 
produced by Th1 cells homing to bone marrow during immune activation has the capacity to 
hinder eosinophil development (de Bruin et al., 2010).  In turn this puts forward the 
possibility of Th2 cells being implicated in eosinophil development, potentially providing the 
reason behind reduced eosinophils in Tcrα-/- mice. This could be assessed by analysis of 
eosinophil generation in the bone marrow of Tcrα-/- mice, which so far has not been 
determined, but would conclude whether there was a requirement for single positive T-cells in 
eosinophil development. If this was not the case, it should be considered that T-cells may 
support tissue eosinophils by modulating the local stromal populations within the thymus and 
spleen which could be necessary to in turn recruit eosinophils.  
 
The thymus appears to further modulate eosinophils not just in terms of absolute numbers but 
also their activation status. Indeed compared to peripheral counterparts, eosinophils in the 
thymus show evidence of upregulated activation, including increased Siglec-F and CD11b 
expression. Interestingly Siglec-F expression by eosinophils was shown in the small intestine 
to be important in preventing degranulation and increasing survival, as well as CD11b 
supporting increased cellular adhesions (Verjan Garcia et al., 2011, Griseri et al., 2015, 
Mahmudi-Azer et al., 2002).  Therefore higher levels of Siglec-F expression by thymic 
eosinophils may prolong eosinophil survival. This functionally could promote enhanced 
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interactions of eosinophils with developing thymocytes, assisted by increased CD11b, to 
support negative selection and T-regulatory cell induction (Throsby et al., 2000, Guerri et al., 
2013). Given the reduction in eosinophil activation seen in the thymus of Tcrα-/- mice, with 
almost total loss of Siglec-F+ cells; it further proposes a role for mTEC and possibly also 
single positive thymocytes in the regulation of this activation process. Therefore this suggests 
that not only is the presence of eosinophils in the thymus medullary dependent but also that 
the medulla regulates eosinophil activation status to support their thymic function.   
 
5.3.2 Role of Eosinophils In Thymic Recovery Post Damage 
Given the role of eosinophils that has been suggested in tissue regeneration post damage, 
initial exploration through a sub-lethal irradiation (SIR) model suggested that dblGATA mice, 
with an absence of eosinophils, suffer from an inability to fully regenerate the thymus (Goh et 
al., 2013, Heredia et al., 2013). Interestingly, initial development of the thymus can occur 
independently of eosinophils as correct development of both T-cell and TEC compartments is 
seen in dblGATA mice under steady state conditions. As a result, it appears that upon damage 
induction through SIR, an eosinophil dependent pathway becomes triggered that is necessary 
to support thymus recovery. However the mechanisms regulating this pathway for thymic 
regeneration have not been explored and require further characterisation.  
 
Thymic eosinophils may be triggered to initiate thymus regeneration following damage 
through the release of the alarmin IL-33 from epithelial surfaces (Oboki et al., 2011). This is 
an axis that has been shown to be active in asthma models upon lung epithelial inflammation 
with IL-33 release activating eosinophils to produce factors such as IL-4 and IL-13 for their 
survival (Willebrand and Voehringer, 2016). However the implication of IL-33 in the process 
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of thymus regeneration needs to be determined and could be addressed by thymus analysis in 
IL-33 deficient mice following SIR to identify if these mice also failed to recover.  This 
would support that this axis is both active and necessary in the regeneration of the thymus 
post damage and if results phenocopied dblGATA mice, it would suggest that this IL-33 
pathway of recovery is eosinophil mediated. 
	
Furthermore, for regeneration of the thymus to occur, it is dependent upon the interplay 
between thymocytes and TEC as the development of one compartment is dependent upon the 
other for complete thymus formation (Akiyama et al., 2008, Hikosaka et al., 2008, Irla et al., 
2008). Eosinophil involvement in regeneration could therefore be either at the level of TEC or 
T-cells. At d4 the difference in cellularity between WT and dblGATA mice correlated to 
thymocyte deficiencies with TEC numbers being unaffected, emphasising that eosinophils 
may be involved in initially targeting thymocytes to regenerate the thymus. Eosinophils could 
orchestrate this by modulating the survival of thymocytes as damage induced a greater loss of 
the irradiation sensitive DP thymocytes in dblGATA mice compared to WT controls at d7 
post SIR (Li et al., 2012). However, at the same time, CD4+ and CD8+ thymocytes were 
equivalently maintained in dblGATA mice to WT control mice. This finding is supported by a 
study on thymus regeneration following SIR that identified a population of intrathymic 
radioresistant stem cells that are maintained following damage (Zuniga-Pflucker and 
Kruisbeek, 1990). It can therefore be suggested that the single positive thymocyte populations 
at d7 post SIR may have developed from this stem cell population, which are unaffected by 
eosinophil absence. It would be interesting to determine if absence of these stem cells or an 
inability for them to proliferate, which is thought to be IL-2 mediated, prevents the 
persistence of these single positive thymocytes following SIR damage, thus supporting the 
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idea that CD4+ and CD8+ development occurs from these stem cells. This could be addressed 
by analysis of IL-2Rα deficient mice at the same timepoint post SIR.  
 
However, it should not be discounted that eosinophils alternatively have the capacity to 
influence TEC after damage and via this axis thymocytes may in turn be regulated for 
recovery.  This potential interaction could occur via production of IL-4 by eosinophils 
signalling on IL-4Rα expressed by TEC as it has been shown that TEC express IL-4Rα and 
possess the ability to respond to IL-4 and IL-13 (White et al., 2017). This axis has previously 
been linked to regeneration of alternative tissues post damage with production of IL-4 by 
eosinophils in liver damage inducing proliferation of IL-4Rα expressing hepatocytes through 
Forkhead box protein M1 (FoxM1) – a master regulator of hepatocyte proliferation (Goh et 
al., 2013) (Davoine and Lacy, 2014). Whether this regulator is induced in TEC following SIR 
in WT mice would also be of interest to determine, to correlate the potential for an active IL-
4/IL-4Rα pathway with thymus regeneration. Considering this, alterations in TEC in Il4ra-/- 
mice following SIR were determined to assess if they mirrored trends in dblGATA mice, 
which would suggest that this was the mechanism of recovery used by eosinophils to 
regenerate TEC. To begin with, reduced TEC populations at d7 post SIR in the dblGATA 
mice failed to be phenocopied in Il4ra-/- mice, causing consideration that eosinophils 
potentially regulate regeneration of the thymus at earlier time points via non-TEC processes. 
This emphasises that eosinophils may have a role in early stages after thymus damage through 
the support of thymocyte development. In turn the failure of dblGATA mice to maintain T-
cell development at d7 post SIR may prevent T-cells from being available in the thymus to 
sustain TEC populations, causing the reported reduction in TEC populations at later time 
points following damage.  
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Continuing to examine the role of eosinophils at later stages of thymus recovery suggested 
that they are still involved in this regeneration process as the thymus failed to recover back to 
that seen in WT mice. The lack of DP thymocytes in dblGATA mice at d7 post SIR was 
maintained with an inability to develop DP thymocytes at the later time point of d35. The 
sustained DP reduction emphasises that in the absence of eosinophils, there is a failure to fully 
recover the T-cell compartment and as a result single positive thymocytes were also reduced 
at d35 post SIR in dblGATA mice. Considering this, previous thymic analysis suggested that 
the thymus recruits a new wave of progenitors from the bone marrow which can repopulate 
the thymus by d28 (Zuniga-Pflucker and Kruisbeek, 1990).  The failure of this process in 
dblGATA mice, with a clear inability to reconstitute the thymus at d35, suggests eosinophil 
involvement in a recruitment mechanism that supports T-cell progenitors in the thymus post 
damage. Therefore it would be interesting to determine directly with ETP analysis at this time 
point as well as the earlier d7 stage post SIR, if there is a failure of dblGATA mice to recover 
thymic reconstitution.  
 
Failings in thymocyte progenitor recruitment could occur as eosinophils have been shown to 
produce factors such as Vascular Endothelial Growth Factor (VEGF) production, often 
reported to be produced by eosinophils in asthma patients (Nishigaki et al., 2003, Asai et al., 
2003). This may be implicated in vascular restructuring that could be necessary for efficient 
entry of thymocyte progenitors. The ability of eosinophils to promote this vascular 
remodeling has previously been shown in tumour models with eosinophils altering the 
vasculature to allow CD8 T-cell recruitment into tumours for destruction (Carretero et al., 
2015). The ability of eosinophils to perform this process in tumours was correlated to their 
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activated phenotype which, relating back to initial finding of eosinophils in the thymus being 
more activated, supports this hypothesis as an idea to pursue in future work.  
 
Despite this, at d35 post SIR, dblGATA mice also failed to support TEC recovery. At this 
point, whether the TEC reduction is due to the interplay between T-cell and TEC populations 
for their reciprocal development is difficult to determine, as both remain reduced. Analysis of 
TEC populations in Il4ra-/- mice at d35 for comparison to dblGATA mice would help to 
determine if eosinophils are acting on the TEC compartment at this late stage of recovery.  
However, we have so far established that at d35 post SIR, thymocytes are reduced in Il4ra-/- 
mice in addition to reductions in the eomesodermal IL-4Rα dependent CD8+ T-cells (Jameson 
et al., 2015). The lack of a requirement for IL-4Rα signals in either CD4+ T-cell development 
or the recruitment of thymocyte progenitors, along with the observation that both of these 
populations are reduced in Il4ra-/- mice at d35 post SIR, proposes the requirement for indirect 
IL-4Rα signalling in the maintenance of these T-cell populations.  
 
Collectively this suggests that the reduction in TEC seen in dblGATA mice at d35, may be 
due to eosinophils being necessary later in thymic recovery to target TEC directly via the IL-
4/IL-4Rα axis for regeneration. Confirmation of this hypothesis through IL-4Rα TEC analysis 
at d35 post SIR would be important to complete.  This eosinophil dependent TEC 
regeneration is likely in turn to be necessary to also influence sustained recruitment of 
thymocyte progenitors to support T-cell development. Faults in this process, which may occur 
in dblGATA mice, could lead to limited production of CCL19/CCL21 and CCL25 by thymic 
stroma, and an inability to effectively attract CCR7+/CCR9+ thymocyte precursor populations 
(Takahama, 2006, Zlotoff et al., 2010). Therefore it would be interesting to determine if 
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chemokine levels failed to increase in dblGATA mice following SIR compared to WT 
controls as TEC failed to recover at later stages.   
 
As a result, it is clear that eosinophils are implicated in thymic recovery. However more 
research is necessary to define the mechanism that thymic eosinophils are employing to 
support thymic regeneration. From this preliminary work it may suggest that in initial thymic 
recovery, eosinophils support regeneration via thymocyte modulation. Furthermore, these 
reduced thymocyte populations in turn may drive the consequential decreases in TEC 
populations at early stages of thymus recovery. Under the presence of eosinophils in WT 
mice, this pathway is likely to support recovery of the thymus with T-cell progenitor 
recruitment and T-cell development assisting TEC regeneration to reciprocally enhance 
thymus regeneration. However through TEC analysis of dblGATA mice and Il4rα-/- mice, it 
revealed that eosinophils potentially have additional mechanisms in place, signalling through 
the IL-4/IL-4Rα axis at later time points on TEC to ensure complete thymus recovery post 
SIR. As a result, this late stage TEC mediated regeneration may be a contingency recovery 
mechanism utilised by eosinophils if there is a failure to promote thymus recovery, possibly 
initially via the regulation of T-cell precursor recruitment for the process of T-cell 
development. However, going forward it will be important to address the relation of this 
finding to the most recent thymic regeneration proposal. This study found thymus damage 
triggered ablation of CD4+CD8+ thymocytes, activated thymic DCs to produce IL-23, which 
then caused LTis to produce IL-22 for thymic microenvironment and thymopoiesis 
regeneration. The implication of eosinophils in this axis or further if eosinophils act 
independently of this recognised process is somewhat unknown and requires consideration in 











6.1 Limitations Of Cre Mouse Models For Cell Type Specific Deletion Of LTβR  
A major aim of this thesis was to examine the role of LTβR in thymus biology and to 
establish mouse knockout models where LTβR is deleted from specific cell types. Initially 
there was the generation of the LtbrTEC mice whereby LTβR was exclusively deleted from the 
TEC population that express the transcription factor FoxN1 through the crossing of Foxn1Cre 
and Ltbrfl/fl mice. Given the success of the LtbrTEC mice with complete deletion of LTβR from 
TEC populations, this system was employed in later experiments to try to delete LTβR from 
thymic mesenchyme and endothelial cells. However this was met with limited success. From 
this, two attempts were made to delete LTβR from thymic mesenchyme (PDGFRβCrexLtbrfl/fl 
and Wnt1CrexLtbrfl/fl) and endothelium (Tie2CrexLtbrfl/fl and Flk1CrexLtbrfl/fl). Only the 
Flk1CreLtbrfl/fl mice targeting endothelium saw complete LTβR deletion and the 
Wnt1CrexLtbrfl/fl was partially successful in the deletion capability. The reasoning behind this 
varied deletion has been more difficult to determine, but it has highlighted that the use of 
Cre/flox models needs to be approached with caution especially if the correct checks for 
functionality of the models are not put in place.  
 
Indeed it is apparent that limitations of incomplete deletion that we faced related to the 
effectiveness of the Cre mice between the strains being generated, as the same Ltbrfl/fl mice 
were continuously used in all generations. Issues have been raised concerning the use of Cre 
recombinase for functional analysis in mice with it previously being reported that there can be 
unreliable localisation of Cre in cells causing defective deletion (Jeannotte et al., 2011). 
Considering this, the fidelity of the Cre expression is often assessed by the use of reporter 
mice with reporter expression indicating successful Cre action. However the literature has 
previously highlighted that this system does not necessarily relate to the level of 
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recombination that will be seen in all experimental mice (Schmidt-Supprian and Rajewsky, 
2007, Srinivas et al., 2001). This may lead to incorrect mapping of effective deletion of Cre 
target genes in mouse models, which we also found to be true in additional analysis that we 
carried out. For this, we crossed all of the Cre only mice to mTmG reporters whereby 
successful recombination of the Cre with the mTmG caused the cells to change colour from 
tomato to green which then allowed recombination to be determined by basic flow cytometry. 
For this, for example, we found that there was successful fate mapping of the 
Foxn1CrexmTmG mice with TEC changing to green only and this Cre action was mirrored 
with TEC specific LTβR deletion in the LtbrTEC mice. Analysis of the Tie2CrexmTmG mice 
also showed that the Cre action was specific with complete conversion of endothelium (data 
not shown), yet when Tie2CrexLtbrfl/fl mice were analysed for LTβR deletion this was 
incomplete. As a result, this highlights that results gained from reporter models may not 
directly correspond to Cre activity in other crosses – leaving further analysis of successful 
deletion necessary. In addition, issues have been reported with Cre models concerning the 
activity of Cre recombinase as the introduction of Cre into cells is thought to potentially lead 
to a detrimental effect on cell viability through Cre-mediated cell toxicity (Carow et al., 
2016).  But, despite this, reduced thymus cellularities in Cre only mice were not found in our 
study, with comparability between Cre only controls and WT mice seen in different analyses. 
Furthermore to consider the possibility of detrimental Cre exposure, in our analysis we used 
heterozygous Cre only mice as controls for comparisons. Therefore, any alterations that we 
saw in the Cre/flox system directly correlated to LTβR deletion rather than overt Cre activity.  
 
From this, the main issue and failure of our Cre/flox mice concerned the levels of deletion of 
LTβR from target cells, rather than any adverse disruption on aspects such as cellularities. 
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Therefore this ineffective deletion likely relates to the ability of the Cre mice that we selected 
to undergo successful and complete Cre recombinase activity when crossed with target Ltbrfl/fl 
mice, which was variable in our hands. Therefore a note of caution needs to be employed 
when using these models or there may be misinterpretation of results if the efficiency of the 
Cre and the deletion that entails are not checked. Nevertheless, by carefully monitoring and 
choosing appropriate Cre models, this allowed us to determine that pre-cDC1 recruitment is 
regulated by LTβR signalling on mesenchymal cells, and further that endothelial mediated 
LTβR signals may dictate pDC regulation.  
 
6.2 The Balance Between DC and mTEC For Central Tolerance Induction 
The main importance of mTEC in T-cell development has been attributed to their 
involvement in the process of central tolerance induction. mTEC have the capacity to present 
self-antigens that are essential to support screening of the TCR repertoire on developing 
thymocytes for correct negative selection (Klein et al., 2009, Klein et al., 2011). This process 
is supported by DC subsets that can cross present self-antigens from mTEC to increase 
antigen frequency in the thymus as well as antigen repertoire (Bonasio et al., 2006, Proietto et 
al., 2008a). As a result, there is strong cooperation between these two compartments for the 
induction of negative selection and prevention of autoimmunity.  
 
Our studies indicate that the thymus contains various mechanisms to protect its primary role 
of central tolerance induction, as disorganisation of the medulla in LtbrTEC mice does not alter 
negative selection. This finding shows that the mTEC compartment can infact compensate for 
itself with substantial reductions, as seen in our findings with LtbrTEC mice, still allowing for 
sufficient provision of self-antigens to support Treg induction and efficient negative selection. 
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This finding alone highlights that due to mTEC being the main compartment necessary for 
central tolerance, it contains its own buffer that supports its full functioning even under 
conditions of substantial population loss.  Furthermore, the sustained presence of DC 
populations in these mice allows for sustained negative selection as determined through 
comparisons between LtbrTEC and Ltbr-/- mice. This is maintained in LtbrTEC mice, as 
sufficient mTEC must remain for the provision of enough TRAs for DC to increase antigen 
frequency by cross-presentation and enable efficient negative selection. This threshold level 
of mTEC is important as models that completely lack an intact medulla suffer from 
autoimmunity due to an inability to provide sufficient TRAs for selection (Weih et al., 1995, 
Riemann et al., 2017, Wu et al., 1998). mTEC are further necessary to regulate DC 
themselves, with our work suggesting that DC require some level of mTEC as they are 
producers of CCL21. This is necessary as through comparison of plt/plt, Ccl19-/- and Ccl21-/- 
mice, we have shown that CCL21 is indeed required for pre-cDC recruitment, potentially via 
a mesenchymal intermediate, for cDC1 generation and autoimmunity prevention.  
 
Considering that autoimmunity is prevented in mice with disrupted medullas due to DC 
presence, it would therefore be interesting to determine what level the DC compartment alone 
can be reduced before central tolerance is disrupted. This may reveal if thymic DC can 
similarly be compensated for by an intact medulla and normal numbers of mTEC. This would 
allow the baseline level of each compartment that is necessary for central tolerance induction 
to be suggested. Nonetheless, the ability for the DC compartment to compensate for 
reductions in mTEC in LtbrTEC mice along with the ability for the medulla itself to maintain 
sufficient provision of TRAs despite population alterations has likely developed as a back-up 
mechanism to preserve central tolerance.  
	227 
As a result, the ability for the thymus to function when there are architectural and numerical 
disruptions brings in to question why the medullary compartment is otherwise maintained at 
such a large size in comparison to what is necessary for its primary role in tolerance. The size 
of the medulla could alternatively relate to roles such as those of γδ and NK T-cell 
development and the requirement for post-selection maturation of developing T-cells (Webb 
et al., 2016, Xing et al., 2013). 
 
Furthermore, considering the ability of the medulla to function effectively under architectural 
disruption, a recent publication utilising Ccl21a-/- mice suggested that the autoimmune 
phenotype present in Ccl21a-/- mice correlated to a defective ability of single positive 
thymocytes to enter into the medullary areas, which are further disrupted in these mice (Kozai 
et al., 2017). However, any potential contribution of altered mTEC populations to the 
defective negative selection reported in the Ccl21a-/- mice is unknown as apart from 
architectural analysis, mTEC population quantitation was not conducted in this study. As a 
result, we would put forward an alternative interpretation that although this study clearly 
highlights through immunofluorescence that there is an alteration in single positive 
thymocytes in the medullas of Ccl21a-/- mice compared to controls, we clearly found DC to 
also be affected– an aspect that they have not considered. Therefore we would suggest from 
this that the autoimmunity seen in the Ccl21a-/- mice does not solely correspond to 
architectural disruption of the medullary areas as LtbrTEC mice have disrupted medullary 
architecture, reduced CCL21 expressing mTEClo cells but maintain tolerance as DC 
populations are conserved. Infact, we would suggest that the breakdown in tolerance in 
Ccl21a-/- mice more likely links to the reduced numbers of thymocytes in the medullary areas 
being unable to undergo correct negative selection due to defective DC populations. 
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Furthermore the reduced DC populations may hinder any cortical level of negative selection 
irrespective of medullary disruption; resulting in autoimmunity. As a result, the concept that 
an altered medulla does not directly correlate with a break in central tolerance is a novel 
finding that may cause previous medullary centric conclusions to be reassessed, with a new 
focus on accessory cell involvement over and above any medullary disorganisation previously 
attributed to tolerance breakdowns.  
 
6.3 Regeneration Strategies For Thymus Recovery 
One of the main findings from this study highlights the ability for the thymus to function 
although the architecture has become altered. Furthermore, if the medulla is not required to be 
fully formed to support the induction of central tolerance then it begins to bring in to question 
the current approaches used in thymus regeneration. Following damage or to reverse thymic 
involution that occurs with age, the research focus appears to be on regenerating or adjusting 
the TEC compartment for enhanced thymopoiesis (Velardi et al., 2014, Min et al., 2007). A 
previous study infact showed that forced expression of the transcription factor Foxn1 in the 
TEC population supported thymus regeneration (Bredenkamp et al., 2014). Furthermore other 
studies have focused on the administration of substances to promote thymus regeneration by 
triggering TEC populations to undergo proliferation. For example, it was noted that KGF 
deficient mice failed to recover post damage compared to WT control mice and therefore 
KGF administration was used to target TEC to enhance their proliferation and has since been 
used in trials to promote thymus function following damage (Erickson et al., 2002, Alpdogan 
et al., 2006).  
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Such mechanisms that focus on TEC regeneration are important, as it is vital that TEC 
undergo regeneration to provide an adequate compartment to support thymus functioning. 
However the amount of regeneration that is necessary is questioned given our findings. 
Therefore a reduction in thymus function in states of damage or involution may not solely 
relate to altered TEC compartments, but rather other regulators such as DC should be studied 
as we found that tolerance was only affected when DC were additionally reduced along with 
defective TEC populations. Furthermore, future treatments to support regeneration of the 
thymus following age related involution must consider additional factors as previously it has 
been suggested that the shrinking of the thymus with age is due to smaller numbers of thymic 
progenitors proliferating in the bone marrow, leading to fewer progenitors being available to 
enter into the thymus and give rise to T-cells (Offner et al., 1999, Min et al., 2006). Therefore, 
increases in thymus size without a concordant increase in thymus settling progenitors may 
lead to situations such as a leukaemia whereby the availability of fewer progenitors causes 
those progenitors to proliferate in the many niches of the large regenerating thymus (Boehm 
and Swann, 2013). As a result, focusing on recovering thymus function without trying to 
expand thymus size too much may help to prevent the detrimental side effects of large empty 
thymic niches. Therefore this raises the option for thymic DC to be enhanced to regenerate 
thymus function. 
 
As a result, once there is establishment of a thymic core structure which may require 
previously established treatments, the maintenance of DC may suffice to regenerate the 
necessary level of thymus function. Having uncovered that LTβR signalling in thymic 
mesenchyme is important for recruitment of pre-cDC to the thymus and that CCR7 ligands 
are implicated in this process, these could provide options that may enhance thymic DC and 
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in turn support smaller TEC numbers for the maintenance of thymic function. Furthermore, as 
DC can be generated in vitro, there is scope for the potential transfer of DC into hosts 
suffering from thymic damage or malfunction to possibly enhance thymic function (Guo et 
al., 2016). However guaranteeing transferred DC homed correctly to the thymus may be 
difficult to regulate. Nevertheless, this provides an alternative angle on the process of thymus 
regeneration with the thought as to whether it is actually essential for the thymus to be fully 
maintained with regards to TEC compartment size to be able to carry out its function in 
central tolerance induction and T-cell generation.  
 
6.3.1 Eosinophil-Mediated Thymus Regeneration 
Given the role for thymic DC in the support of central tolerance and the potential for DC 
mediated therapy to aid the restoration of thymus function following damage, alternative 
mechanisms that support initial regeneration of the physical structure of the thymus still 
requires greater insight. Our finding that the absence of thymic eosinophils causes the thymus 
to be hindered in its ability to recover following damage induction via sub-lethal irradiation, 
suggests a role in thymus regeneration. The preliminary nature of this finding leaves many 
unanswered questions, primarily concerning the mechanism by which eosinophils are able to 
mediate thymus regeneration. Given previous research indicating the potential role of ILC3 in 
thymus regeneration, along with the recent study showing a new pathway via IL-22 and ILC3 
activation for thymic regeneration, the possible involvement of eosinophils in this process 
would be interesting to dissect (Rossi et al., 2007, Dudakov et al., 2012, Lopes et al., 2017). 
This may be possible as it was found in the small intestine that eosinophils were necessary to 
support the maintenance of ILC3 through their production of IL-1β with eosinophil deficient 
mice having reduced Rorγt expressing ILC3 cells, and this was similarly seen in IL-1β 
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deficient mice (Jung et al., 2015). Therefore it may be possible that in the thymus, eosinophils 
support the ILC3 populations already implicated in thymus recovery. Relevant to this, it is 
unknown whether IL-33 is produced by TEC after thymus damage to stimulate other ILC 
populations, which itself may provide alternative links to eosinophils and thymus 
regeneration. ILC2 have infact been associated with eosinophils through their ability to 
produce high levels of IL-5 and IL-13, with IL-5 stimulating eotaxin production (Nussbaum et 
al., 2013). Eotaxin is linked to attraction and recruitment of eosinophils while IL-5 and IL-13 
are also associated with the production and activation of eosinophils themselves, which may 
induce them to generate molecules that are necessary for thymus recovery (Rothenberg and 
Hogan, 2006, Matthews et al., 1998). However eosinophils migrate into the thymus from the 
bone marrow and whether their role in thymus regeneration correlates with a radioresistant 
subset in the thymus, or involves eosinophils migrating into the thymus from the periphery is 
unknown. Therefore greater understanding of how eosinophils may regulate thymus recovery 
post damage could be used in turn to implement either eosinophils themselves or the factors 
that they produce as some form of therapy option, regenerating the thymus size.  
 
For all methods so far utilised as a therapy for the regeneration of the thymus size, none yet 
provide long term protection as withdrawal of treatment leads to regression.  It would be ideal 
to provide a mechanism that following administration appears to kick start the thymus to 
regenerate itself. The transfer of eosinophils or eosinophil products may trigger TEC to 
proliferate and obtain a sufficient TEC compartment to support T-cell development again 
without further treatment being required. This may be possible, as so far our studies have 
demonstrated that in the steady state, mice that lack eosinophils are able to still maintain the 
thymus in a manner that is comparable to WT mice. Further it suggests their role in thymus 
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may simply be in the restarting of the regeneration process to trigger the thymus to maintain 
itself. Therefore following greater research into eosinophil mechanisms in the regeneration 
process of the thymus, it would be interesting to determine if this would be transferable to 
human models in trials for thymus damage and recovery. Furthermore, the possible 
implication of eosinophils in age-related involution is unknown but again would provide an 
interesting route to pursue in future work in the hope of uncovering mechanisms to support 
therapeutics in the future.  
 
6.4 Concluding remarks 
Through this thesis we have been able to dissect the regulation of the mTEC compartment 
from that of thymic DC, conflicting with previous assumptions and concluding that regulation 
of the medulla is distinct from that of thymic DC. Ltbr-/- mice suffer from autoimmunity with 
the cause of this being independent of medullary disorganisation and instead correlating to 
alterations in DC populations. This maps specifically to mesenchymal LTβR signalling for 
recruitment of pre-cDC for cDC1 generation. LTβR signalling in endothelial cells influences 
pDC migration to the thymus potentially through control of adhesion molecules. In addition 
pre-cDC require cell-intrinsic CCR7 signalling for cDC1 persistence in the thymus, in turn 
mapping directly to CCL21. This puts forward the possibility for this CCR7 mediated cDC1 
regulation to converge with the alternative LTβR mechanism as LTβR signals on TEC infact 
control production of CCL21. This leads us to suggest that CCL21 produced by TEC is 
presented by mesenchyme through an LTβR mediated process to regulate pre-cDC migration 
into the thymus for cDC1 development. Knowledge of the maintenance of this population and 
its importance in regulating central tolerance may support future work focusing on sustaining 
thymus function and regulating autoimmune development.  
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In addition alternative preliminary work suggests that thymic eosinophils may potentially 
influence thymic recovery due to the absence of eosinophils in mouse models leading to an 
impaired ability for the thymus to recover. Mechanisms involved in this process have been 
more difficult to uncover but may relate to the ability of eosinophils to potentially influence 
TEC through the IL-4Rα axis and also possibly through their production of factors that may 
alter thymic vasculature to promote thymocyte precursor recruitment. This is the main aspect 
from this thesis that will be followed up in future work due to the prospect of it revealing 
important mechanisms therapeutically.  
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